data_2b38_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2b38 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.35 47.06 0.68 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.655 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -89.94 160.34 16.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.9 p -109.2 145.32 36.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.282 0.563 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.42 55.46 3.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 109.615 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.05 -34.4 76.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.477 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.409 ' HA ' HD21 ' A' ' 7' ' ' LEU . 97.2 mt -78.76 -14.37 59.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.029 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.33 -35.7 2.64 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.473 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.3 m -152.39 154.63 35.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.537 0.208 . . . . 0.0 110.444 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 9' ' ' THR . 27.0 m -68.22 135.7 52.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.33 -20.03 25.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 109.662 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.487 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -74.03 140.66 45.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.579 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 p -73.38 136.58 44.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.157 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.71 -2.08 80.68 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.429 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 59.8 m -97.89 133.04 42.93 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -115.32 154.97 28.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.474 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 85.9 m -87.86 115.07 25.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.081 0.467 . . . . 0.0 110.926 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.514 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -89.12 156.13 19.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' ARG . 4.9 tmtm? -37.33 -35.65 0.12 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.989 1.43 . . . . 0.0 114.253 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -78.06 12.24 1.91 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 18' ' ' ASN . 65.4 ttt180 60.47 38.5 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.915 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 96.1 t -126.84 137.27 58.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.296 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.3 m -68.04 134.37 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.88 0.848 . . . . 0.0 112.984 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -133.23 127.07 32.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.989 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -90.76 -60.34 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -101.3 -41.38 6.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.245 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.18 -26.02 0.55 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.49 135.59 39.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.731 -0.735 . . . . 0.0 110.98 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.48 -34.24 61.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.78 0.8 . . . . 0.0 109.238 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -77.61 61.4 2.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.111 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.117 -179.168 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.13 28.38 53.95 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.512 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.486 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 44.8 tt0 -105.94 159.12 16.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.8 p -126.5 149.11 49.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.528 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 1.8 m -88.19 55.55 3.48 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.125 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.8 tp -57.27 -42.67 82.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.077 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.8 -17.87 61.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.426 0.631 . . . . 0.0 110.112 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.51 -30.3 3.46 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -149.78 151.48 33.64 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.486 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 6.7 m -65.61 147.53 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -88.21 -32.62 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.13 140.95 40.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.632 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -81.95 131.39 35.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.608 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.38 -17.05 44.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.828 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.3 m -88.74 132.76 34.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.104 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.3 p -109.23 151.86 25.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.663 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -87.42 111.99 21.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.665 0.745 . . . . 0.0 111.713 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.1 t30 -82.78 150.46 26.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.974 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.27 -39.84 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.835 1.334 . . . . 0.0 113.063 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' O ' HG21 ' A' ' 22' ' ' VAL . 8.2 t80 -78.48 21.0 0.39 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.49 0.662 . . . . 0.0 110.673 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.528 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 16.6 tpp180 56.52 38.97 30.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 97.0 t -116.66 133.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.588 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 59.8 m -79.06 124.02 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.368 0.604 . . . . 0.0 111.078 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 p -125.37 143.14 51.11 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 9.4 ptmm? -69.12 -17.78 63.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.897 0.38 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.563 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 18.1 p-10 -174.49 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.779 0.8 . . . . 0.0 109.171 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.28 -37.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.486 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 17.1 m -83.16 136.55 34.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.243 -0.479 . . . . 0.0 109.953 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -69.95 -25.9 28.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.352 0.596 . . . . 0.0 111.103 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 28' ' ' SER . 2.6 pp -58.7 150.94 22.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.397 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.536 -178.877 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.022 0.439 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.56 68.26 1.23 Allowed Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.228 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.98 160.1 40.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.7 p -120.98 153.53 37.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.055 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.4 54.41 3.14 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.471 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 tp -55.84 -40.09 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.348 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 7' ' ' LEU . 3.2 mm? -79.15 -12.8 59.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.82 -35.32 2.57 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.575 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.445 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.65 150.0 29.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 m -63.42 138.17 58.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.671 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.32 -30.28 38.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 140.37 44.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.955 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -79.96 135.7 36.46 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.108 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.12 -14.37 59.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.397 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 67.6 m -89.41 141.37 28.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.891 0.377 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.0 p -116.16 150.59 37.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 68.5 m -88.91 114.73 25.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.579 0.704 . . . . 0.0 111.372 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.59 148.89 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.12 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.66 -39.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.705 1.253 . . . . 0.0 113.486 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.6 t80 -79.0 21.04 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.397 0.618 . . . . 0.0 110.6 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.2 ttm180 56.29 40.28 29.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.124 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.8 t -118.48 136.27 56.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.47 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.7 m -76.54 130.0 37.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.392 0.615 . . . . 0.0 111.591 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.8 p -126.06 141.19 52.06 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.566 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.603 ' HD3' ' HB3' ' A' ' 31' ' ' ASN . 20.6 pttp -78.76 -130.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.052 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.68 -48.53 58.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.994 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.6 40.84 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.453 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 22.1 m -156.86 144.26 18.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.573 0.225 . . . . 0.0 110.522 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 22' ' ' VAL . 39.7 t -70.89 -29.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.767 0.794 . . . . 0.0 110.012 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.649 ' H ' HD13 ' A' ' 30' ' ' LEU . 6.8 mp -56.74 155.37 7.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.45 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.603 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 0.0 110.533 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.36 -35.37 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.674 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.531 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 33.5 tt0 -56.75 150.86 15.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.658 0.742 . . . . 0.0 111.928 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.43 HG23 ' HA ' ' A' ' 22' ' ' VAL . 17.4 p -123.59 154.33 39.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.191 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.96 50.19 1.94 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.229 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.73 -36.42 83.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.904 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.428 ' HA ' HD13 ' A' ' 7' ' ' LEU . 15.1 tp -84.66 8.14 17.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.639 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.76 -33.65 6.17 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.29 -0.957 . . . . 0.0 110.94 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -149.79 -159.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.531 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 61.5 m -137.08 146.65 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.0 -26.54 33.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.46 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.4 m -69.72 140.77 53.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.667 0.746 . . . . 0.0 111.162 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -85.56 136.44 33.4 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.714 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 -5.19 81.33 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.681 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.791 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.3 m -89.4 136.37 33.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.45 151.09 28.97 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -86.24 112.06 21.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.693 0.759 . . . . 0.0 111.103 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' OD1' ' HG2' ' A' ' 19' ' ' LYS . 2.3 t30 -86.95 149.33 24.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.744 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG2' ' OD1' ' A' ' 18' ' ' ASN . 9.3 ptpp? -35.65 -42.66 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 125.048 1.467 . . . . 0.0 113.794 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.414 ' O ' HG21 ' A' ' 22' ' ' VAL . 2.6 t80 -78.64 20.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.253 0.549 . . . . 0.0 111.045 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 19' ' ' LYS . 2.3 tpp180 56.97 39.38 29.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.28 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 62.8 t -117.58 132.19 68.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.791 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.5 m -84.79 123.57 30.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.171 0.986 . . . . 0.0 111.638 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 p -120.87 128.27 52.66 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.894 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -86.11 -75.17 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -88.9 50.45 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 0.0 110.099 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.87 -43.89 2.0 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.015 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -85.61 155.64 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.692 0.282 . . . . 0.0 110.472 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.2 t -63.31 -26.34 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.672 0.748 . . . . 0.0 110.465 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.62 152.08 19.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.078 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.091 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.862 0.363 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.98 38.99 1.71 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.707 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 13.6 tt0 -76.6 177.91 7.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.635 -0.782 . . . . 0.0 110.062 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 p -134.46 146.61 49.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m -86.72 57.16 4.34 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.939 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.6 pt? -59.25 -36.94 76.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.487 ' HG ' ' HG ' ' A' ' 6' ' ' LEU . 91.5 mt -91.57 19.75 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.632 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.74 -43.83 1.91 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.465 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 33.5 m -154.19 142.35 20.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.753 -0.223 . . . . 0.0 110.489 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.44 138.39 40.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 110.663 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -86.85 -10.61 53.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -72.21 141.95 49.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.685 0.755 . . . . 0.0 111.395 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -77.7 136.41 38.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.69 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.6 -6.7 77.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.665 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 68.5 m -104.41 130.49 52.29 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.83 0.348 . . . . 0.0 110.291 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.677 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.9 p -116.35 152.79 33.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 21.8 m -87.23 116.95 25.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.84 0.829 . . . . 0.0 111.848 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.4 t30 -90.03 149.86 22.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.363 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.1 -40.14 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.78 1.3 . . . . 0.0 113.708 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.52 22.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.546 . . . . 0.0 110.766 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.2 ttm180 56.03 40.55 30.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.047 0.939 . . . . 0.0 109.93 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.2 t -117.14 130.24 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.707 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 72.5 m -85.35 114.76 22.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.556 0.693 . . . . 0.0 110.628 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -128.64 156.59 43.17 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.042 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 3.8 ptmm? -81.3 0.88 35.01 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.498 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 179.92 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.637 0.732 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.05 -33.7 0.25 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -71.71 140.84 49.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.173 -1.013 . . . . 0.0 110.079 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.4 t -70.72 -16.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.439 0.638 . . . . 0.0 111.168 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.73 146.46 54.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.7 t30 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 123.629 0.772 . . . . 0.0 111.465 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 3' ' ' GLU . 33.5 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.657 0.265 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.69 41.65 1.46 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.413 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.654 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 14.0 tp10 -89.73 155.62 19.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 110.226 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.3 p -123.8 151.22 43.58 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.911 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 1.5 m -88.32 55.22 3.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.07 0.462 . . . . 0.0 109.807 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.88 -41.74 74.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.814 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.407 ' N ' HD13 ' A' ' 7' ' ' LEU . 6.2 mp -94.31 23.97 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.244 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -39.59 2.7 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.646 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 28.6 m -150.57 143.14 24.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.893 0.378 . . . . 0.0 110.06 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.654 ' HB3' ' CG ' ' A' ' 3' ' ' GLU . 3.6 m -68.56 148.49 50.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.08 -20.54 52.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.747 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 139.1 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.0 111.158 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -89.3 141.11 28.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.523 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.04 -16.81 58.69 Favored Glycine 0 CA--C 1.508 -0.356 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.659 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.862 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 56.7 m -89.09 142.59 27.51 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.108 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.778 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.7 p -112.37 149.67 32.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.4 m -85.62 117.66 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 110.96 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.481 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -96.16 152.43 18.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.26 -31.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.093 1.496 . . . . 0.0 114.802 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.549 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 8.8 t80 -79.96 14.86 1.64 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.526 0.679 . . . . 0.0 110.009 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 19' ' ' LYS . 29.2 ttm180 57.44 39.23 28.24 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.641 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.481 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 95.5 t -128.08 138.2 55.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.48 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.862 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.7 m -82.22 132.47 35.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -117.64 125.79 51.36 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.249 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -77.06 -27.53 54.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.351 0.596 . . . . 0.0 109.85 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -168.42 -141.32 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.76 -29.77 74.04 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.889 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -85.92 125.16 33.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.305 -0.447 . . . . 0.0 110.887 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.17 -18.13 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.894 0.854 . . . . 0.0 109.5 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.82 168.38 6.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.387 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.772 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.541 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 71.3 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.65 37.22 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.541 ' OE2' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -166.89 -171.53 1.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.387 0.613 . . . . 0.0 110.307 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -145.63 154.89 42.62 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.298 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.5 m -87.78 55.1 3.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.637 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.6 pt? -60.23 -40.81 91.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.753 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 7' ' ' LEU . 18.9 tp -78.12 -16.64 57.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.051 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.49 -35.17 2.31 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 23.9 m -151.89 144.4 24.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.688 0.28 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -75.74 148.54 38.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.59 -18.08 46.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.0 110.427 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.36 142.07 57.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.284 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -91.54 142.07 28.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.469 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.8 -18.44 47.14 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.964 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.7 m -89.11 139.55 30.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.848 0.356 . . . . 0.0 110.599 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.733 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.4 p -113.73 149.46 34.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.902 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -86.11 116.55 24.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -92.01 153.43 19.44 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -37.09 -31.96 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.143 1.527 . . . . 0.0 114.75 -177.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.614 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.8 t80 -82.08 20.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.273 0.559 . . . . 0.0 109.927 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.7 ptm180 49.86 42.17 23.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.14 1.376 . . . . 0.0 110.341 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.48 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 87.7 t -126.76 136.25 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.332 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.964 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.8 m -79.84 132.72 36.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.182 0.992 . . . . 0.0 113.511 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -118.68 123.38 44.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.012 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 23.9 ttpp -88.84 -45.03 10.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.431 0.634 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -167.35 -144.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.887 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.68 33.97 2.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.044 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -72.03 130.06 40.04 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.5 t -56.6 -35.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.928 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.659 ' H ' HD21 ' A' ' 30' ' ' LEU . 2.3 pt? -108.37 26.69 10.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.283 179.815 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.02 44.33 1.82 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.661 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.532 ' OE2' ' HB3' ' A' ' 10' ' ' CYS . 8.0 pt-20 -83.72 176.91 8.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.707 HG21 HG22 ' A' ' 22' ' ' VAL . 23.5 p -106.92 149.01 27.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.636 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 21' ' ' ARG . 1.7 m -87.65 56.86 4.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -59.15 -34.62 72.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.489 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.99 17.08 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.29 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.46 4.85 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -147.99 145.93 28.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.532 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 19.9 m -66.86 153.49 43.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.861 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -74.82 -25.93 59.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.166 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -80.06 142.72 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.357 0.598 . . . . 0.0 110.517 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -93.8 143.62 26.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.882 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.7 74.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 25.5 m -89.51 147.34 24.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.793 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.5 p -110.59 147.81 33.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.347 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -86.51 112.09 21.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.496 0.665 . . . . 0.0 110.694 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -82.52 152.77 25.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.439 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.51 -38.7 0.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.868 1.355 . . . . 0.0 113.158 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.428 ' O ' HG21 ' A' ' 22' ' ' VAL . 8.5 t80 -77.15 17.61 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.567 0.698 . . . . 0.0 110.474 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' LYS . 17.1 tpp180 56.79 41.7 27.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.981 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 4' ' ' THR . 89.9 t -128.4 136.34 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.906 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 16' ' ' THR . 1.5 m -77.01 136.12 38.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -122.35 136.66 54.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.57 -1.65 . . . . 0.0 109.102 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.669 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -86.38 -136.99 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.669 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 1.3 m-20 -73.03 -30.52 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.402 0.62 . . . . 0.0 109.932 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -52.78 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.979 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 134.51 45.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 t -87.09 -16.52 9.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.49 0.662 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.75 67.89 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.942 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 179.662 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 63.5 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.57 -48.21 2.2 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.263 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -60.75 157.5 14.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.7 p -106.65 163.61 12.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.584 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 m -85.46 59.51 5.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.0 tp -56.87 -38.49 72.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.485 HD11 ' N ' ' A' ' 7' ' ' LEU . 6.8 mp -88.39 15.71 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.44 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.93 -42.26 2.06 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.617 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.658 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 44.9 m -155.26 141.92 18.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.096 . . . . 0.0 110.774 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.6 134.03 36.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -86.34 1.59 50.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.118 0.485 . . . . 0.0 110.308 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 140.4 49.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.455 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.8 p -73.29 129.9 39.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.38 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.33 -15.73 61.51 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.521 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.6 m -89.56 135.3 33.68 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.069 0.461 . . . . 0.0 110.747 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.8 p -126.21 159.45 32.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 62.0 m -88.96 119.82 29.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.876 0.846 . . . . 0.0 112.333 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -89.59 147.18 24.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.082 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -41.35 -32.96 0.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.629 1.206 . . . . 0.0 113.779 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.85 25.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.47 0.652 . . . . 0.0 110.16 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 55.48 41.03 31.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.829 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.73 131.98 66.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.646 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.6 m -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.35 0.595 . . . . 0.0 109.603 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 p -128.33 144.33 51.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.817 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 4.8 ttpt -70.6 -30.63 67.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.428 0.632 . . . . 0.0 110.419 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -153.31 -44.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.68 -35.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -78.68 137.26 37.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.98 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 29' ' ' VAL . 16.9 t -79.1 -9.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.85 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.33 61.53 2.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.287 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.013 179.495 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 t . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.626 0.251 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.33 116.57 0.85 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -174.98 168.26 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 p -100.69 146.94 26.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.058 0.456 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 5.4 m -87.23 60.3 6.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.85 -37.86 74.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.502 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.0 mt -86.43 16.46 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.163 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.72 -41.7 2.42 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.766 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 62.2 m -155.93 141.27 17.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.127 . . . . 0.0 111.28 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.6 m -83.42 128.37 34.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.16 32.2 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.62 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -91.56 143.61 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.46 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -72.61 129.19 37.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.303 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.92 10.38 83.08 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.325 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.62 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 63.5 m -114.56 145.93 41.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.92 0.39 . . . . 0.0 110.625 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 p -138.21 151.9 48.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 26.3 m -88.86 123.92 33.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.786 0.803 . . . . 0.0 112.099 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -88.68 151.06 22.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.552 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -40.5 -38.84 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.514 1.134 . . . . 0.0 113.503 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' O ' HG22 ' A' ' 22' ' ' VAL . 6.2 t80 -81.03 24.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.4 ttm180 56.04 42.04 28.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.926 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 20' ' ' TYR . 55.2 t -116.05 122.14 68.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 14.4 m -74.91 116.32 15.51 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 28' ' ' SER . 66.1 p -133.26 -159.24 0.95 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.687 ' HZ3' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -90.51 -30.33 17.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.467 ' CG ' ' HZ2' ' A' ' 25' ' ' LYS . 13.3 p30 -168.87 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.359 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.528 ' O ' ' HB ' ' A' ' 24' ' ' THR . 19.3 m -80.4 139.39 36.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.04 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 t -67.75 -6.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.46 0.648 . . . . 0.0 111.411 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.55 ' H ' HD12 ' A' ' 30' ' ' LEU . 7.5 mp -65.97 144.69 56.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.503 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.885 0.874 . . . . 0.0 111.943 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 51.2 t . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 48.28 1.81 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.301 -0.475 . . . . 0.0 111.961 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -88.52 174.96 7.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.152 0.581 . . . . 0.0 110.385 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -142.11 145.05 33.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.795 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 2.8 m -94.3 56.69 2.21 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.246 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.45 -42.37 82.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.092 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -74.99 -16.16 60.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.385 0.612 . . . . 0.0 110.178 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.8 -32.08 2.96 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.477 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 17.4 m -143.74 153.92 42.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.35 139.35 37.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -80.29 -27.55 38.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -90.75 148.06 22.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.78 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 p -85.42 148.24 26.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.89 90.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.739 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.1 m -108.06 140.71 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.695 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 41.5 p -109.81 149.5 29.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.44 0.162 . . . . 0.0 110.867 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 99.2 m -88.35 111.71 22.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.979 0.418 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.529 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -87.96 152.3 22.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -39.49 -28.75 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.817 1.323 . . . . 0.0 114.414 -176.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 9.97 4.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.973 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.512 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 17.4 tpp180 60.58 36.42 19.81 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.299 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.529 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 84.5 t -122.61 138.85 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.625 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 61.7 m -75.11 133.71 41.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.846 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -133.92 145.41 49.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.973 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 1' ' ' CYS . 28.7 mmmt -92.76 -89.8 0.19 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 8.6 p-10 -76.25 -38.47 56.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.276 1.036 . . . . 0.0 108.817 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.95 -34.13 0.28 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 m -72.15 134.19 45.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.464 -0.868 . . . . 0.0 110.286 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.42 -25.01 19.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' H ' HD21 ' A' ' 30' ' ' LEU . 3.2 mm? -72.62 62.52 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.349 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 16.9 t-20 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 25' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.562 ' HA3' HD13 ' A' ' 30' ' ' LEU . . . 72.19 45.78 38.21 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.617 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.637 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 4.2 tp10 -152.95 157.89 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 p -141.57 149.99 41.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.832 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.03 52.61 2.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.287 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.432 ' HA ' HD21 ' A' ' 6' ' ' LEU . 96.3 mt -57.71 -45.47 85.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.45 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.916 HD13 ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -74.4 -16.68 60.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.537 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.5 -31.27 3.01 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.474 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.868 ' H ' HD23 ' A' ' 7' ' ' LEU . 25.7 m -151.91 139.74 19.93 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.028 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.0 138.04 49.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.594 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.642 ' HE1' ' HG ' ' A' ' 7' ' ' LEU . 3.9 m-85 -81.01 -32.65 34.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.96 139.92 43.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -82.73 140.18 33.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.51 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 -18.37 56.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.426 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 60.4 m -89.92 138.88 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.549 -0.325 . . . . 0.0 110.312 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.05 150.52 29.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.1 m -87.33 117.01 25.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 0.0 111.177 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.57 ' OD1' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -99.22 150.29 22.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.57 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -38.33 -30.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 O-C-N 125.041 1.463 . . . . 0.0 114.565 -177.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.401 ' O ' HG22 ' A' ' 22' ' ' VAL . 2.5 t80 -78.23 11.14 2.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.421 0.629 . . . . 0.0 109.89 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 19' ' ' LYS . 5.7 tpp85 60.68 33.6 20.22 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.704 1.201 . . . . 0.0 109.701 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.558 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 60.2 t -119.08 140.77 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.1 m -83.5 120.4 25.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.606 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.88 127.62 52.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.118 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.783 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 40.5 tttm -110.52 -152.15 0.49 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.783 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -70.82 -74.13 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.185 0.517 . . . . 0.0 111.692 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.99 40.33 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -66.57 165.58 14.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.249 -0.476 . . . . 0.0 110.512 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -42.42 -50.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.656 HD21 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -112.81 31.39 6.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.052 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.484 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 22.5 t-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.218 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.405 ' HA2' HG11 ' A' ' 29' ' ' VAL . . . 58.6 27.8 61.74 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.797 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 25.1 tt0 -101.27 164.93 11.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.0 p -134.32 148.11 50.7 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -88.27 54.13 2.97 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.153 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.84 -39.47 77.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.054 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.517 HD21 ' N ' ' A' ' 7' ' ' LEU . 3.2 mm? -80.02 -13.47 59.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.529 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.92 -35.61 2.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.7 m -151.62 151.44 31.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.6 m -63.24 144.42 56.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.277 0.56 . . . . 0.0 112.215 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.59 -30.14 18.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.856 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -83.64 146.23 28.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.542 0.687 . . . . 0.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 p -79.29 144.53 34.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.79 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.71 -20.88 44.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.831 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 63.9 m -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.1 p -113.25 157.12 22.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.9 113.95 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.656 0.741 . . . . 0.0 111.635 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.85 149.76 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.993 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -38.89 -38.81 0.46 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.62 1.2 . . . . 0.0 113.699 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.0 t80 -80.24 21.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.376 0.608 . . . . 0.0 110.524 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 19' ' ' LYS . 26.9 ttm180 56.47 39.54 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.005 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 93.9 t -116.67 134.9 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.768 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.831 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.4 m -79.43 122.6 26.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.394 0.616 . . . . 0.0 111.055 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.1 p -133.72 139.58 46.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.162 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -90.84 -96.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.63 -36.74 76.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.619 0.723 . . . . 0.0 110.356 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.08 -42.3 0.23 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 m -78.4 151.2 32.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.229 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG11 ' HA2' ' A' ' 2' ' ' GLY . 23.6 t -65.53 -23.07 32.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.587 0.708 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -56.95 154.37 9.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.969 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.142 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.23 69.05 1.11 Allowed Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.21 161.2 41.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.5 p -116.03 155.64 27.74 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.03 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.67 58.4 5.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.436 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.27 -40.84 68.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.11 19.48 4.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.508 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.41 -37.26 3.56 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.448 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 21.4 m -151.08 148.73 28.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.651 0.262 . . . . 0.0 110.797 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.6 m -66.93 137.09 56.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.337 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.56 -26.48 30.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.0 109.931 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.33 140.04 50.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -79.59 134.12 36.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.165 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -19.13 53.92 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.161 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.75 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.1 m -88.63 135.73 33.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.9 p -114.89 155.5 26.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 65.8 m -89.05 114.73 25.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.67 0.748 . . . . 0.0 111.643 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.5 t30 -83.53 150.35 26.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.034 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.16 -39.72 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 0.0 113.676 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.6 t80 -80.59 22.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 110.777 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 19' ' ' LYS . 46.7 ttp180 56.11 41.82 29.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.61 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 89.5 t -119.53 135.38 60.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.75 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -73.34 130.06 39.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 111.298 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 p -136.77 148.52 47.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.044 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.677 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 9.3 ptmm? -73.71 -140.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.568 ' CG ' ' HZ3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -58.77 -35.47 72.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 110.23 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.51 45.3 0.11 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.703 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.677 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -160.75 151.92 18.99 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.621 -0.341 . . . . 0.0 110.252 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.59 -14.28 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.719 0.771 . . . . 0.0 109.657 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -56.61 143.56 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.257 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.4 p30 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 113.104 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.48 -50.73 0.87 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.257 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -97.97 -166.88 1.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.216 1.007 . . . . 0.0 111.872 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -147.71 156.27 42.59 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.02 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -87.21 55.62 3.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.369 0.604 . . . . 0.0 110.378 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.86 -36.54 84.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.675 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.33 -23.38 59.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.29 -30.42 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.4 m -150.9 152.08 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.89 144.06 53.68 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.563 0.539 . . . . 0.0 111.615 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -82.55 -31.54 29.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.85 143.04 29.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.9 p -85.69 131.84 34.26 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.815 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 -20.69 19.68 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 77.0 m -92.4 143.45 26.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.367 -0.417 . . . . 0.0 109.875 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.5 p -118.45 151.76 37.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.265 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 73.8 m -88.13 111.22 21.34 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.503 ' OD1' ' HB ' ' A' ' 22' ' ' VAL . 4.6 p-10 -83.98 154.24 23.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -34.0 -33.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -176.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' HG21 ' A' ' 22' ' ' VAL . 6.4 t80 -85.36 23.29 1.34 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 0.0 110.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ASN . 13.5 ptm180 49.47 39.67 17.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.133 1.373 . . . . 0.0 110.644 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 23' ' ' CYS . 57.9 t -107.85 154.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.488 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 74.1 m -96.18 129.26 43.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.956 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.77 127.95 45.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.312 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 41.1 tttm -92.67 -146.15 0.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.483 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.576 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 9.3 p-10 -75.97 -48.98 19.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.0 40.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.188 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -74.28 135.53 42.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.57 -36.16 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.324 0.583 . . . . 0.0 111.56 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.725 HD22 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -98.9 31.53 2.94 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.737 0.815 . . . . 0.0 111.664 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.329 0.109 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.27 89.51 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.614 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -160.61 155.88 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 110.233 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 p -119.56 155.84 31.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 m -87.89 56.26 3.81 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.455 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.8 tp -59.66 -41.34 90.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.211 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.14 -22.47 64.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.992 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.49 -26.51 4.1 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -150.51 156.14 40.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.4 m -58.41 139.56 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -83.51 -22.01 32.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.234 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.08 145.04 29.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.067 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 p -78.09 146.34 35.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.678 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.2 -4.72 85.1 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.807 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.789 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 91.2 m -99.51 138.93 35.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -113.14 150.35 32.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.965 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.94 111.94 21.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.073 0.463 . . . . 0.0 110.146 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.5 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -88.57 156.47 19.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.64 -30.15 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 125.232 1.583 . . . . 0.0 114.874 -177.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.544 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 6.3 t80 -82.4 13.17 3.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.704 0.764 . . . . 0.0 109.774 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' ASN . 66.0 ttt180 58.58 38.74 25.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.219 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.5 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 72.3 t -122.8 136.65 58.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.46 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.789 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.0 m -70.68 128.52 36.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.397 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.57 139.69 52.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.43 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HE3' ' SG ' ' A' ' 15' ' ' CYS . 33.3 ttmt -119.54 -43.61 2.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.678 0.275 . . . . 0.0 110.654 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 27' ' ' GLY . 25.9 t70 -159.91 -148.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.555 ' H ' ' CG ' ' A' ' 26' ' ' ASP . . . -79.19 46.7 3.03 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.522 -0.37 . . . . 0.0 112.284 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -73.73 133.46 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.13 -37.0 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 tp -126.4 37.43 4.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.006 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 23' ' ' CYS . 5.9 m120 . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.463 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 25' ' ' LYS . 27.4 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.457 ' HA3' HG13 ' A' ' 29' ' ' VAL . . . -75.28 47.08 1.96 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.494 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.493 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 16.5 pt-20 -83.31 -164.24 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.827 0.822 . . . . 0.0 109.757 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -134.61 149.04 50.54 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.734 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.44 54.65 3.12 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.923 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.5 pt? -60.34 -38.94 85.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.551 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.2 tp -73.69 -19.6 60.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.075 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.69 -29.87 3.5 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -150.75 154.14 36.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.58 142.7 52.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.266 0.626 . . . . 0.0 112.411 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.49 -33.1 48.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.671 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -84.22 145.82 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.75 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.4 p -81.92 144.39 30.99 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.102 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.96 -4.96 85.27 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.947 -0.569 . . . . 0.0 113.142 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 6.6 m -90.96 145.52 24.65 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 48.2 p -116.11 150.39 37.46 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.732 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -87.78 112.54 22.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.73 0.776 . . . . 0.0 111.346 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.488 ' OD1' ' HD2' ' A' ' 19' ' ' LYS . 2.6 t30 -80.73 148.7 30.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -42.38 -32.43 0.52 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -82.09 20.55 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.5 ttm180 56.06 40.05 30.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.06 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 88.4 t -118.38 133.99 63.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.398 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 16' ' ' THR . 84.7 m -78.43 129.19 34.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.612 0.72 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -134.74 141.2 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.305 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' ' SG ' ' A' ' 1' ' ' CYS . 37.7 ttmt -120.27 -50.85 2.22 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.613 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -140.93 40.48 1.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.281 1.039 . . . . 0.0 108.613 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 -44.06 1.36 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.34 134.16 52.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 0.0 112.217 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HA3' ' A' ' 2' ' ' GLY . 42.2 t -76.67 -18.48 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.442 ' HA ' HD21 ' A' ' 30' ' ' LEU . 93.4 mt -75.75 61.4 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.616 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.581 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.918 ' HB2' ' HG3' ' A' ' 25' ' ' LYS . 56.6 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.887 0.375 . . . . 0.0 111.781 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.68 45.28 0.43 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -135.22 -168.92 2.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.74 0.781 . . . . 0.0 111.727 -177.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -137.91 155.04 49.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.327 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 2.2 m -89.28 52.4 2.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.355 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 6' ' ' LEU . 95.2 mt -55.35 -42.26 73.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.945 ' H ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -76.74 -17.07 59.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.68 2.86 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.709 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.844 ' H ' HD21 ' A' ' 7' ' ' LEU . 27.9 m -153.08 139.41 18.52 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -58.33 136.26 57.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.397 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -77.75 -34.35 52.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.22 0.533 . . . . 0.0 109.709 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.834 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.06 145.0 51.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.509 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.4 p -82.77 140.27 33.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.895 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.23 0.56 70.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.66 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.834 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 8.9 m -98.91 138.71 35.64 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.637 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 7.2 p -117.79 146.81 43.56 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.7 m -89.91 118.56 29.57 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.567 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.64 149.1 22.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.7 ptpt -35.49 -38.46 0.11 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.075 1.484 . . . . 0.0 114.433 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -76.23 16.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.441 0.638 . . . . 0.0 110.58 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 19' ' ' LYS . 23.9 ttm180 57.27 35.77 26.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.392 1.077 . . . . 0.0 110.035 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.567 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 91.9 t -118.75 135.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 16' ' ' THR . 60.1 m -76.68 125.13 28.72 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.825 0.821 . . . . 0.0 112.097 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.2 133.93 45.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.918 ' HG3' ' HB2' ' A' ' 1' ' ' CYS . 1.6 mptp? -79.24 125.44 29.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.661 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -108.41 145.87 33.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.442 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.21 -47.8 3.24 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.536 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -152.83 135.81 15.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.887 0.375 . . . . 0.0 109.991 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.29 -32.03 45.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.351 0.595 . . . . 0.0 111.134 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.29 80.3 9.25 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.999 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 0.0 110.72 179.856 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 25' ' ' LYS . 8.9 t . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 69.22 1.44 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -145.41 162.63 36.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.732 0.301 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -108.98 155.95 20.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.423 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 m -85.95 60.17 6.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.89 -38.86 79.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.779 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.409 ' HA ' HD21 ' A' ' 7' ' ' LEU . 92.7 mt -85.53 12.97 7.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.626 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.58 -42.19 2.0 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.711 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 41.3 m -154.5 142.93 20.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 m -75.77 135.59 40.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -81.7 -4.07 55.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.322 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.669 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.46 140.57 51.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.709 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 p -74.09 132.81 42.65 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.805 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 87.34 -5.96 84.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.895 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.669 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 73.4 m -90.11 142.35 27.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.819 0.343 . . . . 0.0 110.677 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.2 p -128.74 152.36 48.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.711 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 59.2 m -89.37 119.16 29.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.686 0.755 . . . . 0.0 111.656 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.8 t30 -88.68 146.85 24.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.278 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.29 -28.21 0.31 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.623 1.202 . . . . 0.0 113.88 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -86.29 20.91 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.545 0.688 . . . . 0.0 109.578 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' ASN . 59.8 ttt180 57.27 40.55 27.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.723 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.06 133.74 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.371 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 16' ' ' THR . 55.7 m -80.15 124.5 28.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.216 0.532 . . . . 0.0 110.067 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.0 p -125.83 126.11 43.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HZ2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -83.77 -15.49 48.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 109.767 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.576 ' HB2' ' HZ2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -156.3 -154.23 0.47 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 -177.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.17 75.93 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -104.52 150.68 24.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.369 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 29' ' ' VAL . 9.3 t -71.88 -2.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 111.002 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -52.77 147.34 8.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.632 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.4 m . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.16 61.49 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.764 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 34.2 tt0 -114.3 166.01 12.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.278 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.401 ' N ' ' HG2' ' A' ' 3' ' ' GLU . 18.7 p -133.03 146.88 52.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.328 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.62 55.64 2.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.704 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.0 pt? -60.76 -34.48 74.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.47 -19.48 57.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.151 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.31 -31.03 3.37 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.52 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.28 152.29 33.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' N ' HG21 ' A' ' 9' ' ' THR . 33.9 m -58.54 144.91 41.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 0.0 111.951 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.29 -32.38 24.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.927 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 m -91.31 146.67 23.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -85.24 139.56 31.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -25.9 17.34 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.516 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 62.9 m -90.74 142.75 27.43 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.862 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.9 p -115.06 150.66 35.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.343 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 97.1 m -87.46 114.14 23.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.023 0.439 . . . . 0.0 111.166 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.61 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -90.9 151.72 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -36.52 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.997 1.436 . . . . 0.0 114.844 -177.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.55 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 8.4 t80 -82.78 21.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.16 0.505 . . . . 0.0 110.024 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.5 ptp85 51.31 39.98 25.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.125 1.37 . . . . 0.0 110.165 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.61 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 87.5 t -121.48 133.77 66.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.8 m -74.37 124.67 26.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -127.64 145.01 51.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.498 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -75.4 -36.93 60.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.254 0.549 . . . . 0.0 109.927 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 28' ' ' SER . 56.9 t0 -169.01 -122.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.79 27.57 3.8 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.392 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 26' ' ' ASP . 66.0 m -160.89 131.57 5.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.859 0.463 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' O ' HG11 ' A' ' 29' ' ' VAL . 24.6 t -71.5 -11.69 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.296 0.569 . . . . 0.0 110.803 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 30' ' ' LEU . 8.2 mp -52.68 155.07 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.683 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.57 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.35 47.06 0.68 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.655 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -89.94 160.34 16.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.9 p -109.2 145.32 36.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.282 0.563 . . . . 0.0 111.132 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.42 55.46 3.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 109.615 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.05 -34.4 76.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.477 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.409 ' HA ' HD21 ' A' ' 7' ' ' LEU . 97.2 mt -78.76 -14.37 59.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.029 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.33 -35.7 2.64 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.473 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.3 m -152.39 154.63 35.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.537 0.208 . . . . 0.0 110.444 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 9' ' ' THR . 27.0 m -68.22 135.7 52.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.33 -20.03 25.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 109.662 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.487 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -74.03 140.66 45.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.579 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 p -73.38 136.58 44.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.157 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.71 -2.08 80.68 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.429 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.646 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 59.8 m -97.89 133.04 42.93 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -115.32 154.97 28.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.474 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 85.9 m -87.86 115.07 25.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.081 0.467 . . . . 0.0 110.926 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.514 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -89.12 156.13 19.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' ARG . 4.9 tmtm? -37.33 -35.65 0.12 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.989 1.43 . . . . 0.0 114.253 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -78.06 12.24 1.91 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 18' ' ' ASN . 65.4 ttt180 60.47 38.5 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.915 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.514 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 96.1 t -126.84 137.27 58.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.296 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.3 m -68.04 134.37 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.88 0.848 . . . . 0.0 112.984 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -133.23 127.07 32.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.989 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -90.76 -60.34 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -101.3 -41.38 6.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.245 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.18 -26.02 0.55 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.49 135.59 39.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.731 -0.735 . . . . 0.0 110.98 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.48 -34.24 61.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.78 0.8 . . . . 0.0 109.238 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -77.61 61.4 2.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.111 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.117 -179.168 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.13 28.38 53.95 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.512 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 44.8 tt0 -105.94 159.12 16.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.8 p -126.5 149.11 49.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.528 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 1.8 m -88.19 55.55 3.48 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.125 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.8 tp -57.27 -42.67 82.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.077 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.8 -17.87 61.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.426 0.631 . . . . 0.0 110.112 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.51 -30.3 3.46 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -149.78 151.48 33.64 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.486 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 6.7 m -65.61 147.53 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -88.21 -32.62 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.13 140.95 40.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.632 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -81.95 131.39 35.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.608 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.38 -17.05 44.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.828 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.3 m -88.74 132.76 34.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.104 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.3 p -109.23 151.86 25.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.663 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -87.42 111.99 21.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.665 0.745 . . . . 0.0 111.713 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.1 t30 -82.78 150.46 26.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.974 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.27 -39.84 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.835 1.334 . . . . 0.0 113.063 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' O ' HG21 ' A' ' 22' ' ' VAL . 8.2 t80 -78.48 21.0 0.39 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.49 0.662 . . . . 0.0 110.673 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.528 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 16.6 tpp180 56.52 38.97 30.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 97.0 t -116.66 133.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.588 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 59.8 m -79.06 124.02 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.368 0.604 . . . . 0.0 111.078 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 p -125.37 143.14 51.11 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 9.4 ptmm? -69.12 -17.78 63.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.897 0.38 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.563 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 18.1 p-10 -174.49 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.779 0.8 . . . . 0.0 109.171 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.28 -37.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.486 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 17.1 m -83.16 136.55 34.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.243 -0.479 . . . . 0.0 109.953 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -69.95 -25.9 28.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.352 0.596 . . . . 0.0 111.103 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' A' ' 28' ' ' SER . 2.6 pp -58.7 150.94 22.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.397 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.536 -178.877 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.022 0.439 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.56 68.26 1.23 Allowed Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.228 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.98 160.1 40.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.7 p -120.98 153.53 37.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.055 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.4 54.41 3.14 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.471 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 tp -55.84 -40.09 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.348 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 7' ' ' LEU . 3.2 mm? -79.15 -12.8 59.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.82 -35.32 2.57 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.575 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.445 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.65 150.0 29.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 m -63.42 138.17 58.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.671 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.32 -30.28 38.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 140.37 44.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.955 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -79.96 135.7 36.46 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.108 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.12 -14.37 59.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.397 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 67.6 m -89.41 141.37 28.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.891 0.377 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.0 p -116.16 150.59 37.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 68.5 m -88.91 114.73 25.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.579 0.704 . . . . 0.0 111.372 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.59 148.89 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.12 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.66 -39.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.705 1.253 . . . . 0.0 113.486 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.6 t80 -79.0 21.04 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.397 0.618 . . . . 0.0 110.6 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.2 ttm180 56.29 40.28 29.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.124 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.8 t -118.48 136.27 56.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.47 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.7 m -76.54 130.0 37.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.392 0.615 . . . . 0.0 111.591 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.8 p -126.06 141.19 52.06 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.566 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.603 ' HD3' ' HB3' ' A' ' 31' ' ' ASN . 20.6 pttp -78.76 -130.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.052 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.68 -48.53 58.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.994 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.6 40.84 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.453 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 22.1 m -156.86 144.26 18.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.573 0.225 . . . . 0.0 110.522 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 22' ' ' VAL . 39.7 t -70.89 -29.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.767 0.794 . . . . 0.0 110.012 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.649 ' H ' HD13 ' A' ' 30' ' ' LEU . 6.8 mp -56.74 155.37 7.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.45 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.603 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 0.0 110.533 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.36 -35.37 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.674 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.531 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 33.5 tt0 -56.75 150.86 15.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.658 0.742 . . . . 0.0 111.928 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.43 HG23 ' HA ' ' A' ' 22' ' ' VAL . 17.4 p -123.59 154.33 39.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.191 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.96 50.19 1.94 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.229 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.73 -36.42 83.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.904 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.428 ' HA ' HD13 ' A' ' 7' ' ' LEU . 15.1 tp -84.66 8.14 17.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.639 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.76 -33.65 6.17 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.29 -0.957 . . . . 0.0 110.94 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -149.79 -159.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.531 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 61.5 m -137.08 146.65 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.0 -26.54 33.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.46 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.4 m -69.72 140.77 53.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.667 0.746 . . . . 0.0 111.162 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -85.56 136.44 33.4 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.714 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 -5.19 81.33 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.681 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.791 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.3 m -89.4 136.37 33.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.45 151.09 28.97 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -86.24 112.06 21.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.693 0.759 . . . . 0.0 111.103 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' OD1' ' HG2' ' A' ' 19' ' ' LYS . 2.3 t30 -86.95 149.33 24.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.744 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG2' ' OD1' ' A' ' 18' ' ' ASN . 9.3 ptpp? -35.65 -42.66 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 125.048 1.467 . . . . 0.0 113.794 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.414 ' O ' HG21 ' A' ' 22' ' ' VAL . 2.6 t80 -78.64 20.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.253 0.549 . . . . 0.0 111.045 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 19' ' ' LYS . 2.3 tpp180 56.97 39.38 29.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.28 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 62.8 t -117.58 132.19 68.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.791 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.5 m -84.79 123.57 30.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.171 0.986 . . . . 0.0 111.638 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.2 p -120.87 128.27 52.66 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.894 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -86.11 -75.17 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -88.9 50.45 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 0.0 110.099 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.87 -43.89 2.0 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.015 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -85.61 155.64 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.692 0.282 . . . . 0.0 110.472 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.2 t -63.31 -26.34 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.672 0.748 . . . . 0.0 110.465 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.62 152.08 19.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.078 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.091 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.862 0.363 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.98 38.99 1.71 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.707 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 13.6 tt0 -76.6 177.91 7.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.635 -0.782 . . . . 0.0 110.062 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 p -134.46 146.61 49.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m -86.72 57.16 4.34 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.939 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.6 pt? -59.25 -36.94 76.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.487 ' HG ' ' HG ' ' A' ' 6' ' ' LEU . 91.5 mt -91.57 19.75 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.632 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.74 -43.83 1.91 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.465 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 33.5 m -154.19 142.35 20.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.753 -0.223 . . . . 0.0 110.489 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.44 138.39 40.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 110.663 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -86.85 -10.61 53.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -72.21 141.95 49.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.685 0.755 . . . . 0.0 111.395 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -77.7 136.41 38.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.69 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.6 -6.7 77.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.665 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 68.5 m -104.41 130.49 52.29 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.83 0.348 . . . . 0.0 110.291 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.677 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.9 p -116.35 152.79 33.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 21.8 m -87.23 116.95 25.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.84 0.829 . . . . 0.0 111.848 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.4 t30 -90.03 149.86 22.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.363 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.1 -40.14 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.78 1.3 . . . . 0.0 113.708 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.52 22.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.546 . . . . 0.0 110.766 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.2 ttm180 56.03 40.55 30.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.047 0.939 . . . . 0.0 109.93 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.2 t -117.14 130.24 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.707 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 72.5 m -85.35 114.76 22.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.556 0.693 . . . . 0.0 110.628 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -128.64 156.59 43.17 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.042 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 3.8 ptmm? -81.3 0.88 35.01 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.498 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 179.92 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.637 0.732 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.05 -33.7 0.25 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -71.71 140.84 49.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.173 -1.013 . . . . 0.0 110.079 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.4 t -70.72 -16.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.439 0.638 . . . . 0.0 111.168 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.73 146.46 54.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.7 t30 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 123.629 0.772 . . . . 0.0 111.465 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 3' ' ' GLU . 33.5 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.657 0.265 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.69 41.65 1.46 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.413 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.654 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 14.0 tp10 -89.73 155.62 19.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 110.226 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.3 p -123.8 151.22 43.58 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.911 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 1.5 m -88.32 55.22 3.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.07 0.462 . . . . 0.0 109.807 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.88 -41.74 74.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.814 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.407 ' N ' HD13 ' A' ' 7' ' ' LEU . 6.2 mp -94.31 23.97 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.244 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -39.59 2.7 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.646 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 28.6 m -150.57 143.14 24.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.893 0.378 . . . . 0.0 110.06 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.654 ' HB3' ' CG ' ' A' ' 3' ' ' GLU . 3.6 m -68.56 148.49 50.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.08 -20.54 52.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.747 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 139.1 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.0 111.158 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -89.3 141.11 28.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.523 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.04 -16.81 58.69 Favored Glycine 0 CA--C 1.508 -0.356 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.659 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.862 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 56.7 m -89.09 142.59 27.51 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.108 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.778 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.7 p -112.37 149.67 32.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.4 m -85.62 117.66 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 110.96 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.481 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -96.16 152.43 18.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.26 -31.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.093 1.496 . . . . 0.0 114.802 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.549 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 8.8 t80 -79.96 14.86 1.64 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.526 0.679 . . . . 0.0 110.009 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 19' ' ' LYS . 29.2 ttm180 57.44 39.23 28.24 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.641 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.481 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 95.5 t -128.08 138.2 55.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.48 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.862 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.7 m -82.22 132.47 35.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -117.64 125.79 51.36 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.249 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -77.06 -27.53 54.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.351 0.596 . . . . 0.0 109.85 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -168.42 -141.32 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.76 -29.77 74.04 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.889 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -85.92 125.16 33.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.305 -0.447 . . . . 0.0 110.887 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.17 -18.13 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.894 0.854 . . . . 0.0 109.5 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.82 168.38 6.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.387 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.772 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.541 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 71.3 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.65 37.22 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.541 ' OE2' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -166.89 -171.53 1.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.387 0.613 . . . . 0.0 110.307 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -145.63 154.89 42.62 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.298 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.5 m -87.78 55.1 3.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.637 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.6 pt? -60.23 -40.81 91.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.753 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 7' ' ' LEU . 18.9 tp -78.12 -16.64 57.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.051 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.49 -35.17 2.31 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 23.9 m -151.89 144.4 24.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.688 0.28 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -75.74 148.54 38.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.59 -18.08 46.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.0 110.427 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.36 142.07 57.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.284 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -91.54 142.07 28.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.469 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.8 -18.44 47.14 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.964 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.7 m -89.11 139.55 30.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.848 0.356 . . . . 0.0 110.599 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.733 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.4 p -113.73 149.46 34.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.902 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -86.11 116.55 24.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -92.01 153.43 19.44 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -37.09 -31.96 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.143 1.527 . . . . 0.0 114.75 -177.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.614 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.8 t80 -82.08 20.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.273 0.559 . . . . 0.0 109.927 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.614 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.7 ptm180 49.86 42.17 23.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.14 1.376 . . . . 0.0 110.341 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.48 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 87.7 t -126.76 136.25 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.332 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.964 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.8 m -79.84 132.72 36.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.182 0.992 . . . . 0.0 113.511 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -118.68 123.38 44.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.012 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 23.9 ttpp -88.84 -45.03 10.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.431 0.634 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -167.35 -144.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.887 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.68 33.97 2.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.044 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -72.03 130.06 40.04 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.5 t -56.6 -35.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.928 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.659 ' H ' HD21 ' A' ' 30' ' ' LEU . 2.3 pt? -108.37 26.69 10.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.283 179.815 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.02 44.33 1.82 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.661 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.532 ' OE2' ' HB3' ' A' ' 10' ' ' CYS . 8.0 pt-20 -83.72 176.91 8.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.707 HG21 HG22 ' A' ' 22' ' ' VAL . 23.5 p -106.92 149.01 27.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.636 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 21' ' ' ARG . 1.7 m -87.65 56.86 4.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.657 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -59.15 -34.62 72.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.489 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.99 17.08 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.29 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.46 4.85 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -147.99 145.93 28.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.532 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 19.9 m -66.86 153.49 43.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.861 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -74.82 -25.93 59.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.166 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -80.06 142.72 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.357 0.598 . . . . 0.0 110.517 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -93.8 143.62 26.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.882 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.7 74.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 25.5 m -89.51 147.34 24.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.793 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.5 p -110.59 147.81 33.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.347 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -86.51 112.09 21.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.496 0.665 . . . . 0.0 110.694 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -82.52 152.77 25.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.439 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.51 -38.7 0.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.868 1.355 . . . . 0.0 113.158 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.428 ' O ' HG21 ' A' ' 22' ' ' VAL . 8.5 t80 -77.15 17.61 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.567 0.698 . . . . 0.0 110.474 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 19' ' ' LYS . 17.1 tpp180 56.79 41.7 27.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.981 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.707 HG22 HG21 ' A' ' 4' ' ' THR . 89.9 t -128.4 136.34 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.906 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.793 ' HA ' ' O ' ' A' ' 16' ' ' THR . 1.5 m -77.01 136.12 38.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -122.35 136.66 54.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.57 -1.65 . . . . 0.0 109.102 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.669 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -86.38 -136.99 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.669 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 1.3 m-20 -73.03 -30.52 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.402 0.62 . . . . 0.0 109.932 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -52.78 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.979 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 134.51 45.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 t -87.09 -16.52 9.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.49 0.662 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.75 67.89 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.942 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 179.662 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 63.5 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.57 -48.21 2.2 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.263 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -60.75 157.5 14.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.7 p -106.65 163.61 12.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.584 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 m -85.46 59.51 5.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.0 tp -56.87 -38.49 72.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.485 HD11 ' N ' ' A' ' 7' ' ' LEU . 6.8 mp -88.39 15.71 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.44 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.93 -42.26 2.06 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.617 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.658 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 44.9 m -155.26 141.92 18.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.096 . . . . 0.0 110.774 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.6 134.03 36.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -86.34 1.59 50.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.118 0.485 . . . . 0.0 110.308 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 140.4 49.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.455 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.8 p -73.29 129.9 39.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.38 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.33 -15.73 61.51 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.521 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.6 m -89.56 135.3 33.68 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.069 0.461 . . . . 0.0 110.747 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.8 p -126.21 159.45 32.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 62.0 m -88.96 119.82 29.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.876 0.846 . . . . 0.0 112.333 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -89.59 147.18 24.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.082 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -41.35 -32.96 0.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.629 1.206 . . . . 0.0 113.779 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.85 25.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.47 0.652 . . . . 0.0 110.16 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 55.48 41.03 31.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.829 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.73 131.98 66.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.646 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.6 m -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.35 0.595 . . . . 0.0 109.603 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 p -128.33 144.33 51.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.817 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 4.8 ttpt -70.6 -30.63 67.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.428 0.632 . . . . 0.0 110.419 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -153.31 -44.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.68 -35.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -78.68 137.26 37.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.98 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 29' ' ' VAL . 16.9 t -79.1 -9.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.85 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.33 61.53 2.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.287 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.013 179.495 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 t . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.626 0.251 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.33 116.57 0.85 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -174.98 168.26 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 p -100.69 146.94 26.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.058 0.456 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 5.4 m -87.23 60.3 6.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.85 -37.86 74.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.502 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.0 mt -86.43 16.46 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.163 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.72 -41.7 2.42 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.766 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 62.2 m -155.93 141.27 17.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.127 . . . . 0.0 111.28 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.6 m -83.42 128.37 34.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.16 32.2 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.62 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -91.56 143.61 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.46 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -72.61 129.19 37.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.303 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.92 10.38 83.08 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.325 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.62 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 63.5 m -114.56 145.93 41.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.92 0.39 . . . . 0.0 110.625 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 p -138.21 151.9 48.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 26.3 m -88.86 123.92 33.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.786 0.803 . . . . 0.0 112.099 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -88.68 151.06 22.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.552 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -40.5 -38.84 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.514 1.134 . . . . 0.0 113.503 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' O ' HG22 ' A' ' 22' ' ' VAL . 6.2 t80 -81.03 24.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 110.669 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.4 ttm180 56.04 42.04 28.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.926 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 20' ' ' TYR . 55.2 t -116.05 122.14 68.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 14.4 m -74.91 116.32 15.51 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 28' ' ' SER . 66.1 p -133.26 -159.24 0.95 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.687 ' HZ3' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -90.51 -30.33 17.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.467 ' CG ' ' HZ2' ' A' ' 25' ' ' LYS . 13.3 p30 -168.87 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.359 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.528 ' O ' ' HB ' ' A' ' 24' ' ' THR . 19.3 m -80.4 139.39 36.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.04 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 t -67.75 -6.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.46 0.648 . . . . 0.0 111.411 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.55 ' H ' HD12 ' A' ' 30' ' ' LEU . 7.5 mp -65.97 144.69 56.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.503 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.885 0.874 . . . . 0.0 111.943 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 51.2 t . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 48.28 1.81 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.301 -0.475 . . . . 0.0 111.961 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -88.52 174.96 7.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.152 0.581 . . . . 0.0 110.385 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -142.11 145.05 33.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.795 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 2.8 m -94.3 56.69 2.21 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.246 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.45 -42.37 82.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.092 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -74.99 -16.16 60.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.385 0.612 . . . . 0.0 110.178 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.8 -32.08 2.96 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.477 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 17.4 m -143.74 153.92 42.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.35 139.35 37.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -80.29 -27.55 38.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -90.75 148.06 22.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.78 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 p -85.42 148.24 26.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.89 90.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.739 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.1 m -108.06 140.71 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.695 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 41.5 p -109.81 149.5 29.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.44 0.162 . . . . 0.0 110.867 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 99.2 m -88.35 111.71 22.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.979 0.418 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.529 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -87.96 152.3 22.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -39.49 -28.75 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.817 1.323 . . . . 0.0 114.414 -176.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 9.97 4.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.973 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.512 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 17.4 tpp180 60.58 36.42 19.81 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.299 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.529 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 84.5 t -122.61 138.85 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.625 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 61.7 m -75.11 133.71 41.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.846 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -133.92 145.41 49.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.973 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 1' ' ' CYS . 28.7 mmmt -92.76 -89.8 0.19 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 8.6 p-10 -76.25 -38.47 56.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.276 1.036 . . . . 0.0 108.817 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.95 -34.13 0.28 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 m -72.15 134.19 45.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.464 -0.868 . . . . 0.0 110.286 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.42 -25.01 19.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' H ' HD21 ' A' ' 30' ' ' LEU . 3.2 mm? -72.62 62.52 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.349 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 16.9 t-20 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 25' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.562 ' HA3' HD13 ' A' ' 30' ' ' LEU . . . 72.19 45.78 38.21 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.617 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.637 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 4.2 tp10 -152.95 157.89 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 p -141.57 149.99 41.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.832 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.03 52.61 2.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.287 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.432 ' HA ' HD21 ' A' ' 6' ' ' LEU . 96.3 mt -57.71 -45.47 85.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.45 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.916 HD13 ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -74.4 -16.68 60.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.537 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.5 -31.27 3.01 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.474 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.868 ' H ' HD23 ' A' ' 7' ' ' LEU . 25.7 m -151.91 139.74 19.93 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.028 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.0 138.04 49.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.594 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.642 ' HE1' ' HG ' ' A' ' 7' ' ' LEU . 3.9 m-85 -81.01 -32.65 34.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.96 139.92 43.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -82.73 140.18 33.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.51 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 -18.37 56.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.426 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 60.4 m -89.92 138.88 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.549 -0.325 . . . . 0.0 110.312 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.05 150.52 29.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.1 m -87.33 117.01 25.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 0.0 111.177 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.57 ' OD1' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -99.22 150.29 22.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.57 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -38.33 -30.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 O-C-N 125.041 1.463 . . . . 0.0 114.565 -177.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.401 ' O ' HG22 ' A' ' 22' ' ' VAL . 2.5 t80 -78.23 11.14 2.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.421 0.629 . . . . 0.0 109.89 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 19' ' ' LYS . 5.7 tpp85 60.68 33.6 20.22 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.704 1.201 . . . . 0.0 109.701 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.558 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 60.2 t -119.08 140.77 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.1 m -83.5 120.4 25.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.606 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.88 127.62 52.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.118 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.783 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 40.5 tttm -110.52 -152.15 0.49 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.783 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -70.82 -74.13 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.185 0.517 . . . . 0.0 111.692 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.99 40.33 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -66.57 165.58 14.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.249 -0.476 . . . . 0.0 110.512 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -42.42 -50.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.656 HD21 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -112.81 31.39 6.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.052 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.484 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 22.5 t-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.218 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.405 ' HA2' HG11 ' A' ' 29' ' ' VAL . . . 58.6 27.8 61.74 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.797 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 25.1 tt0 -101.27 164.93 11.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.0 p -134.32 148.11 50.7 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -88.27 54.13 2.97 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.153 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.84 -39.47 77.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.054 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.517 HD21 ' N ' ' A' ' 7' ' ' LEU . 3.2 mm? -80.02 -13.47 59.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.529 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.92 -35.61 2.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.7 m -151.62 151.44 31.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.6 m -63.24 144.42 56.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.277 0.56 . . . . 0.0 112.215 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.59 -30.14 18.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.856 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -83.64 146.23 28.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.542 0.687 . . . . 0.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 p -79.29 144.53 34.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.79 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.71 -20.88 44.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.831 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 63.9 m -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.1 p -113.25 157.12 22.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.9 113.95 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.656 0.741 . . . . 0.0 111.635 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.85 149.76 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.993 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -38.89 -38.81 0.46 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.62 1.2 . . . . 0.0 113.699 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.0 t80 -80.24 21.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.376 0.608 . . . . 0.0 110.524 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 19' ' ' LYS . 26.9 ttm180 56.47 39.54 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.005 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 93.9 t -116.67 134.9 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.768 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.831 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.4 m -79.43 122.6 26.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.394 0.616 . . . . 0.0 111.055 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.1 p -133.72 139.58 46.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.162 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -90.84 -96.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.63 -36.74 76.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.619 0.723 . . . . 0.0 110.356 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.08 -42.3 0.23 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 m -78.4 151.2 32.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.229 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG11 ' HA2' ' A' ' 2' ' ' GLY . 23.6 t -65.53 -23.07 32.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.587 0.708 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -56.95 154.37 9.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.969 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.142 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.23 69.05 1.11 Allowed Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.21 161.2 41.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.5 p -116.03 155.64 27.74 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.03 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.67 58.4 5.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.436 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.27 -40.84 68.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.11 19.48 4.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.508 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.41 -37.26 3.56 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.448 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 21.4 m -151.08 148.73 28.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.651 0.262 . . . . 0.0 110.797 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.6 m -66.93 137.09 56.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.337 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.56 -26.48 30.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.0 109.931 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.33 140.04 50.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -79.59 134.12 36.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.165 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -19.13 53.92 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.161 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.75 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.1 m -88.63 135.73 33.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.9 p -114.89 155.5 26.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 65.8 m -89.05 114.73 25.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.67 0.748 . . . . 0.0 111.643 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.5 t30 -83.53 150.35 26.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.034 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.16 -39.72 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 0.0 113.676 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.6 t80 -80.59 22.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 110.777 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 19' ' ' LYS . 46.7 ttp180 56.11 41.82 29.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.61 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 89.5 t -119.53 135.38 60.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.75 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -73.34 130.06 39.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 111.298 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 p -136.77 148.52 47.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.044 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.677 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 9.3 ptmm? -73.71 -140.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.568 ' CG ' ' HZ3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -58.77 -35.47 72.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 110.23 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.51 45.3 0.11 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.703 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.677 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -160.75 151.92 18.99 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.621 -0.341 . . . . 0.0 110.252 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.59 -14.28 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.719 0.771 . . . . 0.0 109.657 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -56.61 143.56 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.257 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.4 p30 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 113.104 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.48 -50.73 0.87 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.257 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -97.97 -166.88 1.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.216 1.007 . . . . 0.0 111.872 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -147.71 156.27 42.59 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.02 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -87.21 55.62 3.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.369 0.604 . . . . 0.0 110.378 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.86 -36.54 84.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.675 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.33 -23.38 59.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.29 -30.42 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.4 m -150.9 152.08 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.89 144.06 53.68 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.563 0.539 . . . . 0.0 111.615 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -82.55 -31.54 29.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.85 143.04 29.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.9 p -85.69 131.84 34.26 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.815 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 -20.69 19.68 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 77.0 m -92.4 143.45 26.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.367 -0.417 . . . . 0.0 109.875 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.5 p -118.45 151.76 37.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.265 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 73.8 m -88.13 111.22 21.34 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.503 ' OD1' ' HB ' ' A' ' 22' ' ' VAL . 4.6 p-10 -83.98 154.24 23.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -34.0 -33.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -176.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' HG21 ' A' ' 22' ' ' VAL . 6.4 t80 -85.36 23.29 1.34 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 0.0 110.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ASN . 13.5 ptm180 49.47 39.67 17.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.133 1.373 . . . . 0.0 110.644 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 23' ' ' CYS . 57.9 t -107.85 154.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.488 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 74.1 m -96.18 129.26 43.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.956 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.77 127.95 45.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.312 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 41.1 tttm -92.67 -146.15 0.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.483 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.576 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 9.3 p-10 -75.97 -48.98 19.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.0 40.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.188 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -74.28 135.53 42.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.57 -36.16 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.324 0.583 . . . . 0.0 111.56 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.725 HD22 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -98.9 31.53 2.94 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.737 0.815 . . . . 0.0 111.664 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.329 0.109 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.27 89.51 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.614 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -160.61 155.88 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 110.233 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 p -119.56 155.84 31.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.082 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 m -87.89 56.26 3.81 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.455 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.8 tp -59.66 -41.34 90.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.211 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.14 -22.47 64.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.992 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.49 -26.51 4.1 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -150.51 156.14 40.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.4 m -58.41 139.56 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -83.51 -22.01 32.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.234 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.08 145.04 29.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.067 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 p -78.09 146.34 35.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.678 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.2 -4.72 85.1 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.807 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.789 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 91.2 m -99.51 138.93 35.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -113.14 150.35 32.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.965 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.94 111.94 21.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.073 0.463 . . . . 0.0 110.146 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.5 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -88.57 156.47 19.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.64 -30.15 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 125.232 1.583 . . . . 0.0 114.874 -177.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.544 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 6.3 t80 -82.4 13.17 3.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.704 0.764 . . . . 0.0 109.774 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' ASN . 66.0 ttt180 58.58 38.74 25.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.219 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.5 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 72.3 t -122.8 136.65 58.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.46 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.789 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.0 m -70.68 128.52 36.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.397 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.57 139.69 52.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.43 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HE3' ' SG ' ' A' ' 15' ' ' CYS . 33.3 ttmt -119.54 -43.61 2.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.678 0.275 . . . . 0.0 110.654 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 27' ' ' GLY . 25.9 t70 -159.91 -148.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.555 ' H ' ' CG ' ' A' ' 26' ' ' ASP . . . -79.19 46.7 3.03 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.522 -0.37 . . . . 0.0 112.284 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -73.73 133.46 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.13 -37.0 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 tp -126.4 37.43 4.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.006 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 23' ' ' CYS . 5.9 m120 . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.463 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 25' ' ' LYS . 27.4 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.457 ' HA3' HG13 ' A' ' 29' ' ' VAL . . . -75.28 47.08 1.96 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.494 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.493 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 16.5 pt-20 -83.31 -164.24 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.827 0.822 . . . . 0.0 109.757 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -134.61 149.04 50.54 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.734 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.44 54.65 3.12 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.923 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.5 pt? -60.34 -38.94 85.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.551 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.2 tp -73.69 -19.6 60.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.075 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.69 -29.87 3.5 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -150.75 154.14 36.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.58 142.7 52.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.266 0.626 . . . . 0.0 112.411 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.49 -33.1 48.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.671 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -84.22 145.82 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.75 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.4 p -81.92 144.39 30.99 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.102 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.96 -4.96 85.27 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.947 -0.569 . . . . 0.0 113.142 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 6.6 m -90.96 145.52 24.65 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 48.2 p -116.11 150.39 37.46 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.732 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -87.78 112.54 22.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.73 0.776 . . . . 0.0 111.346 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.488 ' OD1' ' HD2' ' A' ' 19' ' ' LYS . 2.6 t30 -80.73 148.7 30.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -42.38 -32.43 0.52 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -82.09 20.55 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.5 ttm180 56.06 40.05 30.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.06 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 88.4 t -118.38 133.99 63.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.398 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 16' ' ' THR . 84.7 m -78.43 129.19 34.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.612 0.72 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -134.74 141.2 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.305 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' ' SG ' ' A' ' 1' ' ' CYS . 37.7 ttmt -120.27 -50.85 2.22 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.613 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -140.93 40.48 1.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.281 1.039 . . . . 0.0 108.613 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 -44.06 1.36 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.34 134.16 52.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 0.0 112.217 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 ' HA3' ' A' ' 2' ' ' GLY . 42.2 t -76.67 -18.48 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.442 ' HA ' HD21 ' A' ' 30' ' ' LEU . 93.4 mt -75.75 61.4 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.616 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.581 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.918 ' HB2' ' HG3' ' A' ' 25' ' ' LYS . 56.6 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.887 0.375 . . . . 0.0 111.781 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.68 45.28 0.43 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -135.22 -168.92 2.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.74 0.781 . . . . 0.0 111.727 -177.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -137.91 155.04 49.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.327 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 2.2 m -89.28 52.4 2.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.355 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 6' ' ' LEU . 95.2 mt -55.35 -42.26 73.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.945 ' H ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -76.74 -17.07 59.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.68 2.86 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.709 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.844 ' H ' HD21 ' A' ' 7' ' ' LEU . 27.9 m -153.08 139.41 18.52 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -58.33 136.26 57.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.397 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -77.75 -34.35 52.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.22 0.533 . . . . 0.0 109.709 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.834 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.06 145.0 51.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.509 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.4 p -82.77 140.27 33.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.895 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.23 0.56 70.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.66 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.834 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 8.9 m -98.91 138.71 35.64 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.637 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 7.2 p -117.79 146.81 43.56 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.7 m -89.91 118.56 29.57 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.567 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.64 149.1 22.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.7 ptpt -35.49 -38.46 0.11 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.075 1.484 . . . . 0.0 114.433 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -76.23 16.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.441 0.638 . . . . 0.0 110.58 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' H ' ' C ' ' A' ' 19' ' ' LYS . 23.9 ttm180 57.27 35.77 26.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.392 1.077 . . . . 0.0 110.035 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 91.9 t -118.75 135.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 16' ' ' THR . 60.1 m -76.68 125.13 28.72 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.825 0.821 . . . . 0.0 112.097 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.2 133.93 45.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.918 ' HG3' ' HB2' ' A' ' 1' ' ' CYS . 1.6 mptp? -79.24 125.44 29.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.661 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -108.41 145.87 33.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.442 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.21 -47.8 3.24 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.536 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -152.83 135.81 15.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.887 0.375 . . . . 0.0 109.991 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.29 -32.03 45.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.351 0.595 . . . . 0.0 111.134 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.29 80.3 9.25 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.999 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 0.0 110.72 179.856 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 25' ' ' LYS . 8.9 t . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 69.22 1.44 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -145.41 162.63 36.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.732 0.301 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -108.98 155.95 20.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.423 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 m -85.95 60.17 6.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.89 -38.86 79.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.779 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.409 ' HA ' HD21 ' A' ' 7' ' ' LEU . 92.7 mt -85.53 12.97 7.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.626 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.58 -42.19 2.0 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.711 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 41.3 m -154.5 142.93 20.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 m -75.77 135.59 40.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -81.7 -4.07 55.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.322 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.669 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.46 140.57 51.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.709 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 p -74.09 132.81 42.65 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.805 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 87.34 -5.96 84.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.895 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.669 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 73.4 m -90.11 142.35 27.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.819 0.343 . . . . 0.0 110.677 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.2 p -128.74 152.36 48.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.711 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 59.2 m -89.37 119.16 29.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.686 0.755 . . . . 0.0 111.656 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.8 t30 -88.68 146.85 24.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.278 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.29 -28.21 0.31 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.623 1.202 . . . . 0.0 113.88 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -86.29 20.91 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.545 0.688 . . . . 0.0 109.578 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' ASN . 59.8 ttt180 57.27 40.55 27.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.723 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.06 133.74 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.371 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 16' ' ' THR . 55.7 m -80.15 124.5 28.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.216 0.532 . . . . 0.0 110.067 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.0 p -125.83 126.11 43.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HZ2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -83.77 -15.49 48.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 109.767 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.576 ' HB2' ' HZ2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -156.3 -154.23 0.47 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 -177.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.17 75.93 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -104.52 150.68 24.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.369 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 29' ' ' VAL . 9.3 t -71.88 -2.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 111.002 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -52.77 147.34 8.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.632 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.4 m . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.16 61.49 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.764 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 34.2 tt0 -114.3 166.01 12.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.278 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.401 ' N ' ' HG2' ' A' ' 3' ' ' GLU . 18.7 p -133.03 146.88 52.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.328 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.62 55.64 2.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.704 ' H ' HD22 ' A' ' 6' ' ' LEU . 2.0 pt? -60.76 -34.48 74.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.47 -19.48 57.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.151 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.31 -31.03 3.37 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.52 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.28 152.29 33.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' N ' HG21 ' A' ' 9' ' ' THR . 33.9 m -58.54 144.91 41.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 0.0 111.951 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.29 -32.38 24.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.927 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 m -91.31 146.67 23.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -85.24 139.56 31.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -25.9 17.34 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.516 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 62.9 m -90.74 142.75 27.43 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.862 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.9 p -115.06 150.66 35.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.343 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 97.1 m -87.46 114.14 23.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.023 0.439 . . . . 0.0 111.166 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.61 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -90.9 151.72 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -36.52 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.997 1.436 . . . . 0.0 114.844 -177.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.55 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 8.4 t80 -82.78 21.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.16 0.505 . . . . 0.0 110.024 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.5 ptp85 51.31 39.98 25.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.125 1.37 . . . . 0.0 110.165 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.61 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 87.5 t -121.48 133.77 66.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.8 m -74.37 124.67 26.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -127.64 145.01 51.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.498 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -75.4 -36.93 60.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.254 0.549 . . . . 0.0 109.927 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 28' ' ' SER . 56.9 t0 -169.01 -122.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.79 27.57 3.8 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.392 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 26' ' ' ASP . 66.0 m -160.89 131.57 5.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.859 0.463 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' O ' HG11 ' A' ' 29' ' ' VAL . 24.6 t -71.5 -11.69 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.296 0.569 . . . . 0.0 110.803 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 30' ' ' LEU . 8.2 mp -52.68 155.07 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.683 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.57 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.35 47.06 0.68 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.655 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -89.94 160.34 16.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 22' ' ' VAL . 27.9 p -109.2 145.32 36.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.282 0.563 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.42 55.46 3.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 109.615 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.05 -34.4 76.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.477 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.76 -14.37 59.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.029 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.33 -35.7 2.64 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.48 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.3 m -152.39 154.63 35.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.537 0.208 . . . . 0.0 110.444 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.22 135.7 52.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.33 -20.03 25.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 109.662 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.503 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -74.03 140.66 45.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.579 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 p -73.38 136.58 44.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.157 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.71 -2.08 80.68 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.429 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 59.8 m -97.89 133.04 42.93 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -115.32 154.97 28.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.474 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 85.9 m -87.86 115.07 25.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.081 0.467 . . . . 0.0 110.926 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.532 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -89.12 156.13 19.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -37.33 -35.65 0.12 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.989 1.43 . . . . 0.0 114.253 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -78.06 12.24 1.91 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 18' ' ' ASN . 65.4 ttt180 60.47 38.5 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.915 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 4' ' ' THR . 96.1 t -126.84 137.27 58.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.296 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.3 m -68.04 134.37 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.88 0.848 . . . . 0.0 112.984 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -133.23 127.07 32.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.989 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -90.76 -60.34 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -101.3 -41.38 6.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.245 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.18 -26.02 0.55 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.49 135.59 39.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.731 -0.735 . . . . 0.0 110.98 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.48 -34.24 61.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.78 0.8 . . . . 0.0 109.238 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -77.61 61.4 2.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.111 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.117 -179.168 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.13 28.38 53.95 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.512 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.492 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 44.8 tt0 -105.94 159.12 16.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.8 p -126.5 149.11 49.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.539 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 1.8 m -88.19 55.55 3.48 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.125 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.8 tp -57.27 -42.67 82.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.077 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.436 HD22 ' OH ' ' A' ' 11' ' ' TYR . 21.7 tp -73.8 -17.87 61.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.426 0.631 . . . . 0.0 110.112 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.51 -30.3 3.46 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -149.78 151.48 33.64 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 6.7 m -65.61 147.53 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.436 ' OH ' HD22 ' A' ' 7' ' ' LEU . 3.9 m-85 -88.21 -32.62 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.13 140.95 40.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.632 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -81.95 131.39 35.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.608 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.38 -17.05 44.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.828 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.932 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.3 m -88.74 132.76 34.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.104 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.3 p -109.23 151.86 25.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.663 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -87.42 111.99 21.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.665 0.745 . . . . 0.0 111.713 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -82.78 150.46 26.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.974 178.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.27 -39.84 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.835 1.334 . . . . 0.0 113.063 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -78.48 21.0 0.39 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.49 0.662 . . . . 0.0 110.673 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 16.6 tpp180 56.52 38.97 30.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 97.0 t -116.66 133.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.588 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.932 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 59.8 m -79.06 124.02 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.368 0.604 . . . . 0.0 111.078 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 p -125.37 143.14 51.11 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 9.4 ptmm? -69.12 -17.78 63.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.897 0.38 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.573 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 18.1 p-10 -174.49 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.779 0.8 . . . . 0.0 109.171 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.28 -37.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.502 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 17.1 m -83.16 136.55 34.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.243 -0.479 . . . . 0.0 109.953 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -69.95 -25.9 28.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.352 0.596 . . . . 0.0 111.103 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 28' ' ' SER . 2.6 pp -58.7 150.94 22.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.397 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 25' ' ' LYS . 66.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.536 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.022 0.439 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.56 68.26 1.23 Allowed Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.228 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.98 160.1 40.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.7 p -120.98 153.53 37.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.055 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.4 54.41 3.14 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.471 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 tp -55.84 -40.09 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.348 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.15 -12.8 59.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.82 -35.32 2.57 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.575 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.452 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.65 150.0 29.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 m -63.42 138.17 58.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.671 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.32 -30.28 38.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 140.37 44.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.955 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -79.96 135.7 36.46 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.108 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.12 -14.37 59.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.397 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 67.6 m -89.41 141.37 28.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.891 0.377 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.0 p -116.16 150.59 37.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 68.5 m -88.91 114.73 25.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.579 0.704 . . . . 0.0 111.372 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.59 148.89 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.12 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.66 -39.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.705 1.253 . . . . 0.0 113.486 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.0 21.04 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.397 0.618 . . . . 0.0 110.6 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.2 ttm180 56.29 40.28 29.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.124 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.8 t -118.48 136.27 56.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.47 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.7 m -76.54 130.0 37.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.392 0.615 . . . . 0.0 111.591 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.8 p -126.06 141.19 52.06 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.566 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' A' ' 31' ' ' ASN . 20.6 pttp -78.76 -130.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.052 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.68 -48.53 58.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.994 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.6 40.84 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.463 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 22.1 m -156.86 144.26 18.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.573 0.225 . . . . 0.0 110.522 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.89 -29.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.767 0.794 . . . . 0.0 110.012 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 30' ' ' LEU . 6.8 mp -56.74 155.37 7.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.45 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.629 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 52.1 t-20 . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 0.0 110.533 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.36 -35.37 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.674 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.554 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 33.5 tt0 -56.75 150.86 15.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.658 0.742 . . . . 0.0 111.928 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.4 p -123.59 154.33 39.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.191 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.96 50.19 1.94 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.229 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.73 -36.42 83.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.904 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.1 tp -84.66 8.14 17.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.639 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.76 -33.65 6.17 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.29 -0.957 . . . . 0.0 110.94 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -149.79 -159.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.691 ' H ' HG22 ' A' ' 9' ' ' THR . 61.5 m -137.08 146.65 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.0 -26.54 33.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.464 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.4 m -69.72 140.77 53.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.667 0.746 . . . . 0.0 111.162 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -85.56 136.44 33.4 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.714 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 -5.19 81.33 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.681 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.3 m -89.4 136.37 33.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.45 151.09 28.97 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -86.24 112.06 21.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.693 0.759 . . . . 0.0 111.103 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.509 ' OD1' ' HG2' ' A' ' 19' ' ' LYS . 2.3 t30 -86.95 149.33 24.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.744 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 18' ' ' ASN . 9.3 ptpp? -35.65 -42.66 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 125.048 1.467 . . . . 0.0 113.794 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -78.64 20.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.253 0.549 . . . . 0.0 111.045 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 19' ' ' LYS . 2.3 tpp180 56.97 39.38 29.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.28 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 62.8 t -117.58 132.19 68.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.5 m -84.79 123.57 30.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.171 0.986 . . . . 0.0 111.638 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 29' ' ' VAL . 23.2 p -120.87 128.27 52.66 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.894 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 26' ' ' ASP . 42.4 tttm -86.11 -75.17 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 25' ' ' LYS . 73.7 m-20 -88.9 50.45 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 0.0 110.099 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.87 -43.89 2.0 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.015 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -85.61 155.64 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.692 0.282 . . . . 0.0 110.472 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 24' ' ' THR . 37.2 t -63.31 -26.34 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.672 0.748 . . . . 0.0 110.465 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.62 152.08 19.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.078 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.091 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.862 0.363 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.98 38.99 1.71 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 13.6 tt0 -76.6 177.91 7.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.635 -0.782 . . . . 0.0 110.062 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 p -134.46 146.61 49.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m -86.72 57.16 4.34 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.939 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 7' ' ' LEU . 2.6 pt? -59.25 -36.94 76.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 6' ' ' LEU . 91.5 mt -91.57 19.75 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.632 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.74 -43.83 1.91 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.469 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 33.5 m -154.19 142.35 20.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.753 -0.223 . . . . 0.0 110.489 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.44 138.39 40.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 110.663 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -86.85 -10.61 53.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -72.21 141.95 49.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.685 0.755 . . . . 0.0 111.395 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -77.7 136.41 38.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.69 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.6 -6.7 77.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.665 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 68.5 m -104.41 130.49 52.29 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.83 0.348 . . . . 0.0 110.291 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.7 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.9 p -116.35 152.79 33.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 21.8 m -87.23 116.95 25.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.84 0.829 . . . . 0.0 111.848 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.4 t30 -90.03 149.86 22.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.363 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.1 -40.14 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.78 1.3 . . . . 0.0 113.708 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.52 22.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.546 . . . . 0.0 110.766 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.2 ttm180 56.03 40.55 30.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.047 0.939 . . . . 0.0 109.93 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.2 t -117.14 130.24 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 72.5 m -85.35 114.76 22.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.556 0.693 . . . . 0.0 110.628 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -128.64 156.59 43.17 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.042 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.8 ptmm? -81.3 0.88 35.01 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.498 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 179.92 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.637 0.732 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.05 -33.7 0.25 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -71.71 140.84 49.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.173 -1.013 . . . . 0.0 110.079 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.4 t -70.72 -16.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.439 0.638 . . . . 0.0 111.168 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.73 146.46 54.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 123.629 0.772 . . . . 0.0 111.465 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.657 0.265 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.69 41.65 1.46 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.413 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.657 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 14.0 tp10 -89.73 155.62 19.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 110.226 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.696 HG22 HG22 ' A' ' 22' ' ' VAL . 21.3 p -123.8 151.22 43.58 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.911 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 1.5 m -88.32 55.22 3.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.07 0.462 . . . . 0.0 109.807 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.88 -41.74 74.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.814 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 mp -94.31 23.97 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.244 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -39.59 2.7 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.646 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 28.6 m -150.57 143.14 24.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.893 0.378 . . . . 0.0 110.06 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.657 ' HB3' ' CG ' ' A' ' 3' ' ' GLU . 3.6 m -68.56 148.49 50.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.08 -20.54 52.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.747 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 139.1 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.0 111.158 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -89.3 141.11 28.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.523 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.04 -16.81 58.69 Favored Glycine 0 CA--C 1.508 -0.356 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.659 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 56.7 m -89.09 142.59 27.51 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.108 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.781 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.7 p -112.37 149.67 32.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.4 m -85.62 117.66 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 110.96 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -96.16 152.43 18.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.26 -31.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.093 1.496 . . . . 0.0 114.802 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 8.8 t80 -79.96 14.86 1.64 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.526 0.679 . . . . 0.0 110.009 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' LYS . 29.2 ttm180 57.44 39.23 28.24 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.641 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.696 HG22 HG22 ' A' ' 4' ' ' THR . 95.5 t -128.08 138.2 55.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.48 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.7 m -82.22 132.47 35.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -117.64 125.79 51.36 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.249 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -77.06 -27.53 54.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.351 0.596 . . . . 0.0 109.85 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -168.42 -141.32 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.76 -29.77 74.04 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.889 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -85.92 125.16 33.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.305 -0.447 . . . . 0.0 110.887 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.17 -18.13 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.894 0.854 . . . . 0.0 109.5 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.82 168.38 6.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.387 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.772 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.556 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 71.3 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.65 37.22 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.556 ' OE2' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -166.89 -171.53 1.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.387 0.613 . . . . 0.0 110.307 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.794 HG22 HG22 ' A' ' 22' ' ' VAL . 10.6 p -145.63 154.89 42.62 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.298 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.5 m -87.78 55.1 3.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.563 ' HA ' HH12 ' A' ' 21' ' ' ARG . 2.6 pt? -60.23 -40.81 91.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.753 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.12 -16.64 57.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.051 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.49 -35.17 2.31 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 23.9 m -151.89 144.4 24.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.688 0.28 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -75.74 148.54 38.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.59 -18.08 46.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.0 110.427 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.36 142.07 57.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.284 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -91.54 142.07 28.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.469 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.8 -18.44 47.14 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.972 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.7 m -89.11 139.55 30.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.848 0.356 . . . . 0.0 110.599 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.753 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.4 p -113.73 149.46 34.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.902 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -86.11 116.55 24.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.498 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -92.01 153.43 19.44 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -37.09 -31.96 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.143 1.527 . . . . 0.0 114.75 -177.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.625 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.8 t80 -82.08 20.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.273 0.559 . . . . 0.0 109.927 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.7 ptm180 49.86 42.17 23.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.14 1.376 . . . . 0.0 110.341 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.794 HG22 HG22 ' A' ' 4' ' ' THR . 87.7 t -126.76 136.25 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.332 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.972 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.8 m -79.84 132.72 36.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.182 0.992 . . . . 0.0 113.511 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -118.68 123.38 44.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.012 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 23.9 ttpp -88.84 -45.03 10.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.431 0.634 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -167.35 -144.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.887 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.68 33.97 2.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.044 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -72.03 130.06 40.04 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.5 t -56.6 -35.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.928 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -108.37 26.69 10.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.283 179.815 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.02 44.33 1.82 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.661 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.558 ' OE2' ' HB3' ' A' ' 10' ' ' CYS . 8.0 pt-20 -83.72 176.91 8.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.721 HG22 HG22 ' A' ' 22' ' ' VAL . 23.5 p -106.92 149.01 27.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.636 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.502 ' HB2' ' HD2' ' A' ' 21' ' ' ARG . 1.7 m -87.65 56.86 4.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -59.15 -34.62 72.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.489 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.99 17.08 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.29 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.46 4.85 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -147.99 145.93 28.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.558 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 19.9 m -66.86 153.49 43.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.861 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -74.82 -25.93 59.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.166 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -80.06 142.72 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.357 0.598 . . . . 0.0 110.517 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -93.8 143.62 26.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.882 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.7 74.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 25.5 m -89.51 147.34 24.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.791 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.5 p -110.59 147.81 33.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.347 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -86.51 112.09 21.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.496 0.665 . . . . 0.0 110.694 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -82.52 152.77 25.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.439 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.51 -38.7 0.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.868 1.355 . . . . 0.0 113.158 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.5 t80 -77.15 17.61 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.567 0.698 . . . . 0.0 110.474 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.502 ' HD2' ' HB2' ' A' ' 5' ' ' CYS . 17.1 tpp180 56.79 41.7 27.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.981 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 4' ' ' THR . 89.9 t -128.4 136.34 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.906 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 16' ' ' THR . 1.5 m -77.01 136.12 38.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -122.35 136.66 54.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.57 -1.65 . . . . 0.0 109.102 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.685 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -86.38 -136.99 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.685 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 1.3 m-20 -73.03 -30.52 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.402 0.62 . . . . 0.0 109.932 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -52.78 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.979 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 134.51 45.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 t -87.09 -16.52 9.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.49 0.662 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.75 67.89 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.942 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 179.662 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 63.5 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.57 -48.21 2.2 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.263 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -60.75 157.5 14.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 21' ' ' ARG . 42.7 p -106.65 163.61 12.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.584 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 m -85.46 59.51 5.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.0 tp -56.87 -38.49 72.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.39 15.71 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.44 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.93 -42.26 2.06 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.617 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.663 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 44.9 m -155.26 141.92 18.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.096 . . . . 0.0 110.774 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.6 134.03 36.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -86.34 1.59 50.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.118 0.485 . . . . 0.0 110.308 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 140.4 49.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.455 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.8 p -73.29 129.9 39.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.38 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.33 -15.73 61.51 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.521 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.6 m -89.56 135.3 33.68 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.069 0.461 . . . . 0.0 110.747 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.8 p -126.21 159.45 32.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 62.0 m -88.96 119.82 29.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.876 0.846 . . . . 0.0 112.333 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -89.59 147.18 24.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.082 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.35 -32.96 0.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.629 1.206 . . . . 0.0 113.779 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.85 25.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.47 0.652 . . . . 0.0 110.16 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 4' ' ' THR . 25.7 ttp180 55.48 41.03 31.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.829 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.73 131.98 66.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.646 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.6 m -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.35 0.595 . . . . 0.0 109.603 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 p -128.33 144.33 51.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.817 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 4.8 ttpt -70.6 -30.63 67.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.428 0.632 . . . . 0.0 110.419 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -153.31 -44.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.68 -35.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -78.68 137.26 37.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.98 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -79.1 -9.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.85 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.33 61.53 2.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.287 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.013 179.495 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 t . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.626 0.251 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.33 116.57 0.85 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -174.98 168.26 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 p -100.69 146.94 26.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.058 0.456 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 5.4 m -87.23 60.3 6.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.85 -37.86 74.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.502 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.0 mt -86.43 16.46 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.163 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.72 -41.7 2.42 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.766 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 62.2 m -155.93 141.27 17.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.127 . . . . 0.0 111.28 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.6 m -83.42 128.37 34.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.16 32.2 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -91.56 143.61 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.46 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -72.61 129.19 37.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.303 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.92 10.38 83.08 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.325 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 63.5 m -114.56 145.93 41.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.92 0.39 . . . . 0.0 110.625 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 p -138.21 151.9 48.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 26.3 m -88.86 123.92 33.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.786 0.803 . . . . 0.0 112.099 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.414 HD22 ' HB ' ' A' ' 22' ' ' VAL . 1.9 t30 -88.68 151.06 22.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.552 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -40.5 -38.84 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.514 1.134 . . . . 0.0 113.503 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -81.03 24.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 110.669 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.4 ttm180 56.04 42.04 28.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.926 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 18' ' ' ASN . 55.2 t -116.05 122.14 68.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 14.4 m -74.91 116.32 15.51 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 28' ' ' SER . 66.1 p -133.26 -159.24 0.95 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -90.51 -30.33 17.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -168.87 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.359 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' A' ' 24' ' ' THR . 19.3 m -80.4 139.39 36.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.04 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 t -67.75 -6.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.46 0.648 . . . . 0.0 111.411 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 28' ' ' SER . 7.5 mp -65.97 144.69 56.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.503 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.885 0.874 . . . . 0.0 111.943 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 51.2 t . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 48.28 1.81 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.301 -0.475 . . . . 0.0 111.961 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.67 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -88.52 174.96 7.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.152 0.581 . . . . 0.0 110.385 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -142.11 145.05 33.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.795 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.524 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 2.8 m -94.3 56.69 2.21 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.246 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.45 -42.37 82.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.092 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -74.99 -16.16 60.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.385 0.612 . . . . 0.0 110.178 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.8 -32.08 2.96 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.481 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 17.4 m -143.74 153.92 42.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.35 139.35 37.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -80.29 -27.55 38.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -90.75 148.06 22.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.78 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 p -85.42 148.24 26.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.89 90.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.739 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.1 m -108.06 140.71 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 41.5 p -109.81 149.5 29.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.44 0.162 . . . . 0.0 110.867 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 99.2 m -88.35 111.71 22.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.979 0.418 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.55 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -87.96 152.3 22.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -39.49 -28.75 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.817 1.323 . . . . 0.0 114.414 -176.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 9.97 4.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.973 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 17.4 tpp180 60.58 36.42 19.81 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.299 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 84.5 t -122.61 138.85 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.625 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 61.7 m -75.11 133.71 41.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.846 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -133.92 145.41 49.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.973 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 1' ' ' CYS . 28.7 mmmt -92.76 -89.8 0.19 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.25 -38.47 56.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.276 1.036 . . . . 0.0 108.817 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.95 -34.13 0.28 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 m -72.15 134.19 45.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.464 -0.868 . . . . 0.0 110.286 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.42 -25.01 19.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.62 62.52 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.349 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.488 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 16.9 t-20 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 25' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.19 45.78 38.21 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.617 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.651 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 4.2 tp10 -152.95 157.89 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 p -141.57 149.99 41.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.832 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.03 52.61 2.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.287 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.71 -45.47 85.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.635 ' HG ' ' HE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -74.4 -16.68 60.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.537 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.5 -31.27 3.01 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.474 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.582 ' O ' HD11 ' A' ' 7' ' ' LEU . 25.7 m -151.91 139.74 19.93 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.028 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.0 138.04 49.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.594 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.635 ' HE1' ' HG ' ' A' ' 7' ' ' LEU . 3.9 m-85 -81.01 -32.65 34.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.96 139.92 43.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -82.73 140.18 33.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.51 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 -18.37 56.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.426 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 60.4 m -89.92 138.88 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.549 -0.325 . . . . 0.0 110.312 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.05 150.52 29.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.1 m -87.33 117.01 25.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 0.0 111.177 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.582 ' OD1' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -99.22 150.29 22.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -38.33 -30.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 O-C-N 125.041 1.463 . . . . 0.0 114.565 -177.054 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 t80 -78.23 11.14 2.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.421 0.629 . . . . 0.0 109.89 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' LYS . 5.7 tpp85 60.68 33.6 20.22 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.704 1.201 . . . . 0.0 109.701 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.577 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 60.2 t -119.08 140.77 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.1 m -83.5 120.4 25.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.606 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.88 127.62 52.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.118 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.817 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 40.5 tttm -110.52 -152.15 0.49 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.817 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -70.82 -74.13 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.185 0.517 . . . . 0.0 111.692 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.99 40.33 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -66.57 165.58 14.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.249 -0.476 . . . . 0.0 110.512 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -42.42 -50.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -112.81 31.39 6.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.052 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 22.5 t-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.218 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.498 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 58.6 27.8 61.74 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.797 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 25.1 tt0 -101.27 164.93 11.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.0 p -134.32 148.11 50.7 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -88.27 54.13 2.97 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.153 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.84 -39.47 77.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.054 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.02 -13.47 59.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.529 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.92 -35.61 2.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.7 m -151.62 151.44 31.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.6 m -63.24 144.42 56.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.277 0.56 . . . . 0.0 112.215 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.59 -30.14 18.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.856 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -83.64 146.23 28.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.542 0.687 . . . . 0.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 p -79.29 144.53 34.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.79 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.71 -20.88 44.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 63.9 m -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.1 p -113.25 157.12 22.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.9 113.95 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.656 0.741 . . . . 0.0 111.635 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.85 149.76 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.993 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -38.89 -38.81 0.46 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.62 1.2 . . . . 0.0 113.699 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.24 21.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.376 0.608 . . . . 0.0 110.524 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 19' ' ' LYS . 26.9 ttm180 56.47 39.54 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.005 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 93.9 t -116.67 134.9 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.768 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.4 m -79.43 122.6 26.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.394 0.616 . . . . 0.0 111.055 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 29' ' ' VAL . 14.1 p -133.72 139.58 46.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.162 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -90.84 -96.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.63 -36.74 76.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.619 0.723 . . . . 0.0 110.356 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.08 -42.3 0.23 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 m -78.4 151.2 32.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.229 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 24' ' ' THR . 23.6 t -65.53 -23.07 32.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.587 0.708 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -56.95 154.37 9.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.969 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.142 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.23 69.05 1.11 Allowed Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.21 161.2 41.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.45 HG22 HG22 ' A' ' 22' ' ' VAL . 21.5 p -116.03 155.64 27.74 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.03 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.67 58.4 5.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.436 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.27 -40.84 68.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.11 19.48 4.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.508 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.41 -37.26 3.56 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 21.4 m -151.08 148.73 28.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.651 0.262 . . . . 0.0 110.797 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.6 m -66.93 137.09 56.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.337 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.56 -26.48 30.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.0 109.931 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.33 140.04 50.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -79.59 134.12 36.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.165 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -19.13 53.92 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.161 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.1 m -88.63 135.73 33.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.9 p -114.89 155.5 26.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 65.8 m -89.05 114.73 25.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.67 0.748 . . . . 0.0 111.643 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.5 t30 -83.53 150.35 26.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.034 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.16 -39.72 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 0.0 113.676 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.59 22.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 110.777 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 19' ' ' LYS . 46.7 ttp180 56.11 41.82 29.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.61 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 89.5 t -119.53 135.38 60.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -73.34 130.06 39.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 111.298 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 p -136.77 148.52 47.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.044 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 9.3 ptmm? -73.71 -140.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' CG ' ' HZ3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -58.77 -35.47 72.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 110.23 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.51 45.3 0.11 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.703 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.675 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -160.75 151.92 18.99 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.621 -0.341 . . . . 0.0 110.252 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.59 -14.28 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.719 0.771 . . . . 0.0 109.657 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -56.61 143.56 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.257 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.4 p30 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 113.104 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.48 -50.73 0.87 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.257 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 20.6 pt-20 -97.97 -166.88 1.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.216 1.007 . . . . 0.0 111.872 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 22' ' ' VAL . 2.2 p -147.71 156.27 42.59 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.02 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -87.21 55.62 3.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.369 0.604 . . . . 0.0 110.378 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.86 -36.54 84.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.675 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.33 -23.38 59.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.29 -30.42 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.4 m -150.9 152.08 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.89 144.06 53.68 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.563 0.539 . . . . 0.0 111.615 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -82.55 -31.54 29.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.85 143.04 29.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.9 p -85.69 131.84 34.26 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.815 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 -20.69 19.68 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 77.0 m -92.4 143.45 26.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.367 -0.417 . . . . 0.0 109.875 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.5 p -118.45 151.76 37.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.265 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 73.8 m -88.13 111.22 21.34 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.522 ' OD1' ' HB ' ' A' ' 22' ' ' VAL . 4.6 p-10 -83.98 154.24 23.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.0 -33.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.4 t80 -85.36 23.29 1.34 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 0.0 110.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ASN . 13.5 ptm180 49.47 39.67 17.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.133 1.373 . . . . 0.0 110.644 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HB ' ' OD1' ' A' ' 18' ' ' ASN . 57.9 t -107.85 154.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.488 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 74.1 m -96.18 129.26 43.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.956 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.77 127.95 45.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.312 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 41.1 tttm -92.67 -146.15 0.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.483 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.577 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 9.3 p-10 -75.97 -48.98 19.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.0 40.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.188 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -74.28 135.53 42.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.57 -36.16 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.324 0.583 . . . . 0.0 111.56 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.809 HD23 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -98.9 31.53 2.94 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.737 0.815 . . . . 0.0 111.664 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.329 0.109 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.27 89.51 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.614 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -160.61 155.88 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 110.233 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.74 HG22 HG22 ' A' ' 22' ' ' VAL . 40.3 p -119.56 155.84 31.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.082 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 m -87.89 56.26 3.81 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.455 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.8 tp -59.66 -41.34 90.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.211 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.14 -22.47 64.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.992 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.49 -26.51 4.1 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -150.51 156.14 40.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.4 m -58.41 139.56 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -83.51 -22.01 32.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.234 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.08 145.04 29.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.067 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 p -78.09 146.34 35.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.678 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.2 -4.72 85.1 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.807 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 91.2 m -99.51 138.93 35.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -113.14 150.35 32.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.965 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.94 111.94 21.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.073 0.463 . . . . 0.0 110.146 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -88.57 156.47 19.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.64 -30.15 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 125.232 1.583 . . . . 0.0 114.874 -177.477 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.543 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 6.3 t80 -82.4 13.17 3.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.704 0.764 . . . . 0.0 109.774 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' ASN . 66.0 ttt180 58.58 38.74 25.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.219 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.74 HG22 HG22 ' A' ' 4' ' ' THR . 72.3 t -122.8 136.65 58.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.46 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.0 m -70.68 128.52 36.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.397 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.57 139.69 52.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.43 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HE3' ' SG ' ' A' ' 15' ' ' CYS . 33.3 ttmt -119.54 -43.61 2.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.678 0.275 . . . . 0.0 110.654 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 27' ' ' GLY . 25.9 t70 -159.91 -148.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 26' ' ' ASP . . . -79.19 46.7 3.03 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.522 -0.37 . . . . 0.0 112.284 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -73.73 133.46 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.13 -37.0 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 tp -126.4 37.43 4.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.006 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.686 ' HB3' ' O ' ' A' ' 23' ' ' CYS . 5.9 m120 . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.463 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.458 ' SG ' ' HE3' ' A' ' 25' ' ' LYS . 27.4 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.868 ' HA3' HG13 ' A' ' 29' ' ' VAL . . . -75.28 47.08 1.96 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.494 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.515 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 16.5 pt-20 -83.31 -164.24 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.827 0.822 . . . . 0.0 109.757 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.456 HG22 HG22 ' A' ' 22' ' ' VAL . 17.1 p -134.61 149.04 50.54 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.734 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.44 54.65 3.12 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.923 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.5 pt? -60.34 -38.94 85.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.551 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.2 tp -73.69 -19.6 60.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.075 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.69 -29.87 3.5 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -150.75 154.14 36.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.58 142.7 52.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.266 0.626 . . . . 0.0 112.411 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.49 -33.1 48.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.681 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -84.22 145.82 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.75 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.4 p -81.92 144.39 30.99 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.102 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.96 -4.96 85.27 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.947 -0.569 . . . . 0.0 113.142 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.681 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 6.6 m -90.96 145.52 24.65 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 48.2 p -116.11 150.39 37.46 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.732 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -87.78 112.54 22.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.73 0.776 . . . . 0.0 111.346 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 19' ' ' LYS . 2.6 t30 -80.73 148.7 30.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -42.38 -32.43 0.52 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.2 t80 -82.09 20.55 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.5 ttm180 56.06 40.05 30.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.06 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 88.4 t -118.38 133.99 63.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.398 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 16' ' ' THR . 84.7 m -78.43 129.19 34.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.612 0.72 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -134.74 141.2 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.305 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.458 ' HE3' ' SG ' ' A' ' 1' ' ' CYS . 37.7 ttmt -120.27 -50.85 2.22 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.613 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -140.93 40.48 1.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.281 1.039 . . . . 0.0 108.613 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 -44.06 1.36 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.34 134.16 52.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 0.0 112.217 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.868 HG13 ' HA3' ' A' ' 2' ' ' GLY . 42.2 t -76.67 -18.48 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.75 61.4 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.616 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.581 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.941 ' HB2' ' HG3' ' A' ' 25' ' ' LYS . 56.6 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.887 0.375 . . . . 0.0 111.781 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.68 45.28 0.43 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.524 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -135.22 -168.92 2.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.74 0.781 . . . . 0.0 111.727 -177.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -137.91 155.04 49.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.327 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 2.2 m -89.28 52.4 2.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.355 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.35 -42.26 73.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.646 HD11 ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -76.74 -17.07 59.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.68 2.86 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.709 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.646 ' O ' HD11 ' A' ' 7' ' ' LEU . 27.9 m -153.08 139.41 18.52 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -58.33 136.26 57.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.397 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -77.75 -34.35 52.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.22 0.533 . . . . 0.0 109.709 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.848 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.06 145.0 51.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.509 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.4 p -82.77 140.27 33.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.895 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.23 0.56 70.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.66 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.848 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 8.9 m -98.91 138.71 35.64 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 7.2 p -117.79 146.81 43.56 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.7 m -89.91 118.56 29.57 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.64 149.1 22.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.7 ptpt -35.49 -38.46 0.11 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.075 1.484 . . . . 0.0 114.433 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.2 t80 -76.23 16.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.441 0.638 . . . . 0.0 110.58 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 19' ' ' LYS . 23.9 ttm180 57.27 35.77 26.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.392 1.077 . . . . 0.0 110.035 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 91.9 t -118.75 135.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 16' ' ' THR . 60.1 m -76.68 125.13 28.72 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.825 0.821 . . . . 0.0 112.097 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.2 133.93 45.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.941 ' HG3' ' HB2' ' A' ' 1' ' ' CYS . 1.6 mptp? -79.24 125.44 29.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.661 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -108.41 145.87 33.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.442 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.21 -47.8 3.24 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.536 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -152.83 135.81 15.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.887 0.375 . . . . 0.0 109.991 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.29 -32.03 45.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.351 0.595 . . . . 0.0 111.134 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.29 80.3 9.25 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.999 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 0.0 110.72 179.856 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 25' ' ' LYS . 8.9 t . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 69.22 1.44 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -145.41 162.63 36.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.732 0.301 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -108.98 155.95 20.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.423 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 m -85.95 60.17 6.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.89 -38.86 79.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.779 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.53 12.97 7.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.626 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.58 -42.19 2.0 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.718 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 41.3 m -154.5 142.93 20.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 m -75.77 135.59 40.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -81.7 -4.07 55.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.322 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.683 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.46 140.57 51.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.709 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 p -74.09 132.81 42.65 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.805 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 87.34 -5.96 84.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.895 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.683 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 73.4 m -90.11 142.35 27.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.819 0.343 . . . . 0.0 110.677 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.2 p -128.74 152.36 48.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 59.2 m -89.37 119.16 29.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.686 0.755 . . . . 0.0 111.656 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 t-20 -88.68 146.85 24.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.278 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.29 -28.21 0.31 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.623 1.202 . . . . 0.0 113.88 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -86.29 20.91 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.545 0.688 . . . . 0.0 109.578 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' ASN . 59.8 ttt180 57.27 40.55 27.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.723 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.06 133.74 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.371 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' THR . 55.7 m -80.15 124.5 28.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.216 0.532 . . . . 0.0 110.067 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.0 p -125.83 126.11 43.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HZ2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -83.77 -15.49 48.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 109.767 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.529 ' HB2' ' HZ2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -156.3 -154.23 0.47 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 -177.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.17 75.93 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -104.52 150.68 24.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.369 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 t -71.88 -2.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -52.77 147.34 8.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.632 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.4 m . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.16 61.49 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.764 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 34.2 tt0 -114.3 166.01 12.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.278 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.69 HG22 HG22 ' A' ' 22' ' ' VAL . 18.7 p -133.03 146.88 52.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.328 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.62 55.64 2.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.0 pt? -60.76 -34.48 74.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.47 -19.48 57.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.151 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.31 -31.03 3.37 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.525 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.28 152.29 33.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.9 m -58.54 144.91 41.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 0.0 111.951 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.29 -32.38 24.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.927 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 m -91.31 146.67 23.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -85.24 139.56 31.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -25.9 17.34 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.516 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 62.9 m -90.74 142.75 27.43 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.862 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.9 p -115.06 150.66 35.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.343 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 97.1 m -87.46 114.14 23.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.023 0.439 . . . . 0.0 111.166 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.629 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -90.9 151.72 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.435 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -36.52 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.997 1.436 . . . . 0.0 114.844 -177.651 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 8.4 t80 -82.78 21.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.16 0.505 . . . . 0.0 110.024 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.5 ptp85 51.31 39.98 25.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.125 1.37 . . . . 0.0 110.165 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.69 HG22 HG22 ' A' ' 4' ' ' THR . 87.5 t -121.48 133.77 66.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.8 m -74.37 124.67 26.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -127.64 145.01 51.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.498 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -75.4 -36.93 60.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.254 0.549 . . . . 0.0 109.927 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -169.01 -122.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.79 27.57 3.8 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.392 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 30' ' ' LEU . 66.0 m -160.89 131.57 5.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.859 0.463 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.5 -11.69 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.296 0.569 . . . . 0.0 110.803 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 28' ' ' SER . 8.2 mp -52.68 155.07 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.683 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.57 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.35 47.06 0.68 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.655 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -89.94 160.34 16.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 22' ' ' VAL . 27.9 p -109.2 145.32 36.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.282 0.563 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.42 55.46 3.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 109.615 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.05 -34.4 76.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.477 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.76 -14.37 59.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.029 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.33 -35.7 2.64 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.48 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.3 m -152.39 154.63 35.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.537 0.208 . . . . 0.0 110.444 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.22 135.7 52.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.33 -20.03 25.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 109.662 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.503 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -74.03 140.66 45.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.579 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 p -73.38 136.58 44.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.157 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.71 -2.08 80.68 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.429 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 59.8 m -97.89 133.04 42.93 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -115.32 154.97 28.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.474 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 85.9 m -87.86 115.07 25.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.081 0.467 . . . . 0.0 110.926 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.532 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -89.12 156.13 19.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -37.33 -35.65 0.12 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.989 1.43 . . . . 0.0 114.253 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -78.06 12.24 1.91 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 18' ' ' ASN . 65.4 ttt180 60.47 38.5 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.915 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 4' ' ' THR . 96.1 t -126.84 137.27 58.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.296 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.3 m -68.04 134.37 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.88 0.848 . . . . 0.0 112.984 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -133.23 127.07 32.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.989 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -90.76 -60.34 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -101.3 -41.38 6.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.245 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.18 -26.02 0.55 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.49 135.59 39.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.731 -0.735 . . . . 0.0 110.98 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.48 -34.24 61.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.78 0.8 . . . . 0.0 109.238 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -77.61 61.4 2.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.111 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.117 -179.168 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.13 28.38 53.95 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.512 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.492 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 44.8 tt0 -105.94 159.12 16.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.8 p -126.5 149.11 49.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.539 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 1.8 m -88.19 55.55 3.48 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.125 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.8 tp -57.27 -42.67 82.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.077 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.436 HD22 ' OH ' ' A' ' 11' ' ' TYR . 21.7 tp -73.8 -17.87 61.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.426 0.631 . . . . 0.0 110.112 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.51 -30.3 3.46 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -149.78 151.48 33.64 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 6.7 m -65.61 147.53 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.436 ' OH ' HD22 ' A' ' 7' ' ' LEU . 3.9 m-85 -88.21 -32.62 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.13 140.95 40.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.632 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -81.95 131.39 35.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.608 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.38 -17.05 44.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.828 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.932 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.3 m -88.74 132.76 34.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.104 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.3 p -109.23 151.86 25.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.663 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -87.42 111.99 21.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.665 0.745 . . . . 0.0 111.713 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -82.78 150.46 26.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.974 178.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.27 -39.84 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.835 1.334 . . . . 0.0 113.063 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -78.48 21.0 0.39 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.49 0.662 . . . . 0.0 110.673 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 16.6 tpp180 56.52 38.97 30.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 97.0 t -116.66 133.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.588 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.932 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 59.8 m -79.06 124.02 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.368 0.604 . . . . 0.0 111.078 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 p -125.37 143.14 51.11 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 9.4 ptmm? -69.12 -17.78 63.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.897 0.38 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.573 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 18.1 p-10 -174.49 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.779 0.8 . . . . 0.0 109.171 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.28 -37.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.502 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 17.1 m -83.16 136.55 34.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.243 -0.479 . . . . 0.0 109.953 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -69.95 -25.9 28.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.352 0.596 . . . . 0.0 111.103 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 28' ' ' SER . 2.6 pp -58.7 150.94 22.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.397 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 25' ' ' LYS . 66.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.536 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.022 0.439 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.56 68.26 1.23 Allowed Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.228 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.98 160.1 40.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.7 p -120.98 153.53 37.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.055 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.4 54.41 3.14 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.471 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 tp -55.84 -40.09 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.348 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.15 -12.8 59.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.82 -35.32 2.57 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.575 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.452 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.65 150.0 29.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 m -63.42 138.17 58.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.671 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.32 -30.28 38.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 140.37 44.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.955 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -79.96 135.7 36.46 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.108 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.12 -14.37 59.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.397 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 67.6 m -89.41 141.37 28.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.891 0.377 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.0 p -116.16 150.59 37.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 68.5 m -88.91 114.73 25.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.579 0.704 . . . . 0.0 111.372 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.59 148.89 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.12 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.66 -39.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.705 1.253 . . . . 0.0 113.486 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.0 21.04 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.397 0.618 . . . . 0.0 110.6 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.2 ttm180 56.29 40.28 29.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.124 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.8 t -118.48 136.27 56.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.47 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.7 m -76.54 130.0 37.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.392 0.615 . . . . 0.0 111.591 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.8 p -126.06 141.19 52.06 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.566 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' A' ' 31' ' ' ASN . 20.6 pttp -78.76 -130.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.052 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.68 -48.53 58.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.994 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.6 40.84 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.463 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 22.1 m -156.86 144.26 18.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.573 0.225 . . . . 0.0 110.522 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.89 -29.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.767 0.794 . . . . 0.0 110.012 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 30' ' ' LEU . 6.8 mp -56.74 155.37 7.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.45 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.629 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 52.1 t-20 . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 0.0 110.533 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.36 -35.37 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.674 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.554 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 33.5 tt0 -56.75 150.86 15.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.658 0.742 . . . . 0.0 111.928 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.4 p -123.59 154.33 39.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.191 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.96 50.19 1.94 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.229 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.73 -36.42 83.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.904 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.1 tp -84.66 8.14 17.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.639 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.76 -33.65 6.17 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.29 -0.957 . . . . 0.0 110.94 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -149.79 -159.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.691 ' H ' HG22 ' A' ' 9' ' ' THR . 61.5 m -137.08 146.65 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.0 -26.54 33.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.464 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.4 m -69.72 140.77 53.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.667 0.746 . . . . 0.0 111.162 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -85.56 136.44 33.4 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.714 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 -5.19 81.33 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.681 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.3 m -89.4 136.37 33.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.45 151.09 28.97 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -86.24 112.06 21.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.693 0.759 . . . . 0.0 111.103 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.509 ' OD1' ' HG2' ' A' ' 19' ' ' LYS . 2.3 t30 -86.95 149.33 24.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.744 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 18' ' ' ASN . 9.3 ptpp? -35.65 -42.66 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 125.048 1.467 . . . . 0.0 113.794 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -78.64 20.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.253 0.549 . . . . 0.0 111.045 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 19' ' ' LYS . 2.3 tpp180 56.97 39.38 29.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.28 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 62.8 t -117.58 132.19 68.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.5 m -84.79 123.57 30.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.171 0.986 . . . . 0.0 111.638 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 29' ' ' VAL . 23.2 p -120.87 128.27 52.66 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.894 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 26' ' ' ASP . 42.4 tttm -86.11 -75.17 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 25' ' ' LYS . 73.7 m-20 -88.9 50.45 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 0.0 110.099 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.87 -43.89 2.0 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.015 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -85.61 155.64 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.692 0.282 . . . . 0.0 110.472 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 24' ' ' THR . 37.2 t -63.31 -26.34 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.672 0.748 . . . . 0.0 110.465 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.62 152.08 19.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.078 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.091 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.862 0.363 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.98 38.99 1.71 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 13.6 tt0 -76.6 177.91 7.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.635 -0.782 . . . . 0.0 110.062 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 p -134.46 146.61 49.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m -86.72 57.16 4.34 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.939 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 7' ' ' LEU . 2.6 pt? -59.25 -36.94 76.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 6' ' ' LEU . 91.5 mt -91.57 19.75 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.632 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.74 -43.83 1.91 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.469 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 33.5 m -154.19 142.35 20.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.753 -0.223 . . . . 0.0 110.489 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.44 138.39 40.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 110.663 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -86.85 -10.61 53.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -72.21 141.95 49.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.685 0.755 . . . . 0.0 111.395 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -77.7 136.41 38.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.69 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.6 -6.7 77.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.665 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 68.5 m -104.41 130.49 52.29 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.83 0.348 . . . . 0.0 110.291 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.7 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.9 p -116.35 152.79 33.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 21.8 m -87.23 116.95 25.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.84 0.829 . . . . 0.0 111.848 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.4 t30 -90.03 149.86 22.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.363 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.1 -40.14 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.78 1.3 . . . . 0.0 113.708 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.52 22.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.546 . . . . 0.0 110.766 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.2 ttm180 56.03 40.55 30.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.047 0.939 . . . . 0.0 109.93 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.2 t -117.14 130.24 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 72.5 m -85.35 114.76 22.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.556 0.693 . . . . 0.0 110.628 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -128.64 156.59 43.17 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.042 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.8 ptmm? -81.3 0.88 35.01 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.498 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 179.92 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.637 0.732 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.05 -33.7 0.25 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -71.71 140.84 49.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.173 -1.013 . . . . 0.0 110.079 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.4 t -70.72 -16.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.439 0.638 . . . . 0.0 111.168 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.73 146.46 54.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 123.629 0.772 . . . . 0.0 111.465 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.657 0.265 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.69 41.65 1.46 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.413 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.657 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 14.0 tp10 -89.73 155.62 19.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 110.226 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.696 HG22 HG22 ' A' ' 22' ' ' VAL . 21.3 p -123.8 151.22 43.58 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.911 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 1.5 m -88.32 55.22 3.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.07 0.462 . . . . 0.0 109.807 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.88 -41.74 74.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.814 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 mp -94.31 23.97 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.244 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -39.59 2.7 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.646 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 28.6 m -150.57 143.14 24.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.893 0.378 . . . . 0.0 110.06 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.657 ' HB3' ' CG ' ' A' ' 3' ' ' GLU . 3.6 m -68.56 148.49 50.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.08 -20.54 52.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.747 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 139.1 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.0 111.158 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -89.3 141.11 28.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.523 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.04 -16.81 58.69 Favored Glycine 0 CA--C 1.508 -0.356 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.659 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 56.7 m -89.09 142.59 27.51 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.108 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.781 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.7 p -112.37 149.67 32.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.4 m -85.62 117.66 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 110.96 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -96.16 152.43 18.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.26 -31.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.093 1.496 . . . . 0.0 114.802 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 8.8 t80 -79.96 14.86 1.64 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.526 0.679 . . . . 0.0 110.009 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' LYS . 29.2 ttm180 57.44 39.23 28.24 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.641 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.696 HG22 HG22 ' A' ' 4' ' ' THR . 95.5 t -128.08 138.2 55.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.48 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.7 m -82.22 132.47 35.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -117.64 125.79 51.36 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.249 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -77.06 -27.53 54.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.351 0.596 . . . . 0.0 109.85 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -168.42 -141.32 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.76 -29.77 74.04 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.889 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -85.92 125.16 33.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.305 -0.447 . . . . 0.0 110.887 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.17 -18.13 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.894 0.854 . . . . 0.0 109.5 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.82 168.38 6.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.387 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.772 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.556 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 71.3 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.65 37.22 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.556 ' OE2' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -166.89 -171.53 1.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.387 0.613 . . . . 0.0 110.307 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.794 HG22 HG22 ' A' ' 22' ' ' VAL . 10.6 p -145.63 154.89 42.62 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.298 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.5 m -87.78 55.1 3.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.563 ' HA ' HH12 ' A' ' 21' ' ' ARG . 2.6 pt? -60.23 -40.81 91.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.753 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.12 -16.64 57.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.051 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.49 -35.17 2.31 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 23.9 m -151.89 144.4 24.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.688 0.28 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -75.74 148.54 38.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.59 -18.08 46.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.0 110.427 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.36 142.07 57.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.284 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -91.54 142.07 28.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.469 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.8 -18.44 47.14 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.972 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.7 m -89.11 139.55 30.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.848 0.356 . . . . 0.0 110.599 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.753 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.4 p -113.73 149.46 34.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.902 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -86.11 116.55 24.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.498 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -92.01 153.43 19.44 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -37.09 -31.96 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.143 1.527 . . . . 0.0 114.75 -177.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.625 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.8 t80 -82.08 20.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.273 0.559 . . . . 0.0 109.927 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.7 ptm180 49.86 42.17 23.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.14 1.376 . . . . 0.0 110.341 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.794 HG22 HG22 ' A' ' 4' ' ' THR . 87.7 t -126.76 136.25 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.332 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.972 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.8 m -79.84 132.72 36.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.182 0.992 . . . . 0.0 113.511 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -118.68 123.38 44.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.012 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 23.9 ttpp -88.84 -45.03 10.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.431 0.634 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -167.35 -144.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.887 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.68 33.97 2.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.044 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -72.03 130.06 40.04 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.5 t -56.6 -35.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.928 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -108.37 26.69 10.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.283 179.815 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.02 44.33 1.82 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.661 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.558 ' OE2' ' HB3' ' A' ' 10' ' ' CYS . 8.0 pt-20 -83.72 176.91 8.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.721 HG22 HG22 ' A' ' 22' ' ' VAL . 23.5 p -106.92 149.01 27.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.636 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.502 ' HB2' ' HD2' ' A' ' 21' ' ' ARG . 1.7 m -87.65 56.86 4.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -59.15 -34.62 72.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.489 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.99 17.08 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.29 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.46 4.85 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -147.99 145.93 28.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.558 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 19.9 m -66.86 153.49 43.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.861 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -74.82 -25.93 59.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.166 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -80.06 142.72 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.357 0.598 . . . . 0.0 110.517 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -93.8 143.62 26.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.882 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.7 74.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 25.5 m -89.51 147.34 24.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.791 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.5 p -110.59 147.81 33.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.347 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -86.51 112.09 21.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.496 0.665 . . . . 0.0 110.694 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -82.52 152.77 25.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.439 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.51 -38.7 0.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.868 1.355 . . . . 0.0 113.158 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.5 t80 -77.15 17.61 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.567 0.698 . . . . 0.0 110.474 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.502 ' HD2' ' HB2' ' A' ' 5' ' ' CYS . 17.1 tpp180 56.79 41.7 27.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.981 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 4' ' ' THR . 89.9 t -128.4 136.34 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.906 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 16' ' ' THR . 1.5 m -77.01 136.12 38.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -122.35 136.66 54.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.57 -1.65 . . . . 0.0 109.102 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.685 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -86.38 -136.99 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.685 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 1.3 m-20 -73.03 -30.52 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.402 0.62 . . . . 0.0 109.932 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -52.78 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.979 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 134.51 45.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 t -87.09 -16.52 9.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.49 0.662 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.75 67.89 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.942 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 179.662 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 63.5 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.57 -48.21 2.2 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.263 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -60.75 157.5 14.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 21' ' ' ARG . 42.7 p -106.65 163.61 12.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.584 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 m -85.46 59.51 5.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.0 tp -56.87 -38.49 72.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.39 15.71 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.44 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.93 -42.26 2.06 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.617 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.663 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 44.9 m -155.26 141.92 18.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.096 . . . . 0.0 110.774 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.6 134.03 36.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -86.34 1.59 50.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.118 0.485 . . . . 0.0 110.308 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 140.4 49.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.455 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.8 p -73.29 129.9 39.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.38 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.33 -15.73 61.51 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.521 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.6 m -89.56 135.3 33.68 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.069 0.461 . . . . 0.0 110.747 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.8 p -126.21 159.45 32.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 62.0 m -88.96 119.82 29.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.876 0.846 . . . . 0.0 112.333 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -89.59 147.18 24.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.082 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.35 -32.96 0.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.629 1.206 . . . . 0.0 113.779 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.85 25.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.47 0.652 . . . . 0.0 110.16 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 4' ' ' THR . 25.7 ttp180 55.48 41.03 31.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.829 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.73 131.98 66.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.646 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.6 m -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.35 0.595 . . . . 0.0 109.603 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 p -128.33 144.33 51.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.817 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 4.8 ttpt -70.6 -30.63 67.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.428 0.632 . . . . 0.0 110.419 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -153.31 -44.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.68 -35.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -78.68 137.26 37.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.98 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -79.1 -9.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.85 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.33 61.53 2.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.287 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.013 179.495 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 t . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.626 0.251 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.33 116.57 0.85 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -174.98 168.26 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 p -100.69 146.94 26.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.058 0.456 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 5.4 m -87.23 60.3 6.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.85 -37.86 74.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.502 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.0 mt -86.43 16.46 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.163 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.72 -41.7 2.42 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.766 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 62.2 m -155.93 141.27 17.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.127 . . . . 0.0 111.28 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.6 m -83.42 128.37 34.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.16 32.2 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -91.56 143.61 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.46 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -72.61 129.19 37.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.303 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.92 10.38 83.08 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.325 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 63.5 m -114.56 145.93 41.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.92 0.39 . . . . 0.0 110.625 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 p -138.21 151.9 48.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 26.3 m -88.86 123.92 33.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.786 0.803 . . . . 0.0 112.099 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.414 HD22 ' HB ' ' A' ' 22' ' ' VAL . 1.9 t30 -88.68 151.06 22.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.552 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -40.5 -38.84 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.514 1.134 . . . . 0.0 113.503 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -81.03 24.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 110.669 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.4 ttm180 56.04 42.04 28.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.926 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 18' ' ' ASN . 55.2 t -116.05 122.14 68.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 14.4 m -74.91 116.32 15.51 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 28' ' ' SER . 66.1 p -133.26 -159.24 0.95 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -90.51 -30.33 17.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -168.87 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.359 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' A' ' 24' ' ' THR . 19.3 m -80.4 139.39 36.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.04 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 t -67.75 -6.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.46 0.648 . . . . 0.0 111.411 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 28' ' ' SER . 7.5 mp -65.97 144.69 56.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.503 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.885 0.874 . . . . 0.0 111.943 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 51.2 t . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 48.28 1.81 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.301 -0.475 . . . . 0.0 111.961 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.67 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -88.52 174.96 7.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.152 0.581 . . . . 0.0 110.385 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -142.11 145.05 33.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.795 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.524 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 2.8 m -94.3 56.69 2.21 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.246 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.45 -42.37 82.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.092 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -74.99 -16.16 60.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.385 0.612 . . . . 0.0 110.178 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.8 -32.08 2.96 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.481 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 17.4 m -143.74 153.92 42.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.35 139.35 37.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -80.29 -27.55 38.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -90.75 148.06 22.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.78 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 p -85.42 148.24 26.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.89 90.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.739 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.1 m -108.06 140.71 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 41.5 p -109.81 149.5 29.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.44 0.162 . . . . 0.0 110.867 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 99.2 m -88.35 111.71 22.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.979 0.418 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.55 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -87.96 152.3 22.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -39.49 -28.75 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.817 1.323 . . . . 0.0 114.414 -176.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 9.97 4.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.973 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 17.4 tpp180 60.58 36.42 19.81 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.299 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 84.5 t -122.61 138.85 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.625 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 61.7 m -75.11 133.71 41.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.846 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -133.92 145.41 49.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.973 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 1' ' ' CYS . 28.7 mmmt -92.76 -89.8 0.19 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.25 -38.47 56.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.276 1.036 . . . . 0.0 108.817 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.95 -34.13 0.28 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 m -72.15 134.19 45.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.464 -0.868 . . . . 0.0 110.286 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.42 -25.01 19.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.62 62.52 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.349 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.488 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 16.9 t-20 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 25' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.19 45.78 38.21 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.617 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.651 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 4.2 tp10 -152.95 157.89 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 p -141.57 149.99 41.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.832 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.03 52.61 2.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.287 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.71 -45.47 85.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.635 ' HG ' ' HE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -74.4 -16.68 60.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.537 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.5 -31.27 3.01 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.474 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.582 ' O ' HD11 ' A' ' 7' ' ' LEU . 25.7 m -151.91 139.74 19.93 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.028 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.0 138.04 49.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.594 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.635 ' HE1' ' HG ' ' A' ' 7' ' ' LEU . 3.9 m-85 -81.01 -32.65 34.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.96 139.92 43.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -82.73 140.18 33.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.51 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 -18.37 56.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.426 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 60.4 m -89.92 138.88 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.549 -0.325 . . . . 0.0 110.312 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.05 150.52 29.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.1 m -87.33 117.01 25.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 0.0 111.177 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.582 ' OD1' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -99.22 150.29 22.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -38.33 -30.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 O-C-N 125.041 1.463 . . . . 0.0 114.565 -177.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 t80 -78.23 11.14 2.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.421 0.629 . . . . 0.0 109.89 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' LYS . 5.7 tpp85 60.68 33.6 20.22 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.704 1.201 . . . . 0.0 109.701 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.577 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 60.2 t -119.08 140.77 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.1 m -83.5 120.4 25.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.606 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.88 127.62 52.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.118 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.817 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 40.5 tttm -110.52 -152.15 0.49 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.817 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -70.82 -74.13 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.185 0.517 . . . . 0.0 111.692 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.99 40.33 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -66.57 165.58 14.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.249 -0.476 . . . . 0.0 110.512 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -42.42 -50.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -112.81 31.39 6.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.052 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 22.5 t-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.218 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 58.6 27.8 61.74 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.797 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 25.1 tt0 -101.27 164.93 11.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.0 p -134.32 148.11 50.7 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -88.27 54.13 2.97 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.153 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.84 -39.47 77.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.054 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.02 -13.47 59.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.529 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.92 -35.61 2.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.7 m -151.62 151.44 31.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.6 m -63.24 144.42 56.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.277 0.56 . . . . 0.0 112.215 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.59 -30.14 18.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.856 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -83.64 146.23 28.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.542 0.687 . . . . 0.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 p -79.29 144.53 34.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.79 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.71 -20.88 44.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 63.9 m -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.1 p -113.25 157.12 22.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.9 113.95 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.656 0.741 . . . . 0.0 111.635 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.85 149.76 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.993 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -38.89 -38.81 0.46 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.62 1.2 . . . . 0.0 113.699 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.24 21.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.376 0.608 . . . . 0.0 110.524 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 19' ' ' LYS . 26.9 ttm180 56.47 39.54 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.005 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 93.9 t -116.67 134.9 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.768 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.4 m -79.43 122.6 26.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.394 0.616 . . . . 0.0 111.055 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 29' ' ' VAL . 14.1 p -133.72 139.58 46.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.162 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -90.84 -96.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.63 -36.74 76.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.619 0.723 . . . . 0.0 110.356 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.08 -42.3 0.23 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 m -78.4 151.2 32.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.229 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 24' ' ' THR . 23.6 t -65.53 -23.07 32.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.587 0.708 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -56.95 154.37 9.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.969 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.142 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.23 69.05 1.11 Allowed Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.21 161.2 41.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.45 HG22 HG22 ' A' ' 22' ' ' VAL . 21.5 p -116.03 155.64 27.74 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.03 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.67 58.4 5.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.436 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.27 -40.84 68.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.11 19.48 4.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.508 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.41 -37.26 3.56 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 21.4 m -151.08 148.73 28.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.651 0.262 . . . . 0.0 110.797 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.6 m -66.93 137.09 56.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.337 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.56 -26.48 30.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.0 109.931 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.33 140.04 50.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -79.59 134.12 36.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.165 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -19.13 53.92 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.161 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.1 m -88.63 135.73 33.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.9 p -114.89 155.5 26.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 65.8 m -89.05 114.73 25.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.67 0.748 . . . . 0.0 111.643 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.5 t30 -83.53 150.35 26.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.034 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.16 -39.72 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 0.0 113.676 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.59 22.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 110.777 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 19' ' ' LYS . 46.7 ttp180 56.11 41.82 29.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.61 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 89.5 t -119.53 135.38 60.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -73.34 130.06 39.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 111.298 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 p -136.77 148.52 47.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.044 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 9.3 ptmm? -73.71 -140.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' CG ' ' HZ3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -58.77 -35.47 72.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 110.23 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.51 45.3 0.11 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.703 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.675 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -160.75 151.92 18.99 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.621 -0.341 . . . . 0.0 110.252 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.59 -14.28 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.719 0.771 . . . . 0.0 109.657 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -56.61 143.56 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.257 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.4 p30 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 113.104 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.48 -50.73 0.87 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.257 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 20.6 pt-20 -97.97 -166.88 1.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.216 1.007 . . . . 0.0 111.872 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 22' ' ' VAL . 2.2 p -147.71 156.27 42.59 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.02 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -87.21 55.62 3.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.369 0.604 . . . . 0.0 110.378 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.86 -36.54 84.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.675 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.33 -23.38 59.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.29 -30.42 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.4 m -150.9 152.08 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.89 144.06 53.68 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.563 0.539 . . . . 0.0 111.615 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -82.55 -31.54 29.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.85 143.04 29.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.9 p -85.69 131.84 34.26 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.815 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 -20.69 19.68 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 77.0 m -92.4 143.45 26.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.367 -0.417 . . . . 0.0 109.875 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.5 p -118.45 151.76 37.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.265 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 73.8 m -88.13 111.22 21.34 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.522 ' OD1' ' HB ' ' A' ' 22' ' ' VAL . 4.6 p-10 -83.98 154.24 23.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.0 -33.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.4 t80 -85.36 23.29 1.34 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 0.0 110.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ASN . 13.5 ptm180 49.47 39.67 17.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.133 1.373 . . . . 0.0 110.644 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HB ' ' OD1' ' A' ' 18' ' ' ASN . 57.9 t -107.85 154.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.488 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 74.1 m -96.18 129.26 43.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.956 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.77 127.95 45.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.312 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 41.1 tttm -92.67 -146.15 0.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.483 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 9.3 p-10 -75.97 -48.98 19.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.0 40.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.188 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -74.28 135.53 42.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.57 -36.16 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.324 0.583 . . . . 0.0 111.56 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.809 HD23 ' H ' ' A' ' 30' ' ' LEU . 2.3 pt? -98.9 31.53 2.94 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.737 0.815 . . . . 0.0 111.664 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.329 0.109 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.27 89.51 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.614 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -160.61 155.88 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 110.233 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.74 HG22 HG22 ' A' ' 22' ' ' VAL . 40.3 p -119.56 155.84 31.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.082 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 m -87.89 56.26 3.81 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.455 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.8 tp -59.66 -41.34 90.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.211 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.14 -22.47 64.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.992 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.49 -26.51 4.1 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -150.51 156.14 40.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.4 m -58.41 139.56 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -83.51 -22.01 32.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.234 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.08 145.04 29.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.067 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 p -78.09 146.34 35.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.678 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.2 -4.72 85.1 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.807 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 91.2 m -99.51 138.93 35.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -113.14 150.35 32.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.965 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.94 111.94 21.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.073 0.463 . . . . 0.0 110.146 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -88.57 156.47 19.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.64 -30.15 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 125.232 1.583 . . . . 0.0 114.874 -177.477 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.543 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 6.3 t80 -82.4 13.17 3.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.704 0.764 . . . . 0.0 109.774 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' ASN . 66.0 ttt180 58.58 38.74 25.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.219 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.74 HG22 HG22 ' A' ' 4' ' ' THR . 72.3 t -122.8 136.65 58.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.46 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.0 m -70.68 128.52 36.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.397 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.57 139.69 52.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.43 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HE3' ' SG ' ' A' ' 15' ' ' CYS . 33.3 ttmt -119.54 -43.61 2.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.678 0.275 . . . . 0.0 110.654 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 27' ' ' GLY . 25.9 t70 -159.91 -148.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 26' ' ' ASP . . . -79.19 46.7 3.03 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.522 -0.37 . . . . 0.0 112.284 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -73.73 133.46 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.13 -37.0 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 tp -126.4 37.43 4.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.006 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.686 ' HB3' ' O ' ' A' ' 23' ' ' CYS . 5.9 m120 . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.463 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.458 ' SG ' ' HE3' ' A' ' 25' ' ' LYS . 27.4 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.868 ' HA3' HG13 ' A' ' 29' ' ' VAL . . . -75.28 47.08 1.96 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.494 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.515 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 16.5 pt-20 -83.31 -164.24 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.827 0.822 . . . . 0.0 109.757 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.456 HG22 HG22 ' A' ' 22' ' ' VAL . 17.1 p -134.61 149.04 50.54 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.734 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.44 54.65 3.12 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.923 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.5 pt? -60.34 -38.94 85.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.551 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.2 tp -73.69 -19.6 60.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.075 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.69 -29.87 3.5 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -150.75 154.14 36.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.58 142.7 52.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.266 0.626 . . . . 0.0 112.411 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.49 -33.1 48.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.681 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -84.22 145.82 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.75 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.4 p -81.92 144.39 30.99 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.102 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.96 -4.96 85.27 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.947 -0.569 . . . . 0.0 113.142 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.681 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 6.6 m -90.96 145.52 24.65 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 48.2 p -116.11 150.39 37.46 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.732 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -87.78 112.54 22.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.73 0.776 . . . . 0.0 111.346 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 19' ' ' LYS . 2.6 t30 -80.73 148.7 30.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -42.38 -32.43 0.52 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.2 t80 -82.09 20.55 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.5 ttm180 56.06 40.05 30.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.06 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 88.4 t -118.38 133.99 63.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.398 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 16' ' ' THR . 84.7 m -78.43 129.19 34.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.612 0.72 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -134.74 141.2 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.305 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.458 ' HE3' ' SG ' ' A' ' 1' ' ' CYS . 37.7 ttmt -120.27 -50.85 2.22 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.613 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -140.93 40.48 1.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.281 1.039 . . . . 0.0 108.613 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 -44.06 1.36 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.34 134.16 52.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 0.0 112.217 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.868 HG13 ' HA3' ' A' ' 2' ' ' GLY . 42.2 t -76.67 -18.48 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.75 61.4 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.616 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.581 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.941 ' HB2' ' HG3' ' A' ' 25' ' ' LYS . 56.6 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.887 0.375 . . . . 0.0 111.781 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.68 45.28 0.43 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.524 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -135.22 -168.92 2.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.74 0.781 . . . . 0.0 111.727 -177.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -137.91 155.04 49.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.327 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 2.2 m -89.28 52.4 2.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.355 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.35 -42.26 73.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.646 HD11 ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -76.74 -17.07 59.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.68 2.86 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.709 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.646 ' O ' HD11 ' A' ' 7' ' ' LEU . 27.9 m -153.08 139.41 18.52 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -58.33 136.26 57.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.397 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -77.75 -34.35 52.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.22 0.533 . . . . 0.0 109.709 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.848 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.06 145.0 51.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.509 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.4 p -82.77 140.27 33.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.895 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.23 0.56 70.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.66 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.848 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 8.9 m -98.91 138.71 35.64 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 7.2 p -117.79 146.81 43.56 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.7 m -89.91 118.56 29.57 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.64 149.1 22.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.7 ptpt -35.49 -38.46 0.11 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.075 1.484 . . . . 0.0 114.433 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.2 t80 -76.23 16.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.441 0.638 . . . . 0.0 110.58 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 19' ' ' LYS . 23.9 ttm180 57.27 35.77 26.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.392 1.077 . . . . 0.0 110.035 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 91.9 t -118.75 135.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 16' ' ' THR . 60.1 m -76.68 125.13 28.72 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.825 0.821 . . . . 0.0 112.097 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.2 133.93 45.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.941 ' HG3' ' HB2' ' A' ' 1' ' ' CYS . 1.6 mptp? -79.24 125.44 29.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.661 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -108.41 145.87 33.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.442 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.21 -47.8 3.24 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.536 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -152.83 135.81 15.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.887 0.375 . . . . 0.0 109.991 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.29 -32.03 45.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.351 0.595 . . . . 0.0 111.134 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.29 80.3 9.25 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.999 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 0.0 110.72 179.856 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 25' ' ' LYS . 8.9 t . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 69.22 1.44 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -145.41 162.63 36.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.732 0.301 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -108.98 155.95 20.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.423 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 m -85.95 60.17 6.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.89 -38.86 79.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.779 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.53 12.97 7.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.626 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.58 -42.19 2.0 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.718 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 41.3 m -154.5 142.93 20.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 m -75.77 135.59 40.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -81.7 -4.07 55.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.322 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.683 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.46 140.57 51.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.709 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 p -74.09 132.81 42.65 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.805 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 87.34 -5.96 84.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.895 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.683 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 73.4 m -90.11 142.35 27.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.819 0.343 . . . . 0.0 110.677 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.2 p -128.74 152.36 48.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 59.2 m -89.37 119.16 29.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.686 0.755 . . . . 0.0 111.656 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 t-20 -88.68 146.85 24.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.278 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.29 -28.21 0.31 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.623 1.202 . . . . 0.0 113.88 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -86.29 20.91 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.545 0.688 . . . . 0.0 109.578 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' ASN . 59.8 ttt180 57.27 40.55 27.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.723 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.06 133.74 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.371 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' THR . 55.7 m -80.15 124.5 28.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.216 0.532 . . . . 0.0 110.067 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.0 p -125.83 126.11 43.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HZ2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -83.77 -15.49 48.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 109.767 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' HB2' ' HZ2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -156.3 -154.23 0.47 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 -177.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.17 75.93 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -104.52 150.68 24.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.369 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 t -71.88 -2.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -52.77 147.34 8.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.632 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.4 m . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.16 61.49 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.764 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 34.2 tt0 -114.3 166.01 12.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.278 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.69 HG22 HG22 ' A' ' 22' ' ' VAL . 18.7 p -133.03 146.88 52.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.328 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.62 55.64 2.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.0 pt? -60.76 -34.48 74.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.47 -19.48 57.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.151 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.31 -31.03 3.37 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.525 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.28 152.29 33.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.9 m -58.54 144.91 41.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 0.0 111.951 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.29 -32.38 24.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.927 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 m -91.31 146.67 23.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -85.24 139.56 31.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -25.9 17.34 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.516 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 62.9 m -90.74 142.75 27.43 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.862 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.9 p -115.06 150.66 35.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.343 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 97.1 m -87.46 114.14 23.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.023 0.439 . . . . 0.0 111.166 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.629 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -90.9 151.72 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.435 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -36.52 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.997 1.436 . . . . 0.0 114.844 -177.651 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 8.4 t80 -82.78 21.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.16 0.505 . . . . 0.0 110.024 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.5 ptp85 51.31 39.98 25.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.125 1.37 . . . . 0.0 110.165 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.69 HG22 HG22 ' A' ' 4' ' ' THR . 87.5 t -121.48 133.77 66.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.8 m -74.37 124.67 26.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -127.64 145.01 51.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.498 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -75.4 -36.93 60.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.254 0.549 . . . . 0.0 109.927 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -169.01 -122.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.79 27.57 3.8 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.392 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 30' ' ' LEU . 66.0 m -160.89 131.57 5.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.859 0.463 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.5 -11.69 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.296 0.569 . . . . 0.0 110.803 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 28' ' ' SER . 8.2 mp -52.68 155.07 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.683 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.57 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.35 47.06 0.68 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.655 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -89.94 160.34 16.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 22' ' ' VAL . 27.9 p -109.2 145.32 36.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.282 0.563 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.42 55.46 3.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 109.615 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.05 -34.4 76.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.477 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.76 -14.37 59.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.029 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.33 -35.7 2.64 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.48 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.3 m -152.39 154.63 35.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.537 0.208 . . . . 0.0 110.444 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.22 135.7 52.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.33 -20.03 25.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 109.662 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.503 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -74.03 140.66 45.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.579 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 p -73.38 136.58 44.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.157 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.71 -2.08 80.68 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.429 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 59.8 m -97.89 133.04 42.93 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -115.32 154.97 28.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.474 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 85.9 m -87.86 115.07 25.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.081 0.467 . . . . 0.0 110.926 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.532 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -89.12 156.13 19.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -37.33 -35.65 0.12 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.989 1.43 . . . . 0.0 114.253 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -78.06 12.24 1.91 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 18' ' ' ASN . 65.4 ttt180 60.47 38.5 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.915 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 4' ' ' THR . 96.1 t -126.84 137.27 58.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.296 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.3 m -68.04 134.37 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.88 0.848 . . . . 0.0 112.984 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -133.23 127.07 32.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.989 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -90.76 -60.34 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -101.3 -41.38 6.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.245 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.18 -26.02 0.55 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.49 135.59 39.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.731 -0.735 . . . . 0.0 110.98 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.48 -34.24 61.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.78 0.8 . . . . 0.0 109.238 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -77.61 61.4 2.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.111 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.117 -179.168 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.13 28.38 53.95 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.512 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.492 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 44.8 tt0 -105.94 159.12 16.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.8 p -126.5 149.11 49.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.539 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 1.8 m -88.19 55.55 3.48 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.125 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.8 tp -57.27 -42.67 82.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.077 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.436 HD22 ' OH ' ' A' ' 11' ' ' TYR . 21.7 tp -73.8 -17.87 61.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.426 0.631 . . . . 0.0 110.112 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.51 -30.3 3.46 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -149.78 151.48 33.64 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.492 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 6.7 m -65.61 147.53 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.436 ' OH ' HD22 ' A' ' 7' ' ' LEU . 3.9 m-85 -88.21 -32.62 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.13 140.95 40.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.632 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -81.95 131.39 35.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.608 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.38 -17.05 44.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.828 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.932 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.3 m -88.74 132.76 34.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.104 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.3 p -109.23 151.86 25.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.663 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -87.42 111.99 21.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.665 0.745 . . . . 0.0 111.713 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.1 t30 -82.78 150.46 26.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.974 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.27 -39.84 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.835 1.334 . . . . 0.0 113.063 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -78.48 21.0 0.39 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.49 0.662 . . . . 0.0 110.673 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 16.6 tpp180 56.52 38.97 30.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 97.0 t -116.66 133.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.588 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.932 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 59.8 m -79.06 124.02 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.368 0.604 . . . . 0.0 111.078 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 p -125.37 143.14 51.11 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 9.4 ptmm? -69.12 -17.78 63.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.897 0.38 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.573 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 18.1 p-10 -174.49 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.779 0.8 . . . . 0.0 109.171 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.28 -37.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.502 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 17.1 m -83.16 136.55 34.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.243 -0.479 . . . . 0.0 109.953 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -69.95 -25.9 28.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.352 0.596 . . . . 0.0 111.103 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 28' ' ' SER . 2.6 pp -58.7 150.94 22.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.397 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 25' ' ' LYS . 66.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.536 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.022 0.439 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.56 68.26 1.23 Allowed Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.228 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.98 160.1 40.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.7 p -120.98 153.53 37.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.055 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.4 54.41 3.14 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.471 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 tp -55.84 -40.09 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.348 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.15 -12.8 59.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.82 -35.32 2.57 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.575 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.452 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.65 150.0 29.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 m -63.42 138.17 58.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.671 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.32 -30.28 38.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 140.37 44.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.955 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -79.96 135.7 36.46 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.108 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.12 -14.37 59.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.397 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 67.6 m -89.41 141.37 28.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.891 0.377 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.0 p -116.16 150.59 37.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 68.5 m -88.91 114.73 25.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.579 0.704 . . . . 0.0 111.372 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.59 148.89 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.12 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.66 -39.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.705 1.253 . . . . 0.0 113.486 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.0 21.04 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.397 0.618 . . . . 0.0 110.6 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.2 ttm180 56.29 40.28 29.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.124 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.8 t -118.48 136.27 56.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.47 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.7 m -76.54 130.0 37.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.392 0.615 . . . . 0.0 111.591 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.8 p -126.06 141.19 52.06 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.566 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' A' ' 31' ' ' ASN . 20.6 pttp -78.76 -130.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.052 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.68 -48.53 58.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.994 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.6 40.84 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.463 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 22.1 m -156.86 144.26 18.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.573 0.225 . . . . 0.0 110.522 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.89 -29.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.767 0.794 . . . . 0.0 110.012 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 30' ' ' LEU . 6.8 mp -56.74 155.37 7.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.45 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.629 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 0.0 110.533 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.36 -35.37 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.674 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.554 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 33.5 tt0 -56.75 150.86 15.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.658 0.742 . . . . 0.0 111.928 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.4 p -123.59 154.33 39.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.191 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.96 50.19 1.94 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.229 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.73 -36.42 83.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.904 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.1 tp -84.66 8.14 17.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.639 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.76 -33.65 6.17 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.29 -0.957 . . . . 0.0 110.94 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -149.79 -159.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.691 ' H ' HG22 ' A' ' 9' ' ' THR . 61.5 m -137.08 146.65 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.0 -26.54 33.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.464 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.4 m -69.72 140.77 53.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.667 0.746 . . . . 0.0 111.162 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -85.56 136.44 33.4 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.714 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 -5.19 81.33 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.681 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.3 m -89.4 136.37 33.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.45 151.09 28.97 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -86.24 112.06 21.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.693 0.759 . . . . 0.0 111.103 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.509 ' OD1' ' HG2' ' A' ' 19' ' ' LYS . 2.3 t30 -86.95 149.33 24.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.744 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 18' ' ' ASN . 9.3 ptpp? -35.65 -42.66 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 125.048 1.467 . . . . 0.0 113.794 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -78.64 20.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.253 0.549 . . . . 0.0 111.045 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 19' ' ' LYS . 2.3 tpp180 56.97 39.38 29.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.28 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 62.8 t -117.58 132.19 68.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.5 m -84.79 123.57 30.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.171 0.986 . . . . 0.0 111.638 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 29' ' ' VAL . 23.2 p -120.87 128.27 52.66 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.894 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 26' ' ' ASP . 42.4 tttm -86.11 -75.17 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 25' ' ' LYS . 73.7 m-20 -88.9 50.45 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 0.0 110.099 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.87 -43.89 2.0 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.015 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -85.61 155.64 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.692 0.282 . . . . 0.0 110.472 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 24' ' ' THR . 37.2 t -63.31 -26.34 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.672 0.748 . . . . 0.0 110.465 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.62 152.08 19.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.078 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.091 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.862 0.363 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.98 38.99 1.71 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 13.6 tt0 -76.6 177.91 7.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.635 -0.782 . . . . 0.0 110.062 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 p -134.46 146.61 49.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m -86.72 57.16 4.34 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.939 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 7' ' ' LEU . 2.6 pt? -59.25 -36.94 76.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 6' ' ' LEU . 91.5 mt -91.57 19.75 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.632 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.74 -43.83 1.91 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.469 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 33.5 m -154.19 142.35 20.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.753 -0.223 . . . . 0.0 110.489 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.44 138.39 40.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 110.663 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -86.85 -10.61 53.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -72.21 141.95 49.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.685 0.755 . . . . 0.0 111.395 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -77.7 136.41 38.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.69 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.6 -6.7 77.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.665 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 68.5 m -104.41 130.49 52.29 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.83 0.348 . . . . 0.0 110.291 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.7 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.9 p -116.35 152.79 33.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 21.8 m -87.23 116.95 25.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.84 0.829 . . . . 0.0 111.848 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.4 t30 -90.03 149.86 22.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.363 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.1 -40.14 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.78 1.3 . . . . 0.0 113.708 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.52 22.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.546 . . . . 0.0 110.766 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.2 ttm180 56.03 40.55 30.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.047 0.939 . . . . 0.0 109.93 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.2 t -117.14 130.24 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 72.5 m -85.35 114.76 22.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.556 0.693 . . . . 0.0 110.628 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -128.64 156.59 43.17 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.042 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.8 ptmm? -81.3 0.88 35.01 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.498 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 179.92 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.637 0.732 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.05 -33.7 0.25 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -71.71 140.84 49.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.173 -1.013 . . . . 0.0 110.079 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.4 t -70.72 -16.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.439 0.638 . . . . 0.0 111.168 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.73 146.46 54.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.7 t30 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 123.629 0.772 . . . . 0.0 111.465 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.657 0.265 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.69 41.65 1.46 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.413 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.657 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 14.0 tp10 -89.73 155.62 19.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 110.226 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.696 HG22 HG22 ' A' ' 22' ' ' VAL . 21.3 p -123.8 151.22 43.58 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.911 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 1.5 m -88.32 55.22 3.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.07 0.462 . . . . 0.0 109.807 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.88 -41.74 74.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.814 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 mp -94.31 23.97 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.244 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -39.59 2.7 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.646 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 28.6 m -150.57 143.14 24.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.893 0.378 . . . . 0.0 110.06 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.657 ' HB3' ' CG ' ' A' ' 3' ' ' GLU . 3.6 m -68.56 148.49 50.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.08 -20.54 52.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.747 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 139.1 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.0 111.158 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -89.3 141.11 28.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.523 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.04 -16.81 58.69 Favored Glycine 0 CA--C 1.508 -0.356 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.659 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 56.7 m -89.09 142.59 27.51 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.108 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.781 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.7 p -112.37 149.67 32.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.4 m -85.62 117.66 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 110.96 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -96.16 152.43 18.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.26 -31.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.093 1.496 . . . . 0.0 114.802 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 8.8 t80 -79.96 14.86 1.64 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.526 0.679 . . . . 0.0 110.009 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' LYS . 29.2 ttm180 57.44 39.23 28.24 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.641 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.696 HG22 HG22 ' A' ' 4' ' ' THR . 95.5 t -128.08 138.2 55.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.48 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.7 m -82.22 132.47 35.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -117.64 125.79 51.36 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.249 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -77.06 -27.53 54.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.351 0.596 . . . . 0.0 109.85 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -168.42 -141.32 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.76 -29.77 74.04 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.889 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -85.92 125.16 33.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.305 -0.447 . . . . 0.0 110.887 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.17 -18.13 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.894 0.854 . . . . 0.0 109.5 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.82 168.38 6.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.387 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.772 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.556 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 71.3 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.65 37.22 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.556 ' OE2' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -166.89 -171.53 1.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.387 0.613 . . . . 0.0 110.307 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.794 HG22 HG22 ' A' ' 22' ' ' VAL . 10.6 p -145.63 154.89 42.62 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.298 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.5 m -87.78 55.1 3.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.563 ' HA ' HH12 ' A' ' 21' ' ' ARG . 2.6 pt? -60.23 -40.81 91.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.753 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.12 -16.64 57.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.051 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.49 -35.17 2.31 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 23.9 m -151.89 144.4 24.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.688 0.28 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -75.74 148.54 38.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.59 -18.08 46.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.0 110.427 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.36 142.07 57.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.284 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -91.54 142.07 28.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.469 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.8 -18.44 47.14 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.972 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.7 m -89.11 139.55 30.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.848 0.356 . . . . 0.0 110.599 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.753 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.4 p -113.73 149.46 34.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.902 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -86.11 116.55 24.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.498 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -92.01 153.43 19.44 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -37.09 -31.96 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.143 1.527 . . . . 0.0 114.75 -177.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.625 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.8 t80 -82.08 20.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.273 0.559 . . . . 0.0 109.927 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.7 ptm180 49.86 42.17 23.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.14 1.376 . . . . 0.0 110.341 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.794 HG22 HG22 ' A' ' 4' ' ' THR . 87.7 t -126.76 136.25 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.332 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.972 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.8 m -79.84 132.72 36.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.182 0.992 . . . . 0.0 113.511 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -118.68 123.38 44.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.012 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 23.9 ttpp -88.84 -45.03 10.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.431 0.634 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -167.35 -144.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.887 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.68 33.97 2.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.044 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -72.03 130.06 40.04 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.5 t -56.6 -35.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.928 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.727 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.3 pt? -108.37 26.69 10.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.283 179.815 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.02 44.33 1.82 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.661 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.558 ' OE2' ' HB3' ' A' ' 10' ' ' CYS . 8.0 pt-20 -83.72 176.91 8.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.721 HG22 HG22 ' A' ' 22' ' ' VAL . 23.5 p -106.92 149.01 27.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.636 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.502 ' HB2' ' HD2' ' A' ' 21' ' ' ARG . 1.7 m -87.65 56.86 4.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -59.15 -34.62 72.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.489 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.99 17.08 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.29 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.46 4.85 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -147.99 145.93 28.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.558 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 19.9 m -66.86 153.49 43.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.861 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -74.82 -25.93 59.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.166 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -80.06 142.72 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.357 0.598 . . . . 0.0 110.517 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -93.8 143.62 26.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.882 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.7 74.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 25.5 m -89.51 147.34 24.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.791 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.5 p -110.59 147.81 33.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.347 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -86.51 112.09 21.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.496 0.665 . . . . 0.0 110.694 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -82.52 152.77 25.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.439 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.51 -38.7 0.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.868 1.355 . . . . 0.0 113.158 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.5 t80 -77.15 17.61 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.567 0.698 . . . . 0.0 110.474 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.502 ' HD2' ' HB2' ' A' ' 5' ' ' CYS . 17.1 tpp180 56.79 41.7 27.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.981 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 4' ' ' THR . 89.9 t -128.4 136.34 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.906 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 16' ' ' THR . 1.5 m -77.01 136.12 38.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -122.35 136.66 54.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.57 -1.65 . . . . 0.0 109.102 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.685 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -86.38 -136.99 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.685 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 1.3 m-20 -73.03 -30.52 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.402 0.62 . . . . 0.0 109.932 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -52.78 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.979 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 134.51 45.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 t -87.09 -16.52 9.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.49 0.662 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.75 67.89 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.942 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 179.662 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 63.5 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.57 -48.21 2.2 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.263 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -60.75 157.5 14.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 21' ' ' ARG . 42.7 p -106.65 163.61 12.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.584 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 m -85.46 59.51 5.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.0 tp -56.87 -38.49 72.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.39 15.71 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.44 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.93 -42.26 2.06 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.617 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.663 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 44.9 m -155.26 141.92 18.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.096 . . . . 0.0 110.774 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.6 134.03 36.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -86.34 1.59 50.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.118 0.485 . . . . 0.0 110.308 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 140.4 49.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.455 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.8 p -73.29 129.9 39.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.38 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.33 -15.73 61.51 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.521 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.6 m -89.56 135.3 33.68 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.069 0.461 . . . . 0.0 110.747 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.8 p -126.21 159.45 32.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 62.0 m -88.96 119.82 29.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.876 0.846 . . . . 0.0 112.333 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -89.59 147.18 24.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.082 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.35 -32.96 0.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.629 1.206 . . . . 0.0 113.779 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.85 25.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.47 0.652 . . . . 0.0 110.16 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 4' ' ' THR . 25.7 ttp180 55.48 41.03 31.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.829 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.73 131.98 66.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.646 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.6 m -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.35 0.595 . . . . 0.0 109.603 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 p -128.33 144.33 51.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.817 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 4.8 ttpt -70.6 -30.63 67.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.428 0.632 . . . . 0.0 110.419 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -153.31 -44.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.68 -35.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -78.68 137.26 37.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.98 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -79.1 -9.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.85 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.33 61.53 2.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.287 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.013 179.495 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 t . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.626 0.251 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.33 116.57 0.85 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -174.98 168.26 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 p -100.69 146.94 26.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.058 0.456 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 5.4 m -87.23 60.3 6.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.85 -37.86 74.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.502 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.0 mt -86.43 16.46 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.163 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.72 -41.7 2.42 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.766 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 62.2 m -155.93 141.27 17.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.127 . . . . 0.0 111.28 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.6 m -83.42 128.37 34.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.16 32.2 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -91.56 143.61 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.46 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -72.61 129.19 37.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.303 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.92 10.38 83.08 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.325 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 63.5 m -114.56 145.93 41.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.92 0.39 . . . . 0.0 110.625 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 p -138.21 151.9 48.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 26.3 m -88.86 123.92 33.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.786 0.803 . . . . 0.0 112.099 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.414 HD22 ' HB ' ' A' ' 22' ' ' VAL . 1.9 t30 -88.68 151.06 22.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.552 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -40.5 -38.84 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.514 1.134 . . . . 0.0 113.503 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -81.03 24.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 110.669 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.4 ttm180 56.04 42.04 28.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.926 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 18' ' ' ASN . 55.2 t -116.05 122.14 68.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 14.4 m -74.91 116.32 15.51 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 28' ' ' SER . 66.1 p -133.26 -159.24 0.95 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -90.51 -30.33 17.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -168.87 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.359 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' A' ' 24' ' ' THR . 19.3 m -80.4 139.39 36.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.04 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 t -67.75 -6.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.46 0.648 . . . . 0.0 111.411 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 28' ' ' SER . 7.5 mp -65.97 144.69 56.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.503 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.885 0.874 . . . . 0.0 111.943 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 51.2 t . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 48.28 1.81 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.301 -0.475 . . . . 0.0 111.961 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.67 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -88.52 174.96 7.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.152 0.581 . . . . 0.0 110.385 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -142.11 145.05 33.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.795 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.524 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 2.8 m -94.3 56.69 2.21 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.246 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.45 -42.37 82.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.092 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -74.99 -16.16 60.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.385 0.612 . . . . 0.0 110.178 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.8 -32.08 2.96 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.481 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 17.4 m -143.74 153.92 42.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.35 139.35 37.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -80.29 -27.55 38.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -90.75 148.06 22.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.78 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 p -85.42 148.24 26.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.89 90.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.739 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.1 m -108.06 140.71 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 41.5 p -109.81 149.5 29.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.44 0.162 . . . . 0.0 110.867 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 99.2 m -88.35 111.71 22.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.979 0.418 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.55 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -87.96 152.3 22.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -39.49 -28.75 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.817 1.323 . . . . 0.0 114.414 -176.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 9.97 4.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.973 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 17.4 tpp180 60.58 36.42 19.81 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.299 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 84.5 t -122.61 138.85 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.625 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 61.7 m -75.11 133.71 41.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.846 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -133.92 145.41 49.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.973 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 1' ' ' CYS . 28.7 mmmt -92.76 -89.8 0.19 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.25 -38.47 56.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.276 1.036 . . . . 0.0 108.817 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.95 -34.13 0.28 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 m -72.15 134.19 45.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.464 -0.868 . . . . 0.0 110.286 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.42 -25.01 19.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.62 62.52 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.349 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.488 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 16.9 t-20 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 25' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.19 45.78 38.21 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.617 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.651 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 4.2 tp10 -152.95 157.89 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 p -141.57 149.99 41.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.832 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.03 52.61 2.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.287 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.71 -45.47 85.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.635 ' HG ' ' HE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -74.4 -16.68 60.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.537 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.5 -31.27 3.01 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.474 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.582 ' O ' HD11 ' A' ' 7' ' ' LEU . 25.7 m -151.91 139.74 19.93 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.028 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.0 138.04 49.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.594 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.635 ' HE1' ' HG ' ' A' ' 7' ' ' LEU . 3.9 m-85 -81.01 -32.65 34.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.96 139.92 43.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -82.73 140.18 33.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.51 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 -18.37 56.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.426 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 60.4 m -89.92 138.88 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.549 -0.325 . . . . 0.0 110.312 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.05 150.52 29.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.1 m -87.33 117.01 25.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 0.0 111.177 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.582 ' OD1' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -99.22 150.29 22.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -38.33 -30.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 O-C-N 125.041 1.463 . . . . 0.0 114.565 -177.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 t80 -78.23 11.14 2.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.421 0.629 . . . . 0.0 109.89 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' LYS . 5.7 tpp85 60.68 33.6 20.22 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.704 1.201 . . . . 0.0 109.701 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.577 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 60.2 t -119.08 140.77 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.1 m -83.5 120.4 25.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.606 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.88 127.62 52.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.118 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.817 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 40.5 tttm -110.52 -152.15 0.49 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.817 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -70.82 -74.13 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.185 0.517 . . . . 0.0 111.692 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.99 40.33 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -66.57 165.58 14.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.249 -0.476 . . . . 0.0 110.512 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -42.42 -50.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.3 pt? -112.81 31.39 6.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.052 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 22.5 t-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.218 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.498 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 58.6 27.8 61.74 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.797 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 25.1 tt0 -101.27 164.93 11.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.0 p -134.32 148.11 50.7 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -88.27 54.13 2.97 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.153 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.84 -39.47 77.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.054 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.02 -13.47 59.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.529 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.92 -35.61 2.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.7 m -151.62 151.44 31.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.6 m -63.24 144.42 56.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.277 0.56 . . . . 0.0 112.215 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.59 -30.14 18.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.856 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -83.64 146.23 28.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.542 0.687 . . . . 0.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 p -79.29 144.53 34.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.79 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.71 -20.88 44.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 63.9 m -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.1 p -113.25 157.12 22.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.9 113.95 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.656 0.741 . . . . 0.0 111.635 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.85 149.76 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.993 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -38.89 -38.81 0.46 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.62 1.2 . . . . 0.0 113.699 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.24 21.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.376 0.608 . . . . 0.0 110.524 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 19' ' ' LYS . 26.9 ttm180 56.47 39.54 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.005 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 93.9 t -116.67 134.9 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.768 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.4 m -79.43 122.6 26.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.394 0.616 . . . . 0.0 111.055 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 29' ' ' VAL . 14.1 p -133.72 139.58 46.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.162 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -90.84 -96.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.63 -36.74 76.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.619 0.723 . . . . 0.0 110.356 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.08 -42.3 0.23 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 m -78.4 151.2 32.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.229 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 24' ' ' THR . 23.6 t -65.53 -23.07 32.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.587 0.708 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -56.95 154.37 9.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.969 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.142 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.23 69.05 1.11 Allowed Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.21 161.2 41.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.45 HG22 HG22 ' A' ' 22' ' ' VAL . 21.5 p -116.03 155.64 27.74 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.03 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.67 58.4 5.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.436 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.27 -40.84 68.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.11 19.48 4.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.508 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.41 -37.26 3.56 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 21.4 m -151.08 148.73 28.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.651 0.262 . . . . 0.0 110.797 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.6 m -66.93 137.09 56.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.337 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.56 -26.48 30.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.0 109.931 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.33 140.04 50.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -79.59 134.12 36.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.165 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -19.13 53.92 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.161 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.1 m -88.63 135.73 33.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.9 p -114.89 155.5 26.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 65.8 m -89.05 114.73 25.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.67 0.748 . . . . 0.0 111.643 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.5 t30 -83.53 150.35 26.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.034 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.16 -39.72 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 0.0 113.676 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.59 22.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 110.777 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 19' ' ' LYS . 46.7 ttp180 56.11 41.82 29.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.61 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 89.5 t -119.53 135.38 60.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -73.34 130.06 39.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 111.298 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 p -136.77 148.52 47.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.044 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 9.3 ptmm? -73.71 -140.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' CG ' ' HZ3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -58.77 -35.47 72.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 110.23 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.51 45.3 0.11 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.703 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.675 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -160.75 151.92 18.99 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.621 -0.341 . . . . 0.0 110.252 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.59 -14.28 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.719 0.771 . . . . 0.0 109.657 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -56.61 143.56 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.257 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.4 p30 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 113.104 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.48 -50.73 0.87 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.257 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 20.6 pt-20 -97.97 -166.88 1.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.216 1.007 . . . . 0.0 111.872 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 22' ' ' VAL . 2.2 p -147.71 156.27 42.59 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.02 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -87.21 55.62 3.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.369 0.604 . . . . 0.0 110.378 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.86 -36.54 84.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.675 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.33 -23.38 59.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.29 -30.42 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.4 m -150.9 152.08 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.89 144.06 53.68 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.563 0.539 . . . . 0.0 111.615 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -82.55 -31.54 29.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.85 143.04 29.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.9 p -85.69 131.84 34.26 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.815 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 -20.69 19.68 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 77.0 m -92.4 143.45 26.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.367 -0.417 . . . . 0.0 109.875 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.5 p -118.45 151.76 37.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.265 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 73.8 m -88.13 111.22 21.34 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.522 ' OD1' ' HB ' ' A' ' 22' ' ' VAL . 4.6 p-10 -83.98 154.24 23.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.0 -33.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.4 t80 -85.36 23.29 1.34 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 0.0 110.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ASN . 13.5 ptm180 49.47 39.67 17.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.133 1.373 . . . . 0.0 110.644 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HB ' ' OD1' ' A' ' 18' ' ' ASN . 57.9 t -107.85 154.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.488 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 74.1 m -96.18 129.26 43.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.956 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.77 127.95 45.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.312 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 41.1 tttm -92.67 -146.15 0.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.483 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.577 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 9.3 p-10 -75.97 -48.98 19.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.0 40.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.188 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -74.28 135.53 42.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.57 -36.16 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.324 0.583 . . . . 0.0 111.56 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.3 pt? -98.9 31.53 2.94 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.737 0.815 . . . . 0.0 111.664 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.329 0.109 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.27 89.51 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.614 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -160.61 155.88 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 110.233 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.74 HG22 HG22 ' A' ' 22' ' ' VAL . 40.3 p -119.56 155.84 31.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.082 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 m -87.89 56.26 3.81 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.455 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.8 tp -59.66 -41.34 90.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.211 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.14 -22.47 64.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.992 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.49 -26.51 4.1 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -150.51 156.14 40.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.4 m -58.41 139.56 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -83.51 -22.01 32.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.234 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.08 145.04 29.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.067 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 p -78.09 146.34 35.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.678 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.2 -4.72 85.1 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.807 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 91.2 m -99.51 138.93 35.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -113.14 150.35 32.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.965 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.94 111.94 21.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.073 0.463 . . . . 0.0 110.146 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -88.57 156.47 19.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.64 -30.15 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 125.232 1.583 . . . . 0.0 114.874 -177.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.543 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 6.3 t80 -82.4 13.17 3.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.704 0.764 . . . . 0.0 109.774 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' ASN . 66.0 ttt180 58.58 38.74 25.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.219 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.74 HG22 HG22 ' A' ' 4' ' ' THR . 72.3 t -122.8 136.65 58.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.46 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.0 m -70.68 128.52 36.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.397 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.57 139.69 52.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.43 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HE3' ' SG ' ' A' ' 15' ' ' CYS . 33.3 ttmt -119.54 -43.61 2.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.678 0.275 . . . . 0.0 110.654 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 27' ' ' GLY . 25.9 t70 -159.91 -148.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 26' ' ' ASP . . . -79.19 46.7 3.03 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.522 -0.37 . . . . 0.0 112.284 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -73.73 133.46 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.13 -37.0 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 tp -126.4 37.43 4.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.006 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.686 ' HB3' ' O ' ' A' ' 23' ' ' CYS . 5.9 m120 . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.463 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.458 ' SG ' ' HE3' ' A' ' 25' ' ' LYS . 27.4 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.868 ' HA3' HG13 ' A' ' 29' ' ' VAL . . . -75.28 47.08 1.96 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.494 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.515 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 16.5 pt-20 -83.31 -164.24 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.827 0.822 . . . . 0.0 109.757 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.456 HG22 HG22 ' A' ' 22' ' ' VAL . 17.1 p -134.61 149.04 50.54 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.734 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.44 54.65 3.12 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.923 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.5 pt? -60.34 -38.94 85.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.551 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.2 tp -73.69 -19.6 60.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.075 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.69 -29.87 3.5 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -150.75 154.14 36.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.58 142.7 52.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.266 0.626 . . . . 0.0 112.411 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.49 -33.1 48.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.681 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -84.22 145.82 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.75 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.4 p -81.92 144.39 30.99 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.102 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.96 -4.96 85.27 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.947 -0.569 . . . . 0.0 113.142 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.681 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 6.6 m -90.96 145.52 24.65 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 48.2 p -116.11 150.39 37.46 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.732 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -87.78 112.54 22.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.73 0.776 . . . . 0.0 111.346 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 19' ' ' LYS . 2.6 t30 -80.73 148.7 30.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -42.38 -32.43 0.52 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.2 t80 -82.09 20.55 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.5 ttm180 56.06 40.05 30.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.06 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 88.4 t -118.38 133.99 63.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.398 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 16' ' ' THR . 84.7 m -78.43 129.19 34.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.612 0.72 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -134.74 141.2 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.305 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.458 ' HE3' ' SG ' ' A' ' 1' ' ' CYS . 37.7 ttmt -120.27 -50.85 2.22 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.613 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -140.93 40.48 1.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.281 1.039 . . . . 0.0 108.613 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 -44.06 1.36 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.34 134.16 52.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 0.0 112.217 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.868 HG13 ' HA3' ' A' ' 2' ' ' GLY . 42.2 t -76.67 -18.48 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.75 61.4 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.616 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.581 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.941 ' HB2' ' HG3' ' A' ' 25' ' ' LYS . 56.6 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.887 0.375 . . . . 0.0 111.781 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.68 45.28 0.43 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.524 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -135.22 -168.92 2.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.74 0.781 . . . . 0.0 111.727 -177.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -137.91 155.04 49.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.327 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 2.2 m -89.28 52.4 2.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.355 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.35 -42.26 73.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.646 HD11 ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -76.74 -17.07 59.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.68 2.86 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.709 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.646 ' O ' HD11 ' A' ' 7' ' ' LEU . 27.9 m -153.08 139.41 18.52 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -58.33 136.26 57.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.397 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -77.75 -34.35 52.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.22 0.533 . . . . 0.0 109.709 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.848 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.06 145.0 51.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.509 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.4 p -82.77 140.27 33.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.895 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.23 0.56 70.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.66 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.848 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 8.9 m -98.91 138.71 35.64 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 7.2 p -117.79 146.81 43.56 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.7 m -89.91 118.56 29.57 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.64 149.1 22.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.7 ptpt -35.49 -38.46 0.11 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.075 1.484 . . . . 0.0 114.433 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.2 t80 -76.23 16.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.441 0.638 . . . . 0.0 110.58 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 19' ' ' LYS . 23.9 ttm180 57.27 35.77 26.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.392 1.077 . . . . 0.0 110.035 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 91.9 t -118.75 135.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 16' ' ' THR . 60.1 m -76.68 125.13 28.72 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.825 0.821 . . . . 0.0 112.097 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.2 133.93 45.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.941 ' HG3' ' HB2' ' A' ' 1' ' ' CYS . 1.6 mptp? -79.24 125.44 29.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.661 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -108.41 145.87 33.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.442 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.21 -47.8 3.24 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.536 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -152.83 135.81 15.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.887 0.375 . . . . 0.0 109.991 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.29 -32.03 45.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.351 0.595 . . . . 0.0 111.134 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.29 80.3 9.25 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.999 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 0.0 110.72 179.856 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 25' ' ' LYS . 8.9 t . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 69.22 1.44 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -145.41 162.63 36.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.732 0.301 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -108.98 155.95 20.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.423 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 m -85.95 60.17 6.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.89 -38.86 79.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.779 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.53 12.97 7.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.626 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.58 -42.19 2.0 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.718 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 41.3 m -154.5 142.93 20.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 m -75.77 135.59 40.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -81.7 -4.07 55.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.322 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.683 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.46 140.57 51.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.709 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 p -74.09 132.81 42.65 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.805 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 87.34 -5.96 84.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.895 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.683 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 73.4 m -90.11 142.35 27.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.819 0.343 . . . . 0.0 110.677 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.2 p -128.74 152.36 48.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 59.2 m -89.37 119.16 29.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.686 0.755 . . . . 0.0 111.656 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.419 HD22 ' HB ' ' A' ' 22' ' ' VAL . 1.8 t30 -88.68 146.85 24.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.278 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.29 -28.21 0.31 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.623 1.202 . . . . 0.0 113.88 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -86.29 20.91 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.545 0.688 . . . . 0.0 109.578 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' ASN . 59.8 ttt180 57.27 40.55 27.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.723 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HB ' HD22 ' A' ' 18' ' ' ASN . 61.7 t -117.06 133.74 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.371 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' THR . 55.7 m -80.15 124.5 28.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.216 0.532 . . . . 0.0 110.067 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.0 p -125.83 126.11 43.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HZ2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -83.77 -15.49 48.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 109.767 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.529 ' HB2' ' HZ2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -156.3 -154.23 0.47 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 -177.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.17 75.93 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -104.52 150.68 24.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.369 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 t -71.88 -2.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -52.77 147.34 8.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.632 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.4 m . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.16 61.49 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.764 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 34.2 tt0 -114.3 166.01 12.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.278 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.69 HG22 HG22 ' A' ' 22' ' ' VAL . 18.7 p -133.03 146.88 52.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.328 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.62 55.64 2.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.0 pt? -60.76 -34.48 74.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.47 -19.48 57.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.151 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.31 -31.03 3.37 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.525 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.28 152.29 33.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.9 m -58.54 144.91 41.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 0.0 111.951 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.29 -32.38 24.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.927 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 m -91.31 146.67 23.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -85.24 139.56 31.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -25.9 17.34 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.516 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 62.9 m -90.74 142.75 27.43 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.862 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.9 p -115.06 150.66 35.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.343 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 97.1 m -87.46 114.14 23.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.023 0.439 . . . . 0.0 111.166 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.629 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -90.9 151.72 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -36.52 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.997 1.436 . . . . 0.0 114.844 -177.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 8.4 t80 -82.78 21.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.16 0.505 . . . . 0.0 110.024 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.5 ptp85 51.31 39.98 25.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.125 1.37 . . . . 0.0 110.165 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.69 HG22 HG22 ' A' ' 4' ' ' THR . 87.5 t -121.48 133.77 66.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.8 m -74.37 124.67 26.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -127.64 145.01 51.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.498 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -75.4 -36.93 60.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.254 0.549 . . . . 0.0 109.927 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -169.01 -122.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.79 27.57 3.8 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.392 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 30' ' ' LEU . 66.0 m -160.89 131.57 5.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.859 0.463 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.5 -11.69 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.296 0.569 . . . . 0.0 110.803 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 28' ' ' SER . 8.2 mp -52.68 155.07 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.683 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.57 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.35 47.06 0.68 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.579 -0.737 . . . . 0.0 114.655 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -89.94 160.34 16.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 22' ' ' VAL . 27.9 p -109.2 145.32 36.02 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.282 0.563 . . . . 0.0 111.132 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -89.42 55.46 3.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.238 0.542 . . . . 0.0 109.615 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.05 -34.4 76.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.477 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.76 -14.37 59.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.029 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.33 -35.7 2.64 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.625 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.48 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.3 m -152.39 154.63 35.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.537 0.208 . . . . 0.0 110.444 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.22 135.7 52.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.33 -20.03 25.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 109.662 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.503 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -74.03 140.66 45.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.579 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 p -73.38 136.58 44.36 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.157 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.71 -2.08 80.68 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.429 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 59.8 m -97.89 133.04 42.93 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -115.32 154.97 28.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.474 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 85.9 m -87.86 115.07 25.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.081 0.467 . . . . 0.0 110.926 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.532 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -89.12 156.13 19.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -37.33 -35.65 0.12 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.989 1.43 . . . . 0.0 114.253 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -78.06 12.24 1.91 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.372 0.606 . . . . 0.0 110.527 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 18' ' ' ASN . 65.4 ttt180 60.47 38.5 19.14 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.915 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 4' ' ' THR . 96.1 t -126.84 137.27 58.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.296 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.3 m -68.04 134.37 50.55 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.88 0.848 . . . . 0.0 112.984 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 p -133.23 127.07 32.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.989 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -90.76 -60.34 1.94 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -101.3 -41.38 6.71 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.245 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.18 -26.02 0.55 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.4 m -76.49 135.59 39.35 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.731 -0.735 . . . . 0.0 110.98 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.5 t -69.48 -34.24 61.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.78 0.8 . . . . 0.0 109.238 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.5 tp -77.61 61.4 2.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.111 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.117 -179.168 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.1 t . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.13 28.38 53.95 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.512 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.492 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 44.8 tt0 -105.94 159.12 16.28 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.8 p -126.5 149.11 49.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.539 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 1.8 m -88.19 55.55 3.48 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.125 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.8 tp -57.27 -42.67 82.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.077 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.436 HD22 ' OH ' ' A' ' 11' ' ' TYR . 21.7 tp -73.8 -17.87 61.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.426 0.631 . . . . 0.0 110.112 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.51 -30.3 3.46 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -149.78 151.48 33.64 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.492 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 6.7 m -65.61 147.53 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.436 ' OH ' HD22 ' A' ' 7' ' ' LEU . 3.9 m-85 -88.21 -32.62 18.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.13 140.95 40.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.632 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -81.95 131.39 35.25 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.608 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.38 -17.05 44.25 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.828 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.932 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.3 m -88.74 132.76 34.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.104 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.3 p -109.23 151.86 25.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.663 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -87.42 111.99 21.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.665 0.745 . . . . 0.0 111.713 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.1 t30 -82.78 150.46 26.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.974 178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.27 -39.84 0.68 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.835 1.334 . . . . 0.0 113.063 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -78.48 21.0 0.39 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.49 0.662 . . . . 0.0 110.673 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 16.6 tpp180 56.52 38.97 30.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.186 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 97.0 t -116.66 133.65 62.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.588 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.932 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 59.8 m -79.06 124.02 27.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.368 0.604 . . . . 0.0 111.078 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 p -125.37 143.14 51.11 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 9.4 ptmm? -69.12 -17.78 63.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.897 0.38 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.573 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 18.1 p-10 -174.49 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.779 0.8 . . . . 0.0 109.171 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.28 -37.1 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.502 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 17.1 m -83.16 136.55 34.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.243 -0.479 . . . . 0.0 109.953 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.4 t -69.95 -25.9 28.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.352 0.596 . . . . 0.0 111.103 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 28' ' ' SER . 2.6 pp -58.7 150.94 22.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.397 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 25' ' ' LYS . 66.1 m-20 . . . . . 0 N--CA 1.467 0.382 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.536 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.022 0.439 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.56 68.26 1.23 Allowed Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.228 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.98 160.1 40.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.7 p -120.98 153.53 37.19 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.055 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.4 54.41 3.14 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.471 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 tp -55.84 -40.09 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.348 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.15 -12.8 59.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 129.82 -35.32 2.57 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.575 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.452 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.65 150.0 29.76 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.0 m -63.42 138.17 58.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.671 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -80.32 -30.28 38.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 109.706 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.6 140.37 44.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.955 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 p -79.96 135.7 36.46 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.108 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.12 -14.37 59.88 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.397 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 67.6 m -89.41 141.37 28.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.891 0.377 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.0 p -116.16 150.59 37.19 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 68.5 m -88.91 114.73 25.85 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.579 0.704 . . . . 0.0 111.372 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.59 148.89 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.12 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.66 -39.43 0.49 Allowed 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.705 1.253 . . . . 0.0 113.486 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.0 21.04 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.397 0.618 . . . . 0.0 110.6 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.2 ttm180 56.29 40.28 29.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.124 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.8 t -118.48 136.27 56.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.47 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.7 m -76.54 130.0 37.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.392 0.615 . . . . 0.0 111.591 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.8 p -126.06 141.19 52.06 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.566 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' A' ' 31' ' ' ASN . 20.6 pttp -78.76 -130.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.052 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.68 -48.53 58.46 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.282 0.563 . . . . 0.0 110.994 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.6 40.84 0.14 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.463 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 22.1 m -156.86 144.26 18.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.573 0.225 . . . . 0.0 110.522 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.89 -29.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.767 0.794 . . . . 0.0 110.012 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.477 ' H ' HD12 ' A' ' 30' ' ' LEU . 6.8 mp -56.74 155.37 7.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.45 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.629 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 0.0 110.533 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.36 -35.37 1.13 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.674 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.554 ' OE1' ' HB3' ' A' ' 10' ' ' CYS . 33.5 tt0 -56.75 150.86 15.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.658 0.742 . . . . 0.0 111.928 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 22' ' ' VAL . 17.4 p -123.59 154.33 39.43 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.191 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -87.96 50.19 1.94 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.111 -0.635 . . . . 0.0 110.229 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.73 -36.42 83.8 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.904 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.1 tp -84.66 8.14 17.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.639 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 107.76 -33.65 6.17 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.29 -0.957 . . . . 0.0 110.94 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 10' ' ' CYS . 0.9 OUTLIER -149.79 -159.17 1.0 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.691 ' H ' HG22 ' A' ' 9' ' ' THR . 61.5 m -137.08 146.65 45.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 111.202 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.0 -26.54 33.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.464 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.4 m -69.72 140.77 53.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.667 0.746 . . . . 0.0 111.162 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -85.56 136.44 33.4 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.714 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.18 -5.19 81.33 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.681 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.3 m -89.4 136.37 33.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.838 0.351 . . . . 0.0 110.328 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.45 151.09 28.97 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -86.24 112.06 21.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.693 0.759 . . . . 0.0 111.103 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.509 ' OD1' ' HG2' ' A' ' 19' ' ' LYS . 2.3 t30 -86.95 149.33 24.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.603 -1.18 . . . . 0.0 108.744 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HG2' ' OD1' ' A' ' 18' ' ' ASN . 9.3 ptpp? -35.65 -42.66 0.25 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 125.048 1.467 . . . . 0.0 113.794 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -78.64 20.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.253 0.549 . . . . 0.0 111.045 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 19' ' ' LYS . 2.3 tpp180 56.97 39.38 29.45 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.28 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 62.8 t -117.58 132.19 68.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.008 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.5 m -84.79 123.57 30.59 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.171 0.986 . . . . 0.0 111.638 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 29' ' ' VAL . 23.2 p -120.87 128.27 52.66 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.894 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 26' ' ' ASP . 42.4 tttm -86.11 -75.17 0.39 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.917 0.389 . . . . 0.0 110.43 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 25' ' ' LYS . 73.7 m-20 -88.9 50.45 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.265 0.555 . . . . 0.0 110.099 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.87 -43.89 2.0 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.015 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -85.61 155.64 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.692 0.282 . . . . 0.0 110.472 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.488 ' HA ' HG22 ' A' ' 24' ' ' THR . 37.2 t -63.31 -26.34 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.672 0.748 . . . . 0.0 110.465 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.62 152.08 19.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.078 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.091 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 54.0 t . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.862 0.363 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.98 38.99 1.71 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 13.6 tt0 -76.6 177.91 7.11 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.635 -0.782 . . . . 0.0 110.062 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.6 p -134.46 146.61 49.94 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 1.9 m -86.72 57.16 4.34 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.939 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 7' ' ' LEU . 2.6 pt? -59.25 -36.94 76.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.494 ' HG ' ' HG ' ' A' ' 6' ' ' LEU . 91.5 mt -91.57 19.75 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.632 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.74 -43.83 1.91 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.469 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 33.5 m -154.19 142.35 20.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.753 -0.223 . . . . 0.0 110.489 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.44 138.39 40.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 110.663 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -86.85 -10.61 53.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -72.21 141.95 49.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.685 0.755 . . . . 0.0 111.395 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p -77.7 136.41 38.18 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.69 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.6 -6.7 77.57 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.665 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 68.5 m -104.41 130.49 52.29 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.83 0.348 . . . . 0.0 110.291 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.7 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.9 p -116.35 152.79 33.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 21.8 m -87.23 116.95 25.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.84 0.829 . . . . 0.0 111.848 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.4 t30 -90.03 149.86 22.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.363 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.1 -40.14 0.47 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.78 1.3 . . . . 0.0 113.708 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -79.52 22.61 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.546 . . . . 0.0 110.766 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.437 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.2 ttm180 56.03 40.55 30.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.047 0.939 . . . . 0.0 109.93 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 61.2 t -117.14 130.24 72.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.678 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 72.5 m -85.35 114.76 22.66 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.556 0.693 . . . . 0.0 110.628 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -128.64 156.59 43.17 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.042 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.8 ptmm? -81.3 0.88 35.01 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.498 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 179.92 -37.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.637 0.732 . . . . 0.0 109.475 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 165.05 -33.7 0.25 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -71.71 140.84 49.75 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.173 -1.013 . . . . 0.0 110.079 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.4 t -70.72 -16.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.439 0.638 . . . . 0.0 111.168 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.73 146.46 54.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.7 t30 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 123.629 0.772 . . . . 0.0 111.465 -179.261 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.657 0.265 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.69 41.65 1.46 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.413 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.657 ' CG ' ' HB3' ' A' ' 10' ' ' CYS . 14.0 tp10 -89.73 155.62 19.08 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.045 0.45 . . . . 0.0 110.226 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.696 HG22 HG22 ' A' ' 22' ' ' VAL . 21.3 p -123.8 151.22 43.58 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.911 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB3' ' HA ' ' A' ' 9' ' ' THR . 1.5 m -88.32 55.22 3.34 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.07 0.462 . . . . 0.0 109.807 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.88 -41.74 74.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.814 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 mp -94.31 23.97 4.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.244 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.19 -39.59 2.7 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.646 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 28.6 m -150.57 143.14 24.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.893 0.378 . . . . 0.0 110.06 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.657 ' HB3' ' CG ' ' A' ' 3' ' ' GLU . 3.6 m -68.56 148.49 50.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.507 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -78.08 -20.54 52.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.747 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 139.1 50.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.254 0.55 . . . . 0.0 111.158 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.7 p -89.3 141.11 28.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.523 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.04 -16.81 58.69 Favored Glycine 0 CA--C 1.508 -0.356 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.659 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 56.7 m -89.09 142.59 27.51 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.108 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.781 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 16.7 p -112.37 149.67 32.16 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.4 m -85.62 117.66 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.274 0.559 . . . . 0.0 110.96 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -96.16 152.43 18.56 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.26 -31.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 O-C-N 125.093 1.496 . . . . 0.0 114.802 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 8.8 t80 -79.96 14.86 1.64 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.526 0.679 . . . . 0.0 110.009 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' LYS . 29.2 ttm180 57.44 39.23 28.24 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.641 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.696 HG22 HG22 ' A' ' 4' ' ' THR . 95.5 t -128.08 138.2 55.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.48 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.887 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.7 m -82.22 132.47 35.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -117.64 125.79 51.36 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.976 -1.466 . . . . 0.0 109.249 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -77.06 -27.53 54.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.351 0.596 . . . . 0.0 109.85 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -168.42 -141.32 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.76 -29.77 74.04 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.309 -0.948 . . . . 0.0 110.889 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -85.92 125.16 33.14 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.305 -0.447 . . . . 0.0 110.887 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.17 -18.13 12.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.894 0.854 . . . . 0.0 109.5 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.82 168.38 6.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.387 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.772 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.556 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . 71.3 m . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.65 37.22 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.556 ' OE2' ' HB2' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -166.89 -171.53 1.84 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.387 0.613 . . . . 0.0 110.307 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.794 HG22 HG22 ' A' ' 22' ' ' VAL . 10.6 p -145.63 154.89 42.62 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.298 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 1.5 m -87.78 55.1 3.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.563 ' HA ' HH12 ' A' ' 21' ' ' ARG . 2.6 pt? -60.23 -40.81 91.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.753 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.12 -16.64 57.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.051 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.49 -35.17 2.31 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 23.9 m -151.89 144.4 24.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.688 0.28 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -75.74 148.54 38.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.706 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -81.59 -18.08 46.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.0 110.427 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.36 142.07 57.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.284 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 p -91.54 142.07 28.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.469 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.8 -18.44 47.14 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.972 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.7 m -89.11 139.55 30.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.848 0.356 . . . . 0.0 110.599 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.753 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.4 p -113.73 149.46 34.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.902 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -86.11 116.55 24.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 111.324 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.498 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -92.01 153.43 19.44 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -37.09 -31.96 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.143 1.527 . . . . 0.0 114.75 -177.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.625 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 7.8 t80 -82.08 20.53 1.0 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.273 0.559 . . . . 0.0 109.927 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.7 ptm180 49.86 42.17 23.67 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.14 1.376 . . . . 0.0 110.341 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.794 HG22 HG22 ' A' ' 4' ' ' THR . 87.7 t -126.76 136.25 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.332 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.972 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 1.8 m -79.84 132.72 36.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.182 0.992 . . . . 0.0 113.511 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -118.68 123.38 44.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.012 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 23.9 ttpp -88.84 -45.03 10.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.431 0.634 . . . . 0.0 110.015 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -167.35 -144.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.887 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.68 33.97 2.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.044 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -72.03 130.06 40.04 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.5 t -56.6 -35.67 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.928 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.727 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.3 pt? -108.37 26.69 10.16 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.036 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.283 179.815 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.02 44.33 1.82 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.661 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.558 ' OE2' ' HB3' ' A' ' 10' ' ' CYS . 8.0 pt-20 -83.72 176.91 8.62 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.721 HG22 HG22 ' A' ' 22' ' ' VAL . 23.5 p -106.92 149.01 27.92 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.636 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.502 ' HB2' ' HD2' ' A' ' 21' ' ' ARG . 1.7 m -87.65 56.86 4.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -59.15 -34.62 72.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.489 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -89.99 17.08 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.29 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.46 4.85 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.4 m -147.99 145.93 28.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.558 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 19.9 m -66.86 153.49 43.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.861 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -74.82 -25.93 59.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.166 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 m -80.06 142.72 34.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.357 0.598 . . . . 0.0 110.517 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -93.8 143.62 26.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.882 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.11 -10.7 74.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 25.5 m -89.51 147.34 24.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.791 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.5 p -110.59 147.81 33.46 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.347 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.7 m -86.51 112.09 21.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.496 0.665 . . . . 0.0 110.694 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 0.9 OUTLIER -82.52 152.77 25.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.439 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 21' ' ' ARG . 1.4 tmtp? -39.51 -38.7 0.61 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.868 1.355 . . . . 0.0 113.158 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.5 t80 -77.15 17.61 0.45 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.567 0.698 . . . . 0.0 110.474 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.502 ' HD2' ' HB2' ' A' ' 5' ' ' CYS . 17.1 tpp180 56.79 41.7 27.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.981 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.721 HG22 HG22 ' A' ' 4' ' ' THR . 89.9 t -128.4 136.34 60.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.906 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 16' ' ' THR . 1.5 m -77.01 136.12 38.69 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 p -122.35 136.66 54.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.57 -1.65 . . . . 0.0 109.102 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.685 ' HG3' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -86.38 -136.99 0.08 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.685 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 1.3 m-20 -73.03 -30.52 63.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.402 0.62 . . . . 0.0 109.932 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -52.78 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.979 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -72.67 134.51 45.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 t -87.09 -16.52 9.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.49 0.662 . . . . 0.0 110.494 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.75 67.89 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.942 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 179.662 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 63.5 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.57 -48.21 2.2 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.182 -0.463 . . . . 0.0 113.263 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -60.75 157.5 14.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 21' ' ' ARG . 42.7 p -106.65 163.61 12.76 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.584 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 m -85.46 59.51 5.67 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.0 tp -56.87 -38.49 72.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.196 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.39 15.71 7.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.44 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.93 -42.26 2.06 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.617 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.663 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 44.9 m -155.26 141.92 18.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.096 . . . . 0.0 110.774 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.6 134.03 36.45 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -86.34 1.59 50.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.118 0.485 . . . . 0.0 110.308 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 140.4 49.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.455 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.8 p -73.29 129.9 39.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.38 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 92.33 -15.73 61.51 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.521 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.6 m -89.56 135.3 33.68 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.069 0.461 . . . . 0.0 110.747 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.8 p -126.21 159.45 32.98 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 62.0 m -88.96 119.82 29.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.876 0.846 . . . . 0.0 112.333 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -89.59 147.18 24.08 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.082 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.35 -32.96 0.35 Allowed 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.629 1.206 . . . . 0.0 113.779 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.85 25.31 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.47 0.652 . . . . 0.0 110.16 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 4' ' ' THR . 25.7 ttp180 55.48 41.03 31.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.829 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.73 131.98 66.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.646 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 16' ' ' THR . 56.6 m -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.35 0.595 . . . . 0.0 109.603 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.2 p -128.33 144.33 51.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.817 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 4.8 ttpt -70.6 -30.63 67.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.428 0.632 . . . . 0.0 110.419 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -153.31 -44.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.459 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.68 -35.89 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -78.68 137.26 37.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.224 0.535 . . . . 0.0 110.98 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -79.1 -9.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.85 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.33 61.53 2.19 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.287 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.013 179.495 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 t . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.626 0.251 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.33 116.57 0.85 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -174.98 168.26 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.7 p -100.69 146.94 26.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.058 0.456 . . . . 0.0 111.375 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 5.4 m -87.23 60.3 6.05 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.5 mt -57.85 -37.86 74.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.502 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.0 mt -86.43 16.46 4.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.163 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.72 -41.7 2.42 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.766 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 62.2 m -155.93 141.27 17.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.946 -0.127 . . . . 0.0 111.28 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.6 m -83.42 128.37 34.45 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.16 32.2 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.201 0.524 . . . . 0.0 110.214 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.63 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -91.56 143.61 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.46 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.7 p -72.61 129.19 37.69 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.303 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.92 10.38 83.08 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.325 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.63 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 63.5 m -114.56 145.93 41.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.92 0.39 . . . . 0.0 110.625 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 p -138.21 151.9 48.12 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 26.3 m -88.86 123.92 33.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.786 0.803 . . . . 0.0 112.099 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.414 HD22 ' HB ' ' A' ' 22' ' ' VAL . 1.9 t30 -88.68 151.06 22.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.222 -1.354 . . . . 0.0 108.552 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -40.5 -38.84 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.514 1.134 . . . . 0.0 113.503 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -81.03 24.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.278 0.561 . . . . 0.0 110.669 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 19' ' ' LYS . 30.4 ttm180 56.04 42.04 28.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.926 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' HB ' HD22 ' A' ' 18' ' ' ASN . 55.2 t -116.05 122.14 68.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 14.4 m -74.91 116.32 15.51 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 28' ' ' SER . 66.1 p -133.26 -159.24 0.95 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -90.51 -30.33 17.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -168.87 -40.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.359 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.55 -38.18 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.538 ' O ' ' HB ' ' A' ' 24' ' ' THR . 19.3 m -80.4 139.39 36.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.227 -0.486 . . . . 0.0 110.04 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 t -67.75 -6.86 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.46 0.648 . . . . 0.0 111.411 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 28' ' ' SER . 7.5 mp -65.97 144.69 56.6 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.503 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.885 0.874 . . . . 0.0 111.943 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 51.2 t . . . . . 0 CA--C 1.519 -0.213 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 48.28 1.81 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.301 -0.475 . . . . 0.0 111.961 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.67 ' HB3' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -88.52 174.96 7.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.152 0.581 . . . . 0.0 110.385 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -142.11 145.05 33.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.795 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.524 ' HB2' ' CD ' ' A' ' 21' ' ' ARG . 2.8 m -94.3 56.69 2.21 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.246 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.5 mt -57.45 -42.37 82.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.092 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -74.99 -16.16 60.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.385 0.612 . . . . 0.0 110.178 179.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.8 -32.08 2.96 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.481 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 17.4 m -143.74 153.92 42.92 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.7 m -54.35 139.35 37.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -80.29 -27.55 38.47 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -90.75 148.06 22.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.78 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 p -85.42 148.24 26.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.801 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.89 90.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.739 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 61.1 m -108.06 140.71 40.83 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 41.5 p -109.81 149.5 29.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.44 0.162 . . . . 0.0 110.867 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 99.2 m -88.35 111.71 22.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.979 0.418 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.55 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -87.96 152.3 22.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -39.49 -28.75 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.817 1.323 . . . . 0.0 114.414 -176.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 9.97 4.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.973 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' CD ' ' HB2' ' A' ' 5' ' ' CYS . 17.4 tpp180 60.58 36.42 19.81 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.299 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 84.5 t -122.61 138.85 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.625 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 61.7 m -75.11 133.71 41.48 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.846 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -133.92 145.41 49.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.973 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 1' ' ' CYS . 28.7 mmmt -92.76 -89.8 0.19 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -76.25 -38.47 56.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.276 1.036 . . . . 0.0 108.817 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 163.95 -34.13 0.28 Allowed Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 m -72.15 134.19 45.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.464 -0.868 . . . . 0.0 110.286 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.42 -25.01 19.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.659 . . . . 0.0 110.22 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.62 62.52 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.349 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.488 ' OD1' ' HG3' ' A' ' 25' ' ' LYS . 16.9 t-20 . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.676 ' HB2' ' HB2' ' A' ' 25' ' ' LYS . 10.9 t . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.19 45.78 38.21 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.617 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.651 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 4.2 tp10 -152.95 157.89 41.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 p -141.57 149.99 41.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.832 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.03 52.61 2.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.287 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.71 -45.47 85.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.635 ' HG ' ' HE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -74.4 -16.68 60.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.537 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.5 -31.27 3.01 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.474 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.582 ' O ' HD11 ' A' ' 7' ' ' LEU . 25.7 m -151.91 139.74 19.93 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 120.267 -0.573 . . . . 0.0 112.028 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.0 138.04 49.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.594 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.635 ' HE1' ' HG ' ' A' ' 7' ' ' LEU . 3.9 m-85 -81.01 -32.65 34.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.96 139.92 43.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.046 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -82.73 140.18 33.21 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.51 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.67 -18.37 56.2 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.426 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 60.4 m -89.92 138.88 31.13 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.549 -0.325 . . . . 0.0 110.312 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.724 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.8 p -111.05 150.52 29.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.323 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.1 m -87.33 117.01 25.81 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 0.0 111.177 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.582 ' OD1' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -99.22 150.29 22.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -38.33 -30.73 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 O-C-N 125.041 1.463 . . . . 0.0 114.565 -177.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.404 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 t80 -78.23 11.14 2.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.421 0.629 . . . . 0.0 109.89 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' LYS . 5.7 tpp85 60.68 33.6 20.22 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.704 1.201 . . . . 0.0 109.701 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.577 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 60.2 t -119.08 140.77 41.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.903 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 34.1 m -83.5 120.4 25.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.606 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.88 127.62 52.78 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.118 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.817 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 40.5 tttm -110.52 -152.15 0.49 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.817 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -70.82 -74.13 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.185 0.517 . . . . 0.0 111.692 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.99 40.33 0.1 OUTLIER Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.7 m -66.57 165.58 14.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.249 -0.476 . . . . 0.0 110.512 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -42.42 -50.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.728 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.3 pt? -112.81 31.39 6.42 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.052 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 22.5 t-20 . . . . . 0 N--CA 1.469 0.486 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.218 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' HA2' HG12 ' A' ' 29' ' ' VAL . . . 58.6 27.8 61.74 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.4 -0.429 . . . . 0.0 112.797 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 25.1 tt0 -101.27 164.93 11.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.0 p -134.32 148.11 50.7 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.6 m -88.27 54.13 2.97 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.153 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.2 tp -57.84 -39.47 77.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.054 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.02 -13.47 59.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.529 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.92 -35.61 2.42 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.7 m -151.62 151.44 31.52 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.6 m -63.24 144.42 56.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.277 0.56 . . . . 0.0 112.215 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -89.59 -30.14 18.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.856 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -83.64 146.23 28.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.542 0.687 . . . . 0.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 p -79.29 144.53 34.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.79 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.71 -20.88 44.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.581 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 63.9 m -88.68 133.91 34.06 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 62.1 p -113.25 157.12 22.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.8 m -87.9 113.95 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.656 0.741 . . . . 0.0 111.635 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.6 t30 -84.85 149.76 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.993 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -38.89 -38.81 0.46 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 124.62 1.2 . . . . 0.0 113.699 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -80.24 21.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.376 0.608 . . . . 0.0 110.524 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 19' ' ' LYS . 26.9 ttm180 56.47 39.54 29.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.005 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 93.9 t -116.67 134.9 58.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.768 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 83.4 m -79.43 122.6 26.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.394 0.616 . . . . 0.0 111.055 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 29' ' ' VAL . 14.1 p -133.72 139.58 46.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.162 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -90.84 -96.06 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 121.086 -0.246 . . . . 0.0 110.708 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.63 -36.74 76.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.619 0.723 . . . . 0.0 110.356 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.08 -42.3 0.23 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.3 m -78.4 151.2 32.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.184 -0.508 . . . . 0.0 110.229 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.499 ' HA ' HG22 ' A' ' 24' ' ' THR . 23.6 t -65.53 -23.07 32.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.587 0.708 . . . . 0.0 110.147 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -56.95 154.37 9.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.969 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.142 -179.539 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.23 69.05 1.11 Allowed Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.21 161.2 41.24 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.45 HG22 HG22 ' A' ' 22' ' ' VAL . 21.5 p -116.03 155.64 27.74 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.03 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.3 m -85.67 58.4 5.02 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.436 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -54.27 -40.84 68.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 mp -89.11 19.48 4.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.508 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.41 -37.26 3.56 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 21.4 m -151.08 148.73 28.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.651 0.262 . . . . 0.0 110.797 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.6 m -66.93 137.09 56.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.337 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -83.56 -26.48 30.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.0 109.931 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.33 140.04 50.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.713 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.9 p -79.59 134.12 36.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.165 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.45 -19.13 53.92 Favored Glycine 0 CA--C 1.507 -0.429 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.161 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.1 m -88.63 135.73 33.35 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.014 0.435 . . . . 0.0 110.532 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.9 p -114.89 155.5 26.72 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 65.8 m -89.05 114.73 25.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.67 0.748 . . . . 0.0 111.643 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 22' ' ' VAL . 1.5 t30 -83.53 150.35 26.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.034 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.9 ptpt -38.16 -39.72 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 0.0 113.676 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.59 22.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 110.777 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 19' ' ' LYS . 46.7 ttp180 56.11 41.82 29.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.61 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 89.5 t -119.53 135.38 60.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.545 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.766 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -73.34 130.06 39.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 111.298 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 p -136.77 148.52 47.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.044 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 28' ' ' SER . 9.3 ptmm? -73.71 -140.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' CG ' ' HZ3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -58.77 -35.47 72.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.188 0.518 . . . . 0.0 110.23 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.51 45.3 0.11 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.703 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.675 ' HB2' ' HD3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -160.75 151.92 18.99 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 122.621 -0.341 . . . . 0.0 110.252 -179.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.59 -14.28 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.719 0.771 . . . . 0.0 109.657 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.2 tp -56.61 143.56 35.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.257 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.4 p30 . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 124.875 1.27 . . . . 0.0 113.104 -179.564 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 CA--C 1.521 -0.161 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.48 -50.73 0.87 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.257 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 20.6 pt-20 -97.97 -166.88 1.43 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.216 1.007 . . . . 0.0 111.872 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 22' ' ' VAL . 2.2 p -147.71 156.27 42.59 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.02 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.7 m -87.21 55.62 3.63 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.369 0.604 . . . . 0.0 110.378 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.86 -36.54 84.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.675 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.33 -23.38 59.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.428 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.29 -30.42 2.8 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.4 m -150.9 152.08 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.8 m -60.89 144.06 53.68 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.563 0.539 . . . . 0.0 111.615 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -82.55 -31.54 29.02 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.85 143.04 29.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.9 p -85.69 131.84 34.26 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.815 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 -20.69 19.68 Favored Glycine 0 CA--C 1.504 -0.608 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.746 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 77.0 m -92.4 143.45 26.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.367 -0.417 . . . . 0.0 109.875 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.5 p -118.45 151.76 37.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.265 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 73.8 m -88.13 111.22 21.34 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.522 ' OD1' ' HB ' ' A' ' 22' ' ' VAL . 4.6 p-10 -83.98 154.24 23.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 176.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -34.0 -33.04 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.4 t80 -85.36 23.29 1.34 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.304 0.573 . . . . 0.0 110.075 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ASN . 13.5 ptm180 49.47 39.67 17.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.133 1.373 . . . . 0.0 110.644 -178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HB ' ' OD1' ' A' ' 18' ' ' ASN . 57.9 t -107.85 154.35 8.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.488 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 74.1 m -96.18 129.26 43.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.305 0.574 . . . . 0.0 110.956 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.77 127.95 45.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.312 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' HG2' ' H ' ' A' ' 26' ' ' ASP . 41.1 tttm -92.67 -146.15 0.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.483 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 9.3 p-10 -75.97 -48.98 19.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.309 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.0 40.86 0.23 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.188 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -74.28 135.53 42.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -57.57 -36.16 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.324 0.583 . . . . 0.0 111.56 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.3 pt? -98.9 31.53 2.94 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 123.737 0.815 . . . . 0.0 111.664 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 N--CA 1.462 0.136 0 CA-C-O 120.329 0.109 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.05 34.27 89.51 Favored Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.614 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -160.61 155.88 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.011 0.434 . . . . 0.0 110.233 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.74 HG22 HG22 ' A' ' 22' ' ' VAL . 40.3 p -119.56 155.84 31.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.082 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 m -87.89 56.26 3.81 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.455 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.8 tp -59.66 -41.34 90.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.211 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.14 -22.47 64.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.992 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.49 -26.51 4.1 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -150.51 156.14 40.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.4 m -58.41 139.56 55.23 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -83.51 -22.01 32.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.234 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.08 145.04 29.26 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.067 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.5 p -78.09 146.34 35.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.678 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.2 -4.72 85.1 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.807 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 91.2 m -99.51 138.93 35.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 27.8 p -113.14 150.35 32.3 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.965 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.94 111.94 21.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.073 0.463 . . . . 0.0 110.146 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -88.57 156.47 19.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.04 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -38.64 -30.15 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 O-C-N 125.232 1.583 . . . . 0.0 114.874 -177.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.543 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 6.3 t80 -82.4 13.17 3.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.704 0.764 . . . . 0.0 109.774 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 18' ' ' ASN . 66.0 ttt180 58.58 38.74 25.25 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.45 -1.25 . . . . 0.0 109.219 -178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.74 HG22 HG22 ' A' ' 4' ' ' THR . 72.3 t -122.8 136.65 58.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.46 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.0 m -70.68 128.52 36.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.397 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.57 139.69 52.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.43 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HE3' ' SG ' ' A' ' 15' ' ' CYS . 33.3 ttmt -119.54 -43.61 2.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.678 0.275 . . . . 0.0 110.654 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' CG ' ' H ' ' A' ' 27' ' ' GLY . 25.9 t70 -159.91 -148.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' A' ' 26' ' ' ASP . . . -79.19 46.7 3.03 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 121.522 -0.37 . . . . 0.0 112.284 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -73.73 133.46 43.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.13 -37.0 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.0 tp -126.4 37.43 4.32 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.006 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.686 ' HB3' ' O ' ' A' ' 23' ' ' CYS . 5.9 m120 . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.463 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.458 ' SG ' ' HE3' ' A' ' 25' ' ' LYS . 27.4 p . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 121.196 0.522 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.868 ' HA3' HG13 ' A' ' 29' ' ' VAL . . . -75.28 47.08 1.96 Allowed Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.494 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.515 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 16.5 pt-20 -83.31 -164.24 0.86 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.827 0.822 . . . . 0.0 109.757 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.456 HG22 HG22 ' A' ' 22' ' ' VAL . 17.1 p -134.61 149.04 50.54 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.734 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.44 54.65 3.12 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.923 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.5 pt? -60.34 -38.94 85.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.551 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.2 tp -73.69 -19.6 60.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.075 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.69 -29.87 3.5 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -150.75 154.14 36.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.3 m -59.58 142.7 52.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.266 0.626 . . . . 0.0 112.411 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.49 -33.1 48.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.681 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -84.22 145.82 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.75 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.4 p -81.92 144.39 30.99 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.102 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.96 -4.96 85.27 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.947 -0.569 . . . . 0.0 113.142 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.681 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 6.6 m -90.96 145.52 24.65 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 48.2 p -116.11 150.39 37.46 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.732 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -87.78 112.54 22.55 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.73 0.776 . . . . 0.0 111.346 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 19' ' ' LYS . 2.6 t30 -80.73 148.7 30.0 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -42.38 -32.43 0.52 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.406 ' O ' HG23 ' A' ' 22' ' ' VAL . 8.2 t80 -82.09 20.55 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.648 0.737 . . . . 0.0 109.817 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 19' ' ' LYS . 27.5 ttm180 56.06 40.05 30.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.06 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 18' ' ' ASN . 88.4 t -118.38 133.99 63.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.398 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 16' ' ' THR . 84.7 m -78.43 129.19 34.63 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.612 0.72 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -134.74 141.2 46.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.305 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.458 ' HE3' ' SG ' ' A' ' 1' ' ' CYS . 37.7 ttmt -120.27 -50.85 2.22 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.613 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -140.93 40.48 1.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 122.281 1.039 . . . . 0.0 108.613 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 -44.06 1.36 Allowed Glycine 0 CA--C 1.52 0.359 0 CA-C-N 114.314 -1.312 . . . . 0.0 112.706 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.34 134.16 52.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 0.0 112.217 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.868 HG13 ' HA3' ' A' ' 2' ' ' GLY . 42.2 t -76.67 -18.48 14.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.911 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.4 mt -75.75 61.4 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.616 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 C--N 1.324 -0.507 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.581 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.941 ' HB2' ' HG3' ' A' ' 25' ' ' LYS . 56.6 m . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.887 0.375 . . . . 0.0 111.781 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.68 45.28 0.43 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.524 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.2 OUTLIER -135.22 -168.92 2.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.74 0.781 . . . . 0.0 111.727 -177.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -137.91 155.04 49.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.327 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 2.2 m -89.28 52.4 2.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.355 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -55.35 -42.26 73.61 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.646 HD11 ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -76.74 -17.07 59.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.382 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.68 2.86 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.709 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.646 ' O ' HD11 ' A' ' 7' ' ' LEU . 27.9 m -153.08 139.41 18.52 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 2.7 m -58.33 136.26 57.35 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.397 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -77.75 -34.35 52.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.22 0.533 . . . . 0.0 109.709 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.848 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.06 145.0 51.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.509 -179.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.4 p -82.77 140.27 33.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.895 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.23 0.56 70.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.66 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.848 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 8.9 m -98.91 138.71 35.64 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 7.2 p -117.79 146.81 43.56 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.7 m -89.91 118.56 29.57 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -97.64 149.1 22.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 21' ' ' ARG . 19.7 ptpt -35.49 -38.46 0.11 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.075 1.484 . . . . 0.0 114.433 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' O ' HG23 ' A' ' 22' ' ' VAL . 5.2 t80 -76.23 16.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.441 0.638 . . . . 0.0 110.58 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 19' ' ' LYS . 23.9 ttm180 57.27 35.77 26.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.392 1.077 . . . . 0.0 110.035 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.583 ' HB ' ' ND2' ' A' ' 18' ' ' ASN . 91.9 t -118.75 135.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 16' ' ' THR . 60.1 m -76.68 125.13 28.72 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.825 0.821 . . . . 0.0 112.097 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.2 133.93 45.01 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.941 ' HG3' ' HB2' ' A' ' 1' ' ' CYS . 1.6 mptp? -79.24 125.44 29.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.661 -176.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -108.41 145.87 33.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.442 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.21 -47.8 3.24 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.536 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.8 m -152.83 135.81 15.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.887 0.375 . . . . 0.0 109.991 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.29 -32.03 45.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.351 0.595 . . . . 0.0 111.134 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 tp -84.29 80.3 9.25 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.999 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.3 t30 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 0.0 110.72 179.856 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 25' ' ' LYS . 8.9 t . . . . . 0 C--O 1.227 -0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.393 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.51 69.22 1.44 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -145.41 162.63 36.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.732 0.301 . . . . 0.0 110.258 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.7 p -108.98 155.95 20.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.423 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 m -85.95 60.17 6.07 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.2 tp -58.89 -38.86 79.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.779 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.53 12.97 7.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.626 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.58 -42.19 2.0 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.718 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 41.3 m -154.5 142.93 20.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 m -75.77 135.59 40.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.64 0.257 . . . . 0.0 110.598 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -81.7 -4.07 55.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.322 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.683 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -70.46 140.57 51.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.709 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 p -74.09 132.81 42.65 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.805 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . 87.34 -5.96 84.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.895 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.683 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 73.4 m -90.11 142.35 27.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.819 0.343 . . . . 0.0 110.677 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 21.2 p -128.74 152.36 48.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 59.2 m -89.37 119.16 29.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.686 0.755 . . . . 0.0 111.656 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.419 HD22 ' HB ' ' A' ' 22' ' ' VAL . 1.8 t30 -88.68 146.85 24.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.278 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -43.29 -28.21 0.31 Allowed 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.623 1.202 . . . . 0.0 113.88 -178.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -86.29 20.91 2.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.545 0.688 . . . . 0.0 109.578 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' ASN . 59.8 ttt180 57.27 40.55 27.75 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.723 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HB ' HD22 ' A' ' 18' ' ' ASN . 61.7 t -117.06 133.74 62.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.371 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' THR . 55.7 m -80.15 124.5 28.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.216 0.532 . . . . 0.0 110.067 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.0 p -125.83 126.11 43.96 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HZ2' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -83.77 -15.49 48.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.201 0.524 . . . . 0.0 109.767 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' HB2' ' HZ2' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -156.3 -154.23 0.47 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.12 -177.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.17 75.93 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.5 m -104.52 150.68 24.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.369 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 t -71.88 -2.35 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.232 0.539 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -52.77 147.34 8.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.866 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.632 -179.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.4 m . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 56.39 33.16 61.49 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.764 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 34.2 tt0 -114.3 166.01 12.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.278 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.69 HG22 HG22 ' A' ' 22' ' ' VAL . 18.7 p -133.03 146.88 52.13 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.328 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -92.62 55.64 2.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.0 pt? -60.76 -34.48 74.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.4 tp -76.47 -19.48 57.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.151 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.31 -31.03 3.37 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.525 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 23.0 m -151.28 152.29 33.0 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.9 m -58.54 144.91 41.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.406 0.622 . . . . 0.0 111.951 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.29 -32.38 24.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.927 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.0 m -91.31 146.67 23.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.3 p -85.24 139.56 31.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.101 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.91 -25.9 17.34 Favored Glycine 0 CA--C 1.505 -0.591 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.516 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 62.9 m -90.74 142.75 27.43 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.862 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.9 p -115.06 150.66 35.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.343 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 9' ' ' THR . 97.1 m -87.46 114.14 23.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.023 0.439 . . . . 0.0 111.166 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.629 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 0.2 OUTLIER -90.9 151.72 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -36.52 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 O-C-N 124.997 1.436 . . . . 0.0 114.844 -177.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 8.4 t80 -82.78 21.25 1.03 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.16 0.505 . . . . 0.0 110.024 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 20' ' ' TYR . 4.5 ptp85 51.31 39.98 25.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.125 1.37 . . . . 0.0 110.165 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.69 HG22 HG22 ' A' ' 4' ' ' THR . 87.5 t -121.48 133.77 66.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.155 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 78.8 m -74.37 124.67 26.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.988 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.3 t -127.64 145.01 51.02 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.498 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -75.4 -36.93 60.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.254 0.549 . . . . 0.0 109.927 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -169.01 -122.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.79 27.57 3.8 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.392 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 30' ' ' LEU . 66.0 m -160.89 131.57 5.31 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.859 0.463 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.5 -11.69 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.296 0.569 . . . . 0.0 110.803 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 28' ' ' SER . 8.2 mp -52.68 155.07 2.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.683 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.574 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.57 -179.182 . . . . . . . . 1 1 . 1 stop_ save_